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Summary 
Catheterization of coronary arteries, shortly denoted by Interventional 
Cardiology (IC) in medicine, is highly appreciated for its non-invasive 
character in comparison to surgery. Both adults and children can benefit of 
the technique, most frequently for diagnosis and/or treatment of Coronary 
Artery Disease (CAD) and Congenital Heart Disease (CHD) respectively. 
Annual numbers of 4 diagnostic Coronary Angiography (CA) procedures 
and 1.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) 
interventions per thousand inhabitants in Europe (2004) are still increasing.  
As investigation of the coronary arteries is performed through dynamic x-
ray imaging the radiation burden to the patient can be important. The 
procedures belong to those involving ‘high doses’ to patients and the effects 
of these possibly high doses were classified by the International Commission 
on Radiation Protection (ICRP) into deterministic (short-term) and stochastic 
(long-term). Regarding short–term effects, the skin is the tissue at greatest 
risk, and skin dose thresholds as low as 2 Gy have been stated by ICRP in its 
report 85 for onset of transient erythema. For long-term effects, it is mostly 
the youngest generation i.e. the paediatric population that is of highest risk. 
Due to their higher radiosensitivity and the longer post-exposure life-time 
expectance, possible radiation induced sequelae are more likely to occur. 
The first part (publication 1) of this dissertation deals with skin doses during 
IC of an adult population in a multicentre setting by a grid of Thermo-
Luminescent Dosimeters (TLD) covering the entire skin dose distribution. In 
3% of the procedures, the Maximum Skin Dose (MSD) exceeded the 
threshold dose of 2 Gy in one single procedure. Action levels in terms of 
Dose-Area Product (DAP), indicating an important probability that MSD has 
the threshold levels of skin exposure, were proposed. National Dose 
Reference Levels (DRL) were put forward for diagnostic and therapeutic 
procedures and serve for comparison of specific hospital data with respect to 
radiation burden to the patient.  
Publications 2 and 3, on the other hand, deal with stochastic effects for the 
considered adult population, submitted to IC. Effective dose (E) was 
 x 
calculated from exposure and geometric parameters, using Monte Carlo 
simulation software (PCXMC). The predicting value of DAP in terms of E, 
was translated into Conversion Factors (CF) that provide a fast and 
straightforward way of E-assessment. The influence of additional copper 
(Cu) filtration was studied and was found to favourably influence DAP and 
E towards lower values.  Fluoroscopy contributions to DAP and risk factors 
for cancer induction were derived.  
Publication 4 studied the radiation burden related to IC on a paediatric 
population, with ages < 10 year. The large variety in body mass and length 
according to age of the population required an individual calculation of E 
using Monte Carlo simulations (MCNP). Risk for cancer induction was 
obtained using the age-dependent life-time risk factors from ICRP 
publication 60 and is demonstrated to be increased with a factor of ten 
compared to the risk for the adult population. Skin doses, on the other hand, 
are a factor hundred smaller, putting the issue of skin injuries at a less 
probabilistic level. Additional Cu filtration with a thickness of 0.2 mm for 
implementation of low-dose fluoroscopy lowered E with 18%. Also within 
this study, DAP values and fluoroscopy contributions to DAP were 
considered. 
The last part of this dissertation (publication 5) comprises a comparative 
study between a conventional Image Intensifier (II) and the recent 
technology of Flat Detectors (FD) for image capture in IC. Both contrast -
detail (CD) measurements for assessment of image quality (IQ) and patient 
dose measurements were performed. Distinction was made between 
fluoroscopy and cinegraphy mode, for analysis of IQ-dose relation. FD 
presented with better and more efficient imaging performance in cinegraphy 
mode for the same entrance exposure rate.  With respect to fluoroscopy 
mode no significant difference was noted. No dose reduction was found in 
daily practice, when using this new imaging technology. 
 xi 
Samenvatting 
Catheterisatie van de kransslagaders wordt als discipline in de geneeskunde  
omschreven als Interventionele Cardiologie (IC) en kent een grote 
appreciatie omwille van zijn niet invasief karakter in vergelijking met 
chirurgische alternatieven. Zowel volwassenen als kinderen kunnen 
genieten van de voordelen van deze techniek, voor de diagnose en/of 
behandeling van ‘kransslagader lijden’ (CAD) en ‘congenitaal hartlijden’ 
(CHD). Statistieken geven een aantal van 4 diagnostische procedures 
(Coronaire Angiografie) (CA) en 1.5 therapeutische procedures (Percutane 
Transluminale Coronaire Angioplastie (PTCA)) per duizend inwoners in 
Europa (2004), per jaar. Deze aantallen nemen nog steeds toe. 
Aangezien onderzoek van de kransslagaders gebeurt onder dynamische 
röntgenstralen beeldvorming, kan de stralingsbelasting van de patiënt 
betrekkelijk oplopen. IC procedures worden geclassificeerd als ‘hoge dosis 
onderzoeken’ en de effecten van deze mogelijk hoge dosissen onderscheiden 
zich volgens de ‘Internationale Commissie voor Stralingsbescherming’ 
(International Commission on Radiation Proctection (ICRP)) in 
deterministische (korte termijn) en stochastische (lange termijn) effecten.  
Met betrekking tot de korte termijn effecten loopt de huid het hoogste risico. 
In rapport 85 stelt de ICRP drempelwaarden voor de huiddosis voorop 
vanaf 2 Gy voor optreden van voorbijgaand erytheem. Wat betreft de lange 
termijn effecten, loopt vnl. de jongste generatie het hoogste risico. Door de 
hogere stralingsgevoeligheid en de grotere levensverwachting na de 
blootstelling aan röntgenstralen, is de kans op stralingsgeïnduceerde 
gevolgen bij deze populatie groter. 
Het eerste deel (publicatie 1) van dit doctoraatsproefschrift onderzoekt in 
verschillende catheterisatie afdelingen de dosis op de huid van volwassen 
patiënten. Hiervoor beslaat een rooster Thermo-Luminescente Detectoren 
(TLDs) de volledige huiddosis distributie. In 3% van de procedures 
overschreed de Maximale Huid Dosis (MSD) de 2 Gy drempelwaarde in een 
enkel onderzoek. Actieniveaus in termen van Dosis Oppervlakte Product 
(DAP) werden vooropgesteld bij een belangrijke waarschijnlijkheid voor 
overschrijden van de drempelwaarden. In deze studie was afleiding van 
 xii 
Nationale Dosis Referentie Niveaus (DRL) voor diagnostische en 
therapeutische procedures mogelijk. Gegevens uit specifieke ziekenhuizen 
met betrekking tot de stralingsbelasting van de patiënt kunnen hiermee 
worden vergeleken.  
Publicaties 2 en 3, nemen voor de beschouwde volwassen populatie de lange 
termijn effecten gerelateerd aan IC onder de loep. Berekening van de 
Effectieve Dosis (E) uit de parameters die de blootstelling en de geometrie 
beschrijven, gebeurde aan de hand van Monte Carlo simulatie software 
(PCXMC). De voorspellende waarde van DAP met betrekking tot E liet 
distillatie van Conversie Factoren (CF) voor snelle en gemakkelijke 
afschatting van deze waarde toe. Onderzoek naar de invloed van extra 
koper filtratie toonde een gunstige verlaging van DAP en E aan. Relatieve 
bijdragen van fluoroscopie tot de totale DAP en risicofactoren voor 
kankerinductie werden beschouwd. 
Publicatie 4 bestudeert de stralingsbelasting van kinderen jonger dan 10 jaar, 
die een IC procedure ondergaan. De grote variatie in lichaamsgewicht en 
lengte per leeftijd in deze populatie vereist een geïndividualiseerde aanpak 
voor E berekening aan de hand van Monte Carlo simulaties (MCNP). 
Risicoschatting voor kankerinductie, gebaseerd op de leeftijdsafhankelijke 
risicofactoren uit ICRP rapport 60, resulteerde in een toename met factor 10, 
vergeleken met de volwassen populatie. De huiddosis waarden zijn voor de 
pediatrische groep echter een factor honderd kleiner, zodat hier de 
problematiek van stralingsgeïnduceerde huidletsels naar de achtergrond 
verschuift. Een extra filtratie uit koper met een dikte van 0.2 mm verlaagde E 
in een lage-dosis-fluoroscopie toepassing met 18 %. Ook in deze studie 
werden DAP waarden en fluoroscopie bijdragen tot DAP beschouwd. 
Het laatste deel van deze verhandeling (publicatie 5) houdt een  
vergelijkende studie in tussen een conventioneel beeldversterker (II) systeem 
en een systeem met vlakke detector (FD), de recente ontwikkeling voor 
beeldvorming in IC. Zowel contrast-detail (CD) metingen voor bepaling van 
beeldkwaliteit (IQ) als patiëntdosis metingen werden uitgevoerd. Bij de 
analyse van de IQ-versus-dosis relatie werd een onderscheid gemaakt tussen 
fluoroscopie en cinegrafie mode. In deze laatste mode oversteeg de recente 
FD technologie de conventionele met een betere en meer efficiënte 
beeldvorming voor een zelfde intrede dosistempo. In fluoroscopie mode 
echter werd geen significant verschil vastgesteld. Een reductie van de 
patiëntdosis bij klinisch gebruik van deze nieuwe techniek kon niet worden 
waargenomen. 
 1 
Chapter  1  
Introduction 
 
1.1 Interventional Cardiology (IC) 
Before the discovery of x-rays by Wilhelm Röntgen in 1895, the only source 
of radiation that human beings were exposed to, was natural radiation.  
Rapidly scientists became aware of the promising applications of x-rays in 
terms of medical imaging. From then on – and still up to now - medical 
applications of x-rays expanded enormously and became the main 
contribution to human’s radiation burden. In 2006, medical applications 
represented 48% of the sources of ionizing radiation for inhabitants of 
Dutch-speaking Belgium (Flanders), being responsible for a dose of 1.92 mSv 
per head [1]. In Belgium, an average of 1.2 x-ray examinations is performed 
per person, per year [1]. Both benefit and risks of the new techniques became 
clear.  Appreciation of the new world to diagnose went hand in hand with a 
growing concern about the hazardous side effects of radiation.  Very soon, 
optimisation of the dose versus diagnostic benefit relation became 
important. 
One of the medical applications involving x-rays and being the research 
domain of this thesis is interventional cardiology (IC).  Imaging and/or 
treatment of the coronary arteries is performed by means of catheterization 
under x-ray guidance.  In 1977 Andreas Gruentzig [2] dared to perform the 
first angioplasty (Percutaneous Transluminal Coronary Angioplasty 
(PTCA)) on a human being (stenosis of the Left Anterior Descending (LAD) 
artery (Figure 1)).  After the first excellent results achieved for this patient 
(and subsequent ones) belief grew and rapid development of new 
catheterization tools occurred.  
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Figure 1. Left: Sternocostal surface of heart. Right: Plan of the branches. The only branches of the 
ascending aorta are the two coronary arteries, which supply the heart; they arise near the 
commencement of the aorta immediately above the attached margins of the semilunar valves. 
(figures 492 and 506 [3]). 
 
The importance of medical applications involving x-rays and especially 
interventional cardiovascular procedures, is reflected by the number and 
time-evolution of the occurrence per inhabitant of a certain population (per 
country or region). Many (governmental) societies keep up with statistics 
about medical procedures.  An overview for Europe and Belgium is given 
below. 
The European Society of Cardiology (ESC) notices in its publication of 1999, 
describing IC in Europe in 1995, an incidence of 1937 coronary 
angiographies (CA) per million inhabitants [4]. The newest data by ECS 
(2004), however, report a total number of 3928  (CA) per million inhabitants, 
revealing a 3.2-fold increase since 1992 [5].  With its 4.06 CA’s and 1.09 
PTCA’s per 1000 inhabitants, a third place for Belgium in the European 
classification was reserved (1995).  A rate of 0.27 PTCA’s per CA was 
reported (1995) [4]. A number of 1553 PTCA’s per million inhabitants in 2004 
constitutes an almost 6-fold increase compared to 1992 in Europe [5].  1350 
stents per million inhabitants were placed in 2004, being a 22% increase 
compared to 2003. The European Society of Cardiology (ECS) reports 2.6 
cardiac catheterization facilities per million inhabitants in Europe in 2004 [5].  
Time-evolution of the number of procedures is given in Figure 2. 
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Figure 2. Number of  IC procedures (CA, PTCA and Stenting) in Europe from 1992 till 2004 (data 
from ESC-report 2007 [5].  
 
Recent data and specific for Belgium are presented in the MIRA-T report 
about ionising radiation (Vlaamse Milieumaatschappij) [1]. Figure 3 shows 
the evolution of the annual figures from 1997 until 2006 of cardiovascular 
imaging procedures in Belgium.  Mean numbers of about 2.5 to 9 procedures 
per 1000 inhabitants (therapeutic and diagnostic respectively) can be read 
from the graph. Latest statistics show a number of more than three 
therapeutic procedures per thousand inhabitants. Data was provided by the 
RIZIV Belgium (Rijksinstituut voor Ziekte- en Invaliditeitsverzekering).  In 
comparison with the ESC publications, lower values were reported.  A 
worldwide gradual increase for both diagnostic and therapeutic procedures 
is the consequence of many advantages of this technique. Mainly the non-
invasive character of the intervention leading to short recovery time, a short 
stay in the hospital and a reduced risk for the patient during treatment of 
narrowed coronaries make it very popular, against the alternative of 
surgery. Indeed, ESC concludes from its data that procedures are performed 
safer now. This is reflected by an unchanged mortality rate of 0.5% since 
1992 and a slightly decreased need for emergency coronary artery bypass 
grafting (CABG) of 0.2%. Specifically for Belgium, diagnostic procedures 
show a regression in the year 2006. This is explained by the MIRA-report by 
an increased use of non-radiation imaging techniques as echography and 
Magnetic Resonance Imaging (MRI). However, this finding was not reported 
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by ECS, on the contrary. An increased performance of cardiac-CT 
procedures needs also to be mentioned. The statistics of the next years will 
show whether this trend will be continued. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Evolution of relative numbers of procedures using x-rays, performed in Belgium. Data 
are taken from MIRA-T report (2007) [1] and form S. Dieltiens [6]. 
 
However, within a larger medical context, the number of IC procedures is 
not that high.  For comparison, Figure 3 also includes the relative number of 
chest radiography and (computed tomography) CT examinations in 
Belgium.  A 10-fold larger occurrence for CT and a 20-fold larger occurrence 
for chest radiography are apparent.  The importance of taking a closer look 
at the IC procedures lies in the fact that they are known as ‘high dose 
procedures’ [7-10].  The guidance of the catheters in fluoroscopy mode and 
image acquisition in cinegraphy mode generates literally thousands of 
images, combined together to video-fragments during one procedure.  This 
way of viewing, diagnosing and treating is inherent to the dynamic 
character of anatomical structures as the heart with its coronaries. 
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1.2 Imaging of the coronary arteries, great vessels 
and heart chambers 
During cardiac catheterization, viewing of the coronary arteries, great 
vessels and heart chambers is performed through x-ray imaging of a 
radiocontrast, injected at the locations of interest. Occlusion, stenosis, 
restenosis, thrombosis or aneurysmal enlargement of the coronary artery 
lumens can be visualised. Heart chamber size; heart muscle contraction 
performance; perfusion problems e.g. through septal defects and some 
aspects of heart valve function can be recognized during the test. Several 
internal heart and lung blood pressures, not measurable from outside the 
body, can be accurately measured. Most frequently, the main focus of heart 
catheterization with adults is visualization and treatment of atherosclerosis 
(paragraph 1.3). To a lesser extend, valvular, heart muscle, or arrhythmia 
issues are of primary interest. With children, treatment of Congenital Heart 
Diseases (CHD) is the major goal (paragraph 1.3). 
The use of catheters became practically feasibly when Dr. Sven-Ivar 
Seldinger introduced in 1953 a new technique to access hollow organs in a 
safe way [11]. First, a sharp needle is introduced in the artery, mostly arteria 
femoralis or arteria brachialis for IC. Following, a round-tipped guidewire 
passes through the needle. After withdrawal of the needle, a “sheath” or 
blunt cannula is passed over the guidewire into the vessel.  Finally a catheter 
of typically ~2.0 mm (6-French) in diameter with a new guidewire inside 
(different shape at the top end) accesses the artery through the sheath.  A 
next step in an IC procedure consists in moving guidewire and catheter up 
to the aorta and the right and left coronary arteries for injection of 
radiocontrast.  Differences in attenuation characteristics of tissue, 
radiocontrast and used devices make visualization by x-rays possible.  
Two modes of x-ray imaging, named fluoroscopy and cinegraphy, are used 
during IC.  Guiding of guidewires and catheters to the desired location and 
confirmation of their position is performed under fluoroscopy. Normally 
brief looks provide the practitioner with sufficient information. As no 
images in this mode are stored nor are of purpose to diagnose, a lower dose 
and correspondingly lower image quality are allowed. X-ray tube current in 
this mode ranges from 50 to 150 mA for adult patients and from 4 to 18 mA 
for paediatric patients. Pulse rates of 12.5 frames/s are mostly used. 
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Figure 4. Monoplane x-ray system for IC. The x-ray source is mounted at the bottom, the IR is 
located at the top [12]. 
In contrary with fluoroscopy mode, cinegraphy mode is used for a diagnosis 
to be made. Injection of blood compatible radiocontrast (typically 3-8 cc) 
visualizes the coronaries, heart chambers or great vessels for 3-5 seconds, 
before it is washed away into (coronary) capillaries. Details of internal 
coronary structure or the heart chambers (by examination of the blood flow) 
are discernible. Video fragments at a higher dose rate with higher image 
quality are saved in patient’s record. Typical pulse rate numbers for adult 
catheterisation are 12.5 to 30 frames per second, combined with tube current 
values of 200 till 900 mA. During paediatric catheterisation, up to 50 frames 
per second are necessary due to higher heart rates. Tube current values vary 
around 300 mA. 
The setup in the cardiac catheterization laboratory consists of a rotational C-
arm system where the x-ray tube is mounted in an under-couch 
configuration (Figure 4). The other end of the configuration contains the 
image receptor (IR), i.e. a conventional image intensifier (II) or a flat detector 
(FD).  Sometimes two C-arm systems are installed together in 
‘perpendicular’ configuration in order to have two different views with one 
injection of radiocontrast.  This configuration is called biplane; the former is 
called monoplane. The center of the photon beam coincides with the center 
of the IR. The point round which the configuration rotates is called the 
isocentre of the system. The heart is considered as being located in the 
isocentre of the system. 
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Figure 5. Geometrical indications in IC: caudal and cranial angles in saggital plane and RAO and 
LAO angles in transverse plane. 
Geometry of the tube and IR relative to the patient during an intervention is 
described by angles in two planes through the patient. The sagital plane 
includes the length-axis of the patient and the transverse plane is 
perpendicular to the length-axis of the patient (Figure 5). The angles indicate 
the position of the IR relative to the patient.  The reference system is 
considered as fixed to the patient with the origin in the heart. The number of 
degrees that the IR inclines right or left in the coronal plane is indicated 
respectively by RAO or LAO (Richt/Left Anterior Oblique), whereas the 
number of degrees that de IR inclines in the sagital plane towards head or 
feet of the patient is indicated respectively with cranial (CRAN) or caudal 
(CAUD). Two frequent used projections receive special names. RAO0- 
CRAN0 is the anterior-posterior (AP) projection and LAO90-CRAN0 is the 
lateral (LAT) projection. 
As so far, diagnostic procedures as coronary angiography (CA) (Figure 6) 
with or without additive ventriculography or investigation of the great 
vessels and heart chambers due to CHD are described.  However, by 
changing the diagnostic catheter into a guiding catheter, a variety of 
instruments can be moved up to a lesion in a vessel. In this way, 
endoluminal, therapeutic procedures such as angioplasty (reshaping of a 
vessel) or closing of an Atrial Septal Defect (ASD) (see paragraph 1.3) can be 
performed.  
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Figure 6 a, b and c. x-ray images of adult coronary arteries, taken during coronary catheterization. 
Parts 6a. and 6b. represent the left coronary artery (LCA) with the circumflex. The tube geometry 
for 6a was RAO 0, CRAN 10. Geometry for 6b. was RAO 0; CAUD 20 . 6c represents the right 
coronary artery with side branches (geometry LAO 90, CAUD 0). 
The most commonly performed procedure is balloon dilatation.  A balloon 
of specific length is folded around the tip of a catheter and brought as such 
through a luminal or valvular stenotic area.  Expansion of the balloon, due 
to radiocontrast filling, widens the narrowed passage. The hydraulic 
pressure applied within the balloon may extend to as high as 2500 kPa. (For 
comparison: normal coronary artery pressures are within the 27 kPa range = 
200 mmHg).  The expanding process is followed under fluoroscopy and as 
much hydraulic pressure and duration of the inflation is applied as judged 
needed. With children, the size of the devices needs to be much smaller. 
When a large balloon is needed for a child (e.g. for opening a pulmonary 
valve), 2 balloon devices will be introduced. Whilst one will take the arterial 
way, the other will pass through the venous way to meet at the pulmonary 
valve (figure 7). 
Additionally, several other devices can be introduced into the artery via a 
guiding catheter. These include stent catheters, IVUS (Intravascular 
Ultrasound) catheters, Doppler catheter, pressure or temperature 
measurement catheter and various grinding devices.  Of all these devices, 
stents are the most popular ones. These are specially manufactured 
expandable stainless steel mesh tubes, mounted on a balloon catheter.  By 
inflation of the balloon, the stent is expanded, widening and stiffening the 
coronary.  Recent developments resulted in drug eluting stents, allowing a 
protracted delivery of drugs in order to avoid early restenosis. Different 
especially designed occluder devices similar to stents exist for treatment of 
CHD  (e.g. ASD) in paediatric patients (paragraph 1.3). 
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Figure 7. Balloon dilatation of a pulmonary valve of a child. Use was made of two balloons. A 
notch is still visible corresponding to the stenotic area of the valve. The balloon had to be 
inflated further to widen the narrowing. 
Whereas for adults the main points of interest are the coronary arteries, 
these are the heart chambers and the great vessels with children. This makes 
that proportionally more contrast is needed in children (mean: 3.4 ml/kg, 
range: 3 to 6 ml/kg) than in adults (mean 2.4 ml/kg, max: 4 ml/kg). 
Moreover, higher heart beats with children result in the contrast medium 
washing away faster than with adults. Mean values of 185 ml for the amount 
of contrast used, and of 78 kg for weight were obtained for the adult 
population followed in this work (irrespective whether the procedure is 
diagnostic or therapeutic).  Values of 40 ml and 11.7 kg were obtained for the 
paediatric population. With respect allergic reactions, the amount of contrast 
used is a very important and defining parameter. 
1.3 Patient population and indication for IC 
Within IC, the patient population consists mainly of two groups according to 
age and with different indications: children and adults. Although this 
partition is a broad notion, the difference in age is very pronounced 
especially as it pertains to young children (mean age around 4y [13-15]) and 
elderly people (mean age 63 y [16-18]).  Indications for IC in these two groups 
are very different.  IC in adults mainly comprises treatment of Coronary 
Artery Disease (CAD), whereas for children treatment of Congenital Heart 
Diseases (CHD) dominates. 
CAD is the narrowing or blockage of the coronaries, with reduced blood 
flow and thus preventing oxygen and nutrients to reach the heart.  As the 
heart is a continuously working muscle, these elements are of capital need. 
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Decrease in supply, mainly of oxygen, will cause the muscle to cramp. This 
situation is called “ischemia” and mostly occurs during exertion (activity), 
eating, excitement or stress, entailing extra oxygen for the heart.  Ischemia – 
usually noticed by the patient as chest pain – can be relieved in less than 10 
minutes with rest or medications but CAD can progress to a point where 
ischemia lasts, even at rest. 
Typically, CAD occurs when the elastic lining inside a coronary artery 
develops atherosclerosis.  Fatty deposits and inflammatory cells form an 
atheromatous plaque that hardens and narrows the artery’s lining. The 
plaques initially expand into the walls of the arteries, but with progression 
they expand into the lumen of the vessel, affecting the flow of blood through 
the arteries. 
In an advanced stage of CAD, Acute Myocardial Infarction (AMI or MI), more 
commonly known as a heart attack, can occur.  If oxygen shortage is left 
untreated for a sufficient period, damage and/or death of the heart tissue 
can result. Chest pain (eventually extended to the left arm and throat), 
shortness of breath, palpitations, sweating, nausea, vomiting and anxiety are 
typical symptoms of MI.  The most common triggering event is the 
disruption of an atherosclerotic plaque in an epicardial coronary artery, 
leading to obstruction or sometimes-total occlusion of an artery. Myocardial 
infarction is the leading cause of death for both men and women all over the 
world [19]. 
There are many risk factors which are associated with (but are not all causes 
of) various forms of cardiovascular disease. These include: 
• Genetic factors/Family history of cardiovascular disease 
• Age (CAD incidence increase with age) 
• Gender (men present a higher incidence of CAD than women) [20] 
• Smoking  
• Excessive alcohol consumption 
• High LDL (low-density lipoprotein, "bad cholesterol") and low HDL 
(high density lipoprotein, "good cholesterol"),  
• Insulin resistance & Diabetes mellitus  
• High blood pressure 
• Obesity  
• Chronic high stress levels  
• Elevated heart rate [21] 
• Physical inactivity 
• Medication nonadherence, that is, neglecting or refusing to take 
prescribed drugs [22] 
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If pre-test likelihood for CAD is considerable, a diagnostic coronary 
angiography (CA) on the IC-department can be advised, with immediate 
treatment of the culprit lesion if necessary. As was described in paragraph 
1.2, different devices are used for treatment. The most common are 
dilatation balloons for PTCA (percutaneous transluminal coronary 
angioplasty) and stents for ad-hoc stenting or stenting after PTCA (Figure 8). 
 
 
 
 
 
 
Figure 8. Shematic representation of balloon dilatation and stenting of coronary artery. 
[http://www.georgetownuniversityhospital.org] 
 
Percutaneous treatment of other diseases as narrowed cardiac valves, 
arrhythmias, CHD (e.g. Atrial Septal Defect (ASD)) in adults or removal of 
thrombus (blood clot) is possible.  Respectively valvuloplasty, 
electrophysiology, ASD-occlusion by Amplatzer Septal occluder and 
coronary thrombectomy are not described here. Information about 
percutaneous treatment of many other heart and/or coronary diseases can 
be found in specialised literature. 
When considering the paediatric patient population, CHD is the most 
frequent indication for IC. CHD occurs when the heart or blood vessels next 
to the heart are not developed properly before birth, or when the necessary 
structural changes in blood flow immediately after birth do not take place. 
These structural defects lead to arrhythmias and malfunction of the heart 
muscles. CHD is mostly detected in newborns; however, sometimes this is 
eventually noticed in adulthood. Stenosis or obstruction of heart-related 
vessels or a defect in atrial or ventricular septum cause abnormal and 
suboptimal conditions for the heart making it work harder and/or beat 
faster. 
Two specific forms of CHD, namely Atrial Septal Defect (ASD) and Patent 
Ductus Arteriosus (PDA) are described briefly here. 
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Atrial Septal Defect (ASD) is a specification of CHD related to a hole (foramen 
ovale) in the septum, i.e. the division between right and left atria. With 
septum deficiency, blood may flow from the left side of the heart to the right 
side, or vice versa, resulting in the mixing of arterial and venous blood. 
During development of the foetus, the foramen ovale remains open, to allow 
blood from the venous system to bypass the lungs (oxygenation is provided 
through the placenta) and enter directly in the circulatory system. When the 
septum does not entirely seal after birth, the foramen ovale is considered as 
patent foramen ovale. If necessary, percutaneous closure of ASD or patent 
foramen is possible. Numerous closure devices are available. The most 
popular for ASD closure is the Amplatzer Septal Occluder consisting of two 
self-expandable round discs connected to each other with a 4-mm waist, 
made of a wire mesh filled with Dacron fabric (Figure 9). Percutaneous 
closure is the preferred method of treatment, if the anatomy of the defect is 
suitable, due to minimal invasiveness of the method [23, 24]. The alternative 
treatment is surgical closure and involves opening up at least one atrium 
and closing the defect with a patch under direct visualization during cardiac 
bypass. 
Patent ductus arteriosus (PDA) is another type of CHD wherein a child's 
ductus arteriosus fails to close after birth. This opening connects pulmonary 
artery and aortic arch of the developing foetus, to protect the right ventricle 
to pump against the foetus’ fluid-filled compressed lungs. Normally, within 
12-24 hours after birth, the ductus arteriosus is closed, with complete sealing 
after 3 weeks. Symptoms in the first year of life include difficult breathing 
and poor weight gain.  If left uncorrected a patent ductus can lead to 
congestive heart failure in later childhood or adulthood. 
 
Figure 9. Amplatzer Septal Occluder for closure of Atrial Septal Defect. 
[http://www.stronghealth.com] 
 
PDA can be treated with both surgical and non-surgical methods. PDA 
devices, specially designed , yield satisfactory results [24].  
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A number of other CHD-types can be treated percutaneously. Aortic 
coarctation, stenosis of pulmonary artery branches, pulmonary and aortic 
valve stenosis are few of them.  Isolated diagnostic procedures become 
rather rare in paediatric patients, as other tools as echocardiography and 
magnetic resonance provide sufficient data for complete diagnosis of most 
CHD. 
1.4 Assessment of patient dose and image quality 
Several quantities describing patient dose from radiation exposures have 
been defined by the  International Commission on Radiation Protection 
(ICRP), in its report 60 [8] and by the International Commission on Radiation 
Units and Measurements (ICRU), in its report 33 [25], and more recently 
(2005) in its Report 74 [9]. The fundamental quantities (Report 33) are based 
on measures of the energy deposited in organs and tissues of the human 
body. Often, these variables are not directly measurable and therefore 
operational quantities are used for the assessment of “dose”.  Two main 
quantities will be described here shortly.  
Absorbed dose is the basic quantity used in different radiation related medical 
fields as radiation biology, radiotherapy, radiology, and nuclear medicine. It 
is defined as the quotient of mean energy imparted by ionising radiation in a 
volume element and the mass of matter in this volume.  Its unit is Gray (Gy). 
With respect to skin and underlying dermis, the absorbed dose is related 
with the direct pathological effects of radiation.  Thus, if short-term effects 
are considered to be a possibility, the absorbed dose to the more heavily 
radiated regions at the surface of the body is the radiation quantity of 
interest. 
Effective dose E is a quantity designed to describe the ‘amount’ of exposure 
quantitatively related to the probability of late radiation induced effects in 
human bodies. This probability is assumed to be related to the average 
absorbed dose in an organ and strongly depends on the type of organ or 
tissue and the type of radiation. Thus, the detriment of lethal cancer 
induction is assumed the summed products of weighted organ doses DR,T 
(weighting factors: wR and wT). The tissue weighting factors wT represent the 
relative contribution of that specific organ or tissue to the total detriment 
due to radiation effects resulting from uniform irradiation of the whole 
body. This implies that the sum of the tissue weighting factors is normalized 
to unity. Detailed description of the tissue weighting factors wT can be found 
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in paragraph 1.5.1.  The radiation weighting factors wR represent the relative 
biological effectiveness of the radiation.  The unit of E is Sievert (Sv). 
∑ ∑=
T
RT
R
RT DwwE ,  
A practical quantity for measurement of the output of an x-ray tube, giving 
an indication of the absorbed dose is dose-area product (DAP). It is the 
product of dose to air (air kerma) and the area of the x-ray beam, in units of 
Gycm2.  A flat large-area ionization chamber is mounted at the exit window 
of the x-ray tube and intercepts the entire useful beam (irrespective of 
collimation).  The use of a DAP-meter provides a complete measurement of 
the total exposure of the patient and hence to be closely related to the 
radiation risk. The reasoning is that this risk is considered as depending 
both on the extent of the irradiated volume within the patient and the 
exposure at the centre of the x-ray beam (point-measurement with small 
ionisation chamber).  A practical advantage regarding positioning of this 
measurement instrument is inherent at the concept of DAP (Figure 10). The 
product of both quantities is approximately invariable for all planes 
perpendicular to the beam axis between collimators and the patient.   
 
 
 
 
 
 
 
 
 
 
Figure 10. Schematic overview of the principle of DAP. Due to relative proportionality and 
inverse proportionality of the squared distance for area and dose, the product remains constant. 
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If properly calibrated against a reference or standard dosimeter, the DAP-
meter can serve as a monitor of imparted energy in the patient. In 
combination with procedure parameters, dose values from phantom 
measurements or computer simulations, its value can lead to different useful 
and practical radiation and risk related quantities. 
To this end, Monte Carlo simulation code can be used. Monte Carlo codes 
enable researchers to calculate organ doses normalized to easily measurable 
quantities such as DAP. Different examples of radiation transport codes are 
PCXMC [26] and  MCNP [27],  both used in this work for E calculation. 
Registration of the absorbed dose to the skin and more specifically the 
Maximum Skin Dose (MSD) in IC, can only be guaranteed by entire coverage 
of the whole patient’s thorax by a suitable dosimeters (Figure 11). Three-
dimensional rotation of the C-arm equipment result in a dose, spread over 
almost the entire thorax of the patient. Appropriate measuring devices are 
radiographic film and Thermo Luminescence Dosimeters (TLDs), both 
calibrated to the right dose conversion. Due to their characteristics, they do 
not appear on clinical images.  Positioning of film under patient’s back 
implies missing of the radiation field at the lateral side.  Therefore, a grid of 
TLDs attached equidistantly at patient’s thorax, provides reconstruction of 
the complete skin dose distribution and is thus a better solution. 
Unfortunately, this implies a high workload. Some alternatives have been 
stated, combining film and TLDs with predicting methods for the location 
where the highest dose might be located [28, 29]. However, this is a rather 
speculative method especially for individual patient measurements. 
Anatomical structures and location of the lesion influence largely the 
irradiation geometry during each individual procedure. 
 
 
 
 
 
 
 
Figure 11.  Wrap-around (paragraph 3.1) with grid for TLDs (a) and the positioning of the wrap-
arounds (b) to cover entire skin dose distribution. 
 16 
Image quality and dose are directly related quantities in x-ray imaging, since 
both are influenced by combinations of tube voltage, filtration and tube 
current.  Assessment of IQ is a complex issue, because the quality of a 
medical x-ray image is assumed to be  task dependent.  This means that an 
image should be judged satisfactory to accomplish the clinical task. The next 
step is to consider whether the dose to the subject can be reduced, 
preserving the same or optimal ‘task dependent IQ’.  
There are a number of ways quantifying the quality of x-ray images, all with 
their specific advantages and emphasises.  The most mathematical way of 
analysing an image is the determination of physical parameters such as 
Modulation Transfer Function (MTF), Contrast to Noise Ration (CNR), 
Noise Power Spectrum (NPS) describing spatial resolution, contrast and 
noise. These parameters are required for any objective determination of 
system performance, but they are largely ‘task independent’. They do not 
provide any definitive way of ranking systems but they serve as the basic 
means of system IQ specification.  Detective Quantum Efficiency (DQE) 
describes mathematically the efficiency by which an imaging system 
transfers absorbed x-ray energy into useful information.   
2
2
in
out
SNR
SNR
DQE =  
DQE combines Signal to Noise Ratio (SNR) at input and output of the 
system and is plotted as a function of spatial frequency. It depends on x-ray 
spectrum, radiation dose and the detector medium. It is regarded as the 
most covering indicator for imaging performance but measurement is 
unfortunately rather unpractical and sensitive to setup [12, 30-32].  
Besides determination of physical parameters, a psychophysical approach can 
be considered. These subjective methods – ‘subjective’ meaning involvement 
of human observers – have the advantage that clinical utility can be assessed 
more directly. Receiver Operating Characteristic (ROC) methods and 
Multiple Alternative Forced Choice (MAFC) methods are examples. In ROC, 
images from actual clinical cases, phantoms or computer simulations are 
presented with or without a known target. The observer is asked to grade on 
a predefined scale his/her degree of certainty that the target is present. The 
graded response methodology approaches clinical practice where a 
radiologist also scores lesions as apparent by a certain level of confidence.  
MAFC methods use phantom images with a certain signal located at one of 
M alternative positions with equal probability of occupation. The other M-1 
locations only contain noise. The observer is asked to score the location of 
the signal. Forced choice methods are often combined with contrast-detail 
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(CD) methods. CD diagrams depict the borders of detectability represented 
by the minimum detectable contrast of an image signal as a function of its 
diameter.   
 
 
 
 
 
 
 
 
Figure 12. Digital Acquisition (right) of the CDRAD 2.0 phantom (left). The CDRAD 2.0 
phantom consists of a PMMA plate ( 265 x 265x10 mm) with an array (15x15) of 225 square cell 
regions in  which circular holes are drilled. For each column the and for each row diameter and 
respectively depth vary logarithmically from 8.0 to 0.3. For a diameter < 4.0 mm 4AFC method is 
to be applied [33]. 
MAFC CD studies allow assessment of the imaging chain as a whole, with 
image formation (through data acquisition), image processing and display 
integrated.  This relatively fast technique lends itself to take images in busy 
clinical departments, demanding minimum clinical downtime.  Due to the 
known target position of the phantom and the correction scheme after 
scoring, 4AFC provides a more objective IQ measure. The involvement of 
human observers, however, demands a sufficient number of them for 
averaging purposes [34]. In this work the preferred method for IQ 
assessment was 4AFC method with the CDRAD 2.0 CD phantom (Figure 12) 
[33].   
The third and last method for image quality assessment is the use of clinical 
patient data.  Although scoring of these images best approaches clinical 
practice, huge databases for optimal statistics and ethical considerations 
(Can I image the same patient on two different modalities, without clinical 
indication or relevance of the second imaging procedure?) are necessary 
making this method very time consuming and difficult in practice. 
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1.5 Radiation risks related to IC 
Biologic effects of radiation exposure can be classified as either stochastic or 
deterministic. For stochastic effects, the probability, not the severity, increases 
with dose. Both radiation-induced cancer and heritable effects are included 
in stochastic effects.  In case of higher exposure, deterministic effects may 
occur, resulting mainly from killing many cells in the exposed tissue, such 
that the tissue function is decreased. A threshold dose below no effect is seen 
exists and from there on, incidence and severity of the injury increases with 
dose. Skin lesions, erythema, fibrosis and haematopoietic damage are typical 
deterministic effects. 
 
1.5.1 Stochastic Effects 
Cancer induction is the most important effect of radiation to consider at dose 
levels below 1 Gy. It results as chemical changes at the atomic and molecular 
level of e.g. a biological macromolecule as DNA. Most of the available 
experimental and epidemiological data support the assumption that the 
induction of tumors is a probabilistic (therefore stochastic) function of 
radiation dose [8, 35, 36]. An increase in the dose is assumed to increase the 
probability of the effect but to have little or no influence on its severity. No 
threshold is assumed for cancer induction and even a small dose of radiation 
is assumed to increase the risk of radiation-induced cancers.  
Table 1. Estimates of Mean Latent periods for various tumors following external radiation [38]. 
Tumor type Mean Latent 
Period (y) 
Thyroid 20 
Breast 22 
Lung 25 
Stomach 14 
Colon 26 
Bone 10-15 
Leukaemia 7-10 
Skin 24 
 
Between exposure to radiation and clinical appearance of a cancer there is a 
certain time span. The mean latent period for solid tumors is approximately 
20 to 30 years (Table 1). Data are available from epidemiological studies and 
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long-term follow-up of atomic bomb survivors. UNSCEAR (1994) 
recommends that ‘for risk assessment purposes, most solid tumors should 
be assumed to have a latent period of at least 10 year, since risks, if any, 
before that time are extremely small’ [37].   
Within risk calculation for radiological protection, E is developed to be a 
quantity, describing possible stochastic effects in the public. The concept of 
E, associated with a given exposure, involves weighting of individual organs 
and tissues of interest by the relative detriments for these parts of the body. 
Derivation of the organs at interest themselves, and more specifically their 
radiation detriment is complex, and is mainly based on incidence and 
mortality data for cancers from the studies of the Japanese atomic bomb 
survivors (LSS-study).  Table 2 represents the outcome of these nominal risk 
and detriment calculations, as performed in report 103 of the ICRP. The sum 
of the tissue detriments at the bottom of the third column represents the 
total detriment due to radiation and is estimated to be 5.7 10-2/Sv. In the 
former report 60 of the ICRP, this value was estimated to be 7.3 10-2/Sv. The 
difference is explained by novel understanding in incidence and risks for 
heritable effects. 
Table 2. Summary of sex-averaged nominal risk and detriment for the whole population. Taken 
from ICRP publication 103 [39]. 
Tissue 
Nominal Risk 
Coeff. 
(cases per 10 000 
Persons per Sv) 
Detriment 
(relating to 
column 1) 
Relative 
Detriment 
Oesophagus 15 13.1 0.023 
Stomach 79 67.7 0.118 
Colon 65 47.9 0.083 
Liver 30 26.6 0.046 
Lung 114 90.3 0.157 
Bone 7 5.1 0.009 
Skin 1000 4.0 0.007 
Breast 112 79.8 0.139 
Ovary 11 9.9 0.017 
Bladder 43 16.7 0.029 
Thyroid 33 12.7 0.022 
Bone Marrow 42 61.5 0.107 
Other Solid 144 113.5 0.198 
Gonads (heritable) 20 25.4 0.044 
Total 1715 574 1.000 
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Total radiation detriments for cancer induction, heritable effects and the 
total of these two in comparison of the two ICRP reports 60 (1990) and 103 
(2007) can be found in Table 3. The most significant change from ICRP 60 is 
the 6-8 fold reduction in the total detriment (nominal risk coefficients) for 
heritable effects. However, given the uncertainties, the ICRP considers the 
small difference in the estimate of nominal risk since 1990 of no practical 
significance. The approximated overall fatal risk coefficient of 5% per Sievert 
on which current international radiation safety standards are based, 
continues to be appropriate for the purposes of radiological protection. 
 
Table 3. Detriment-adjusted nominal risk coefficients (10-2 Sv-1) for stochastic effects after 
exposure to radiation at low dose. Taken from ICRP 103 [39]. 
Cancer  Heritable effects  Total Exposed  
population ICRP103 ICRP60  ICRP103 ICRP60  ICRP103 ICRP60 
         
Whole 5.5 6.0  0.2 1.3  5.7 7.3 
Adult 4.1 4.8  0.1 0.8  4.2 5.6 
 
Now, for derivation of the tissue weighting factors wT, the relative detriment 
(last column, Table 2) is considered.  Due to inherent uncertainties 
associated with their estimation, the relative radiation detriments are 
grouped into four categories and the relative detriment is translated into 
rounded weighted factors. Table 4 represents these four groups with their 
assigned weighted factors. Changes between the ICRP reports 60 and 103 are 
clear. New information of the LSS study (follow-up until 1998) (Preston et al. 
2007) [40] and a revised approach in calculation of radiation detriment 
associated with both cancer and heritable effects (gonads) explains 
adaptation of the factors. The current estimate (ICRP 103) is based on 
lethality/life-impairment-weighted data on cancer incidence, with 
adjustment for relative life lost. The tissue weighting factors are sex-
averaged and are for the assessment of E for workers as well as members of 
the public, including children. 
The most important differences with ICRP 60 comprise the following: 
• The detriments for heritable effects and cancer following gonadal 
irradiation were aggregated to give a wT of 0.08, which is only 40% of 
the estimated value in ICRP 60. This is due to the fact that genetic 
damage sustained by germ cells of individuals who are beyond the 
reproductive period, or who are not procreating for any reason, poses 
no risk.  
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Table 4. ICRP Recommendations for tissue weighting factors in Publication 60 (1990) [8] and 
Publication 103 (2007) [39].  
ICRP Publication 60 (1990)  ICRP Publication 103 (2007) 
Tissue Tissue weighting  
factor, wT 
 Tissue Tissue weighting  
factor, wT 
Lung  
Stomach 
Colon 
Bone Marrow 
 
0.12 
 Lung  
Stomach 
Colon 
Bone Marrow 
Breast 
Remainder 
0.12 
Gonads 0.20  Gonads 0.08 
Thyroid 
Oesophagus 
Bladder 
Liver 
Breast 
Remainder 
0.05 
 Thyroid 
Oesophagus 
Bladder 
Liver 
0.04 
Bone surface 
Skin 
0.01 
 Bone surface 
Skin 
Brain 
Salivary Glands 
0.01 
 
• wT for breast tissue changed from 0.05 to 0.12 due to raised risk 
estimates for breast cancer in incidence analysis of the extended data 
in the LSS study. Those exposed as juveniles in the LSS cohort now 
make a larger contribution to the overall breast cancer risk. This 
implies that E for women that have been submitted to an IC 
procedure, will now be remarkably higher. An increase of 5% to 20% 
was estimated by  Einstein et al. [41]. 
• The ‘remainder tissue’-group previously comprising 10 tissues 
(adrenals, brain, upper large intestine, small intestine, kidneys, 
muscle, pancreas, spleen, thymus, uterus) includes now 14 tissues ((13 
in each sex): adrenals, extrathoracic tissue (ET), gall bladder, heart, 
kidneys, lymphatic nodes, muscle, oral mucosa, pancreas, prostate (♂), 
small intestine (SI), spleen, thymus, uterus/cervix (♀)).  The weighting 
factor is increased from 0.05 to 0.12. The reason again is the extended 
data from different studies and exclusion of mass-weighting of the 
tissues in the remainder fraction. (In Publication 60, wT for the 
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remainder was divided among the five remainder tissues which 
receive the highest dose, implying a non-additive system). 
• Salivary glands and brain are considered separately and weighting 
factors of 0.01 are assigned. Their cancer risk is now judged to be 
greater than that of other tissues in the remainder fraction. 
Thus, from Table 4 one roughly derives that the relative contribution of bone 
marrow to the total detriment resulting from a uniform irradiation of the 
whole body is estimated to be 12%, reflecting the relative high 
radiosensitivity of this tissue. This is also the case for colon, stomach, lung 
and breast. 
With respect to age dependency of total radiation risk, Figure 13 shows the 
attributable life–time risk in % per Sievert versus the age at time of exposure 
as derived in the 1990 Recommendations of the ICRP 60 [8]. 
A gender dependency is clear from this figure. Females have been 
considered more likely to develop radiation-induced cancers than males, for 
all cancers except for leukaemia and especially for breast and thyroid 
cancers.  The sex difference may be due to interactions between other factors 
such as hormone dependent promoting factors rather than a difference in 
radiation sensitivity [39]. 
A more explicit dependency exists with respect to age.  Paediatric patients 
are more susceptible to radiation-induced cancers than adults are. This is 
explained by the fact that radiation sensitivity is related to the rate of cell 
division, in accordance with the law of Bergonié and Tribondeau (1906). 
During their research on cells and their characteristics affecting 
radiosensitivity, they formulated their law. “Radiosensitivity is greatest for 
those cells that (a) have a high mitotic rate, (b) have a long mitotic future, and (c) 
are undifferentiated.”  In other words, actively proliferating cells with a high 
turnover rate and long mitotic periods but that are poorly differentiated (e.g. 
stem cells in red bone marrow) are very radiosensitive [12, 38]. Children 
have a wider and increased cellular distribution of red bone marrow, that is 
far most located at the upper part of the body [42-44]. A second reason is 
that the post-exposure life expectance for children is larger than for adults, 
as they have their entire lives in front of them. 
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Figure 13. Comparison of attributable life-time risk versus age data form ICRP 60 [8] and the 
findings published by Preston et al. [45]. The curves reported by Preston et al. represent 
estimates for LSS (Life Span Study) life-time solid cancer mortality risk for a 1 Sv exposure. Note 
that life-time mortality risk for leukaemia, other haematopoietic tumors or hereditary effects is 
not included, contrary to the ICRP 60 data. For derivation of the ICRP60-curve, a DDREF of 2 
was applied. 
Figure 13 also documents on the estimates arising from recent data from the 
A-bomb survivors (1950-1997 Preston et al. [45]). It has to be stressed that the 
radiation related solid cancer mortality risk in the latter study was 
determined from people exposed to acute doses of about 200 mSv or more. 
However, in radiation protection, mostly risks from continuous exposures or 
fractionated exposures with acute fractions of a few mSv or less are 
involved. Experimental investigations tend to show that fractionation or 
protraction of dose is associated with reduced risk.  Thus, to obtain values 
applicable for low doses and low dose rates from dose specific estimates 
based on high-dose, acute exposure data (as that form A-bomb survivors), 
ICRP suggests division by a DDREF (Dose and Dose Rate Effectiveness 
Factor). The magnitude of DDREF is assumed to be 2, as a broad whole 
number judgement for practical purposes of radiological protection and 
comprising elements of uncertainty. With respect to Figure 13, application of 
a DDREF of 2 to the data from Preston et al.  yields the curve used in ICRP 
60. 
 When considering IC, paediatric procedures may even last longer than 
interventions on adults.  Higher heart rates, smaller cardiovascular 
structures and smaller body size are specific additional difficulties related to 
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paediatric IC, requiring higher frame rates and magnification modes to be 
used.  A wider variety of unusual anatomic variants implies the potential 
need for relatively lengthy and complex procedures. Some of the tissues 
sensitive to radiation (the eyes, the gonads and the thyroid) are significantly 
closer to the heart in young children than in adults.  This places them closer 
to scattered rays and to the primary beam [46]. Moreover, due the increased 
survival of children with complex heart-anatomy, frequent catheterizations 
within the first few years for treatment of chronic cardiac disease are needed 
[47]. 
Compared to children, radiosensitivity and post-exposure life-time 
expectance for adults is lower. Based on these two most important facts, 
possible induction of radiation induced injuries e.g. for a population with 
mean age of 65 years (paragraph 3.1, publication 1) is relatively low. 
However, even with adults care should be taken in view of the high doses of 
IC, especially when they are relatively young (age 30-40 years).  
The UNSCEAR 2000 report [36] indicates an average value of 7.3 mSv for E 
for interventional procedures in health care level I countries. Multi-slice 
spiral computed tomography of the chest and the abdomen/pelvis induces 
similar doses of 5.7 mSv and 14.4 mSv respectively [48]. UNSCEAR reported 
an average dose for a diagnostic CT-exam (data 1991-1996) of 8.8 mSv [49]. 
The average E for a PTCA intervention reported in the UNSCEAR 2000 
report is 22 mSv, while individual patient data range from 7.5 up to 57 mSv 
in the study of Neofotistou [50]. Because of this, coronary angiography is 
among the medical applications of diagnostic x-rays with a high patient 
radiation burden.  
 
1.5.2 Deterministic Effects 
For all deterministic effects, cell killing is the central issue. The main direct 
effects to the skin result through damage to proliferating cells at the basal 
layer of the epidermis.   The epidermis is the upper layer of the skin and 
serves as the first barrier of the human body against the environment. The 
underlying layer is called the dermis. Renewal of the skin by migration of 
new cells from basal layer to the top of the epidermis, takes about 14 days to 
1 month. The time course of expression of radiation injury to the skin and 
restoration of tissue components generally depends on this normal rate of 
renewal, and is dose dependent at low doses but not at high doses. The 
upper part of the dermis – itself consisting of two layers: superficial 
papillary dermis and deeper thicker reticular dermis- is highly vascularised. 
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Approximately 90% of the blood flow is concerned with temperature 
regulation.  Nutritional aspects of blood flow are also important.  Hair 
follicles are embedded in the lower part of the dermis [38, 51, 52].  
The response of the skin to high levels of ionizing radiation follows a typical 
pattern.  The severity and the time-course may vary depending on the dose, 
the treatment characteristics and patient condition. Distinct phases are listed 
below [51, 53-55]: 
1. Transient early erythema. This effect occurs within a few hours after a 
single dose in excess of about 2 Gy and represents an early phase of 
inflammation, with dilatation of capillary vessels, often referred to as 
radiodermatitis.  The area is well defined and matches the entrance 
site of the beam (mostly at the back or under the right armpit of the 
patient in case of IC). The reaction - often faint and similar to sunburn 
- peaks at about 24 hours and vanishes after 48 hours.  
2. Main erythema.  After about 10 days (and after a dose of about 6 Gy) a 
second reddening of the skin occurs, explained by an inflammatory 
reaction to damage of the epidermal basal cell population.  Either a 
dry or moist desquamation response may be seen after 3-6 weeks 
(dose: 14-18 Gy). Temporary or permanent epilation may occur within 
3 weeks, for a dose >3 Gy. When skin desquamation is severe, 
dehydration and infection can easily complicate healing and increase 
the risk for second ulceration of the healed fragile skin. 
3. Late erythema, dermal ischemia and necrosis. Between 8 to 10 weeks, 
mauve skin discoloration becomes apparent (dose > 15 Gy). 
Microvascular damage occurs and overall reduction in capillary 
density leads to progressive vascular insufficiency of the dermis. The 
probability of the development of ischemic necrosis increases with 
increasing dose after a threshold dose of ~18 Gy. Radiation ulcers 
recur and require – in a progressed stage – surgical excision and 
grafting [56-59].  
4. Late skin damage. This is the result of damage to deeper layers of the 
skin, mainly the dermis. This last phase is characterised by dermal 
atrophy, a thinning of dermal tissue, telangiectasia (atypical dilatation 
of superficial dermal capillaries) and necrosis (> 52 weeks). 
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Table 5. Radiation induced skin injuries: effects with dose and onset. NR = not reported [53].  
Effect Dose (Gy) onset 
Early transient erythema 2 hours 
Main erythema 6 ~ 10 days 
Temporary epilation 3 ~ 3 wk 
Permanent epilation 7 ~ 3 wk 
Dry desquamation 14 ~ 4 wk 
Moist desquamation 18 ~ 4 wk 
Secondary ulceration 24 > 6 wk 
Late erythema 15 ~ 8-10 wk 
Ischemic dermal necrosis 18 > 10 wk 
Dermal atrophy (1st phase) 10 > 12 wk 
Dermal atrophy (2nd phase) 10 > 1 y 
Invasive fibrosis 10 NR 
Telangiectasia 10 > 1 y 
Late dermal necrosis >12 ? > 1 y 
Skin cancer - > 5 y 
 
Skin tolerance to radiation depends significantly on the volume of tissue 
irradiated. As the volume of skin irradiated becomes smaller, the dose 
required to produce necrosis increases. For example, the skin threshold dose 
for a circular field of 150 cm2 (diameter = 14 cm) is approximately 15 Gy in a 
single dose, whereas for a circular field of 50 cm2 (diameter = 4 cm) the 
threshold dose is almost 20 Gy [38, 60]. In most tissues, responses are greater 
when irradiated volumes are larger. With early skin reactions, the volume 
effect is due largely to the decreasing ability to heal large areas mainly 
because of limited cell migration from the margins [39]. Moreover, different 
regions of the skin also show a different radiosensitivity; chest, abdomen, 
thigh, back and face are progressively more radiosensitive. The neck skin 
tissue, by contrast, is very resistant to radiodermatitis [58, 61]. 
For low-dose-rate application, sublethal cell injuries can be repaired and 
killed cells replaced during the entire process of dose accumulation [51] 
Fractionation of the total dose, as seen in patients undergoing several 
procedures separated by days or weeks, increases overall tissue tolerance, 
but tolerance for each subsequent individual session may decrease. This is 
the case for patients, in need of different subsequent catheterizations. It is 
clear that the effect of decrease of skin tolerance overrules the effect of skin 
recover, with fractionation. This is emphasized by the fact that almost all 
medical files of patients presenting with radiodermatitis document on 
multiple catheterizations [53, 57-59, 62]. 
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Figure 14. Photograph of the back of a 40-year old man, approximately 18-21 months after 
multiple coronary angiography and angioplasty procedures (all performed on one same 
intervention – 1990). Skin dose was unknown, but probably exceeded 20 Gy. Skin grafting was 
necessary for treatment of tissue necrosis [63]. 
 
Treatment and healing of skin injuries diagnosed as radiation dermatitis is 
not straightforward.  Depending on the severity of the damage to the 
epidermis, dermis and subcutaneous tissues, the evolution of the lesion 
towards healing seems to be ‘all or nothing’. If depopulation of clonogenic 
cells in the epidermis, and/or of matrix cells of the hair follicle is not that 
severe, erythema, ulceration and hair loss may cure. A repopulation of the 
basal cells either by surviving clonogenic cells within the irradiated area or 
through migration of cells from the surrounding borders will occur.  Wound 
care by silver sulfadiazine 1% cream and sterile dressings twice daily were 
reported by Nahass et al. [61] to result in gradual reepithelialization within 3 
weeks of a tender erythematous rectangular plaque (7x14 cm) with several 
ulcers. However, most reported cases involving necrosis do not respond to 
good wound care. Oral or intralesional administration of corticosteroids, 
oral antibiotic agents, absorbent silicone-coated foam dressings, cream and 
hydrocolloid dressings all appeared to be insufficient in terms of wound 
healing and were unable to relief persistent pain [56, 58, 59]. Conversely, the 
lesion becomes worse and evolution from erythema to a deep wound may 
take one to several years.  Wound exploration under general anesthesia and 
final excision of the diseased tissue and skin grafting seemed to be the only 
solution [52, 56, 58, 59]. 
More than 70 injuries, related to fluoroscopically guided procedures have 
been reported in literature up to the beginning of the 21 century  [53, 55] and 
 28 
even more cases were described in recent literature [56, 58, 59] (Figure 14).  
As already stated above, a serious injury may require a prolonged course of 
intense care that sometimes lasts for years.  Often, Interventionalists are 
unaware of the exact magnitude of the radiation dose to the skin, due to 
large intervariability of the individual procedures and lack of a direct skin-
dose-indicator at the x-ray equipment. It is not within expectations that such 
injuries would occur with modern and new equipment; unfortunately, the 
opposite is true.  Complexity of the procedures, multiple cine-runs and 
prolonged use of fluoroscopy are the main reasons for overexposures [7, 53, 
57, 62, 64, 65]. In addition, due to delay of the onset of these injuries, 
physicians frequently do not recognize skin lesions as being related to the 
procedure, since they cannot investigate their patients immediately after the 
intervention. 
Within IC, deterministic effects are mainly an issue for adult patients. Due to 
the smaller body size and tissue material thickness for passage of the x-ray 
beam, the difference between input and output intensity of the beam is 
smaller in children than with adults. Skin dose values for IC procedures on 
paediatric procedures are well below threshold values for skin injuries [13, 
14].  
1.6 Specific equipment 
Examination of dynamical anatomical structures (as the heart) requires real-
time imaging with high temporal resolution. Before 1950, real-time imaging 
was possible by viewing the faint shine of a patient, produced on a thick 
fluorescent screen. It implied a huge step for medical world, but for the 
radiologists this posed a problem with respect to radiation protection [12].  
After 1950, a second generation of fluoroscopy systems coupled an image 
intensifier (II) - being new technological development at that time - to a 
video-circuit [66, 67]. With time course, better image quality and indirectly 
digitised images by use of Charged Coupled Device (CCD) cameras became 
available [68, 69]. The latest evolution in x-ray digital imaging represents 
introduction of flat-panel detectors (FD), also known as Active-Matrix Flat-
Panel Imagers (AMFPI) [70, 71]. In the mid nineties, this new type of IR 
became fully integrated in x-ray systems for static examinations. However, it 
was only till 2003 that FD’s became operational for dynamic imaging [72].  
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Figure 15. Structure and principle of image intensifier. Left: G1, G2 and G3 are the focussing 
electrodes. Right: detail of the input layer. Four layers are discernable : housing of vacuum 
chamber, carrier, CsI phosphor layer and photocathode [12].  
 
The structure and principle of an image intensifier is schematically 
represented in Figure 15. An II consists of a vacuum housing, an input layer 
that converts x-ray photons into an electrical signal, a system of dynodes to 
focus and multiply electrons and an output phosphor, converting electrons 
into a light signal. The input layer itself consists of four layers. The first is 
part of the vacuum housing and the second serves as extra support: both are 
of aluminium (Al) in order to resist high pressures preserving the vacuum 
inside. On top of the additional Al support, a phosphor layer consisting of 
CsI crystal needles converts incoming x-rays into visible light.  The needles 
behave like light pipes, minimizing lateral diffusion of light. Therefore, a 
relatively thick layer is produced for an optimal photon to light conversion. 
The fourth layer is a photocathode layer and converts the light into 
electrons. 
An electric field is applied between photocathode and first dynode. Each 
dynode is more positively charged than its predecessor is. Secondary 
emission occurs at the surface of each dynode. Such an arrangement is able 
to amplify the small current emitted by the photocathode. Multiplication is 
proportional to the energy of the incoming photons. Light with a 
wavelength characteristic for the output layer (green (~530 nm) for 
ZnCdS:Ag) is emitted. This output layer is preferentially as thin as possible 
with view of low spatial spreading. 
Transmittance of the image at the phosphor layer to a television screen first 
was possible through video capitation.  Now, (from 1986 on) CCD cameras 
are used for direct digitisation of the image [69]. A photosensitive silicon (Si) 
layer serves as carrier for discrete pixel-electronics. Light, falling onto this 
layer of pixels is converted into an electrical signal, proportional to the 
intensity of the light [12, 68, 69]. Read out of the exposed CCD yields a 
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digital image. Pixel size and number (e.g. 1024 x 1024 for a surface of 2.5 cm2 
x 2.5 cm2) determines resolution of the camera. For applications in 
fluoroscopy, the intensified light form the II is focused by means of lenses 
and fibre-optics to the small CCD surface. 
 
 
 
 
 
 
 
 
Figure 16. Multiplication of electrons by the dynodes of an image intensifier [12].  
The advantages of digital images are numerous. Processing, storing, 
transporting, multiple viewing, duplicating becomes very easy, given high 
computer capacity and extended hospital network. 
Different magnification modes are possible by changing the electrical fields 
between the dynodes. As the magnification factor increases, a smaller area 
on the input of the II is visualised. In order to obtain the same signal to the 
output phosphor a higher input dose is necessary, increasing the dose to the 
patient. Switching from a field of view of 23 cm to one of 18 cm increases the 
exposure rate by  a factor of (23/18)2 = 1.6. Switching from the largest to the 
smallest field (e.g. 13 cm) increases exposure rate with a factor 3.1. This 
holds true if only the tube current is increased when going to a magnified 
mode. With changes in tube potential, the actual increase in dose is less, than 
described above. Nonetheless, an increased dose is certain. 
The newest generation of IRs: flat panel detectors are classified into two 
groups: those that are based on direct conversion of x-rays into electrical 
signal and those based on indirect conversion. (However, II-systems coupled 
to CCD are also often seen as indirect conversion digital systems [73].) Direct 
conversion detectors use amorphous Selenium (a-Se) as x-ray 
photoconductor.  Indirect type (AMFPI) detectors use amorphous Silicon (a-
Si) in a two-step process for electrical signal generation. Both a-Se and a-Si 
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detectors send electrical charges to an array of Thin Film Transistors (TFTs). 
Readout of the TFTs and Analog-to-Digital Conversion (ADC) yields a 
digital image. In general, the structure of a FD (both for direct or indirect 
conversion type) consists sandwich-like of following layers: first a layer 
sensitive to x-rays (eventually combined with a light- sensitive layer), 
secondly a TFT array with read-out electronics and thirdly a supporting 
layer. Putting everything into a housing and connecting it to the computer, 
yields the FD. 
 
 
 
 
 
 
Figure 17. Left Top : a-Si:H photodiode layer on TFT array. The arrow indicates a distance of 143 
µm. Left bottom : Detail of 1 TFT element (pixel) [http://www.trixell.com]. Right:  Part of a TFT-
array consisting of 3 by 3 pixels, seen through an optical microscope. The scheme shows the 
read-out mechanism. Indices i and j denominate rows and columns. S, D, and G denominate 
Source, Drain and Gate of the transistor [74]. 
 
The support layer of TFTs consists of a glass substrate, upon which read-out 
electronics and charge collecting arrays are etched at different levels.  
Typically, electronics are packed together in the corner of each pixel (Figure 
17) to occupy smallest place possible. The reason is that this place is inactive 
in collecting charge, thus reducing fill factor. Electronics comprise a 
capacitor to hold the charge, built up during exposure. After exposure, TFT 
are read-out one by one or combined (‘binning’ of detector elements) and are 
reset afterwards. Current TFTs are capable of readout an entire image in 
1/30 of second, sufficient to perform fluoroscopy. 
The principle of direct and indirect AMFPIs will be described here shortly 
[71, 73, 75, 76]. 
Detectors of the direct conversion type use an a-Se photo-conducting layer 
turning x-rays directly into electrical charge. An electrical field is applied 
across the material to conduct the electrons directly to the capturing TFT-
array, resulting in very low spatial spreading, and thus high spatial 
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resolution On the other hand, Se has less favourable x-ray absorption 
characteristics (compared to Cesium (Cs) or gadolinium (Gd)) at  diagnostic 
energies > 40 keV. A thicker Se layer will compensate for this. 
 
 
Figure 18. Illustration of the principle of direct (a-Se) conversion and indirect (a-Si and coupling 
with CCD) conversion digital x-ray detectors [73]. 
 
With indirect systems, a scintillator and an a-Si photodiode replace the a-Se 
photoconductor layer.  The scintillator emits light proportionally with the 
energy of incoming x-rays and the a-Si photodiode converts the light into 
electrical charge. Captured by the TFT-array and passing ADC-electronics, 
the digital image is generated. As in IIs, the scintillation material used is CsI, 
grown in crystal-like needles that avoid lateral diffusion of the light. Both 
high DQE and high spatial resolution can be obtained. 
Figure 18 schematically represents principles of direct and indirect 
conversion for x-ray detectors. 
Both II and FD imaging techniques have their specific characteristics and 
plus-points. In comparison with conventional II, FDs have shown 
convincing advantages of better ergonomics with better patient access, lack 
of geometric distortion, little or no veiling glare, no vignetting, insensitivity 
to magnetic fields and wider dynamic range [77-80]. However, questions 
regarding the capabilities of FD have not been answered completely, 
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particularly as it pertains to IQ at low exposure levels. In IC, real–time 
viewing of vascularisation of the heart and tiny devices such as stents and 
guidewires impose stringent requirements on the imaging techniques used.  
Up to now, IIs achieve essentially ‘noiseless’ gain at low exposure rates, due 
to their characteristics of high electronic brightness gain and minification 
gain [79]. For FDs, on the other hand, system noise becomes a limiting factor 
in determining system performance at low exposure rates [81-83].   
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Chapter  2  
Objectives and outline of the thesis 
2.1 Objectives and outline 
Within respect to deterministic effects of ionising radiation, skin dose is of 
major concern in IC ([8, 53, 63]), as fluoroscopy guided procedures with 
cinegraphy – in general - are recognised as involving high-doses to patients 
[7]. Moreover, due to their advantages upon surgical alternatives, the 
number of procedures per year increases [1, 4, 5]. Several recommendations 
for physicians working extensively with x-rays in IC have been published in 
order to reduce patient doses and to avoid radiation induced injuries [7, 84-
87]. Dose thresholds as low as 2 Gy for maximum skin dose have been stated 
by the ICRP in its report 85 [10] for onset of transient erythema. Therefore, 
the Commission recommends assessment of MSD and of location of most 
exposed skin site. The purpose of the first study in the framework of this 
PhD dissertation was to derive and propose action levels for skin exposure 
in terms of DAP. These levels indicate a reasonable probability that MSD has 
exceeded the acceptable level of skin exposure. Medical follow-up of the 
patients can be advised, based upon the proposed levels. The concept of 
trigger levels was proposed by Vaño et al. [62].  However, never MSD was 
measured earlier with this extensive number of TLDs in order to reconstruct 
the entire skin dose distribution. It is also the first study in Belgium for dose 
inventarisation in IC. 
Besides the recommendations regarding MSD, The ICRP also imposed the 
use of Diagnostic Reference Levels (DRLs). These values serve as first 
criterion to decide whether in routine conditions, the levels of patient dose 
from a specified imaging procedure are unusually high (or low). Mostly the 
75th percentile point of the distribution of a certain dose indicator is used [8, 
85]. DRLs should be reviewed at intervals at regional, national or even 
international scale. The second purpose of the first study was to derive and 
36 
propose dose reference levels for diagnostic and therapeutic examinations in 
IC in Belgium. 
The results of this study are presented in Publication 1: A large-scale 
multicenter study of patient skin doses in interventional cardiology: Dose-
Area Product action levels and Dose Reference Levels. (p 39) 
A second study deals with the stochastic effects of ionising radiation 
exposure, for an adult patient population involved in IC. As E is the general 
quantity for long-term risks [8, 39], calculation by a Monte Carlo simulation 
code PCXMC was performed [26]. In addition, doses to organs most at risk 
were investigated separately. Risk factors were determined using the life-
time risk coefficients proposed by the ICRP in report 60 [8]. However, this is 
the first study that translates individual IC procedures in terms of standard 
geometries of a clinical protocol and combining detailed DAP contributions 
for calculation of E. It is the first study for calculation of  E and risk 
assessment for IC procedures  in Belgium. The same patient population of 
the multicentre study of publication 1 was considered. Differences between 
hospitals were highlighted and measures to lower patient dose were 
proposed. Results were reported in Publication 2: A large-scale multicentre 
study in Belgium of Dose-Area Product values and effective doses in 
interventional cardiology using contemporary x-ray equipment. (p 61) 
A practical approach to obtain E was worked out in the third study. Specific 
conversion factors (CF) for E based on  recorded DAP values were proposed. 
The influence of additional Cu filtration was taken into account.   The effect 
of irradiation geometries on CF was studied. Details can be found in 
Publication 3: Interventional cardiovascular procedures in Belgium: 
effective dose and conversion factors. (p 85) 
As children are more radiosensitive than adults, due to a higher fraction of 
actively proliferating cells and high post-exposure life expectancies [40, 45, 
47], special attention has to be paid to the doses administered. A paediatric 
population, with ages < 10 year, receiving diagnostic or therapeutic 
procedures in IC was followed and the risk for late effects, by means of 
individual E calculations was assessed [27]. The impact of additional Cu 
filtration was studied. Findings were reported in Publication 4: Patient-
Specific dose and radiation risk estimation in paediatric cardiac 
catheterization. (p 95) 
New technologies in IC, mainly with respect to image capture have been 
settled well in clinical practice now [79, 88]. At the moment, Flat Detectors 
(FD) are preferred above conventional Image Intensifiers (II), but their 
response and image quality at low dose rates is still unclear. In a 
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comparative study between II and FD, both CD measurements for 
assessment of image quality and patient dose measurements were 
performed. Distinction was made between fluoroscopy mode and 
cinegraphy mode. It was our aim to investigate the dose versus image 
quality relation in clinical practice for conventional II and recent flat panel 
technologies. Results were reported in Publication 5: Does digital flat 
detector technology tip the scale towards better image quality or reduced 
patient dose in interventional cardiology? (p 113) 
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Abstract 
For 318 patients in eight different Belgian hospitals the entire skin-dose distribution was mapped 
using a grid of 70 Thermoluminescence Dosemeters (TLDs) per patient, allowing an accurate 
determination of MSD. Dose-Area Product (DAP) values, exposure parameters, geometry, 
procedure-, patient- and cardiologist-characteristics were also registered. Procedures were divided 
into two groups: diagnostic procedures (Conorary Angiography CA) and therapeutic procedures 
(dilatation, stent, combined procedures (e.g. CA+dilatation+stent)). The mean value of MSD was 
0.310 Gy for diagnostic and 0.699 Gy for therapeutic procedures. The most critical projection for 
receiving the MSD is the LAO90 (Left Anterior Oblique) geometry. In 3% of the cases MSD 
exceeded the 2 Gy dose threshold for deterministic effects. Action levels in terms of DAP values as 
the basis for a strategy for the follow-up of patients for deterministic radiation skin effects were 
derived from measured Maximum Skin Dose (MSD) and cumulative Dose-Area Product (DAP) 
values. Two DAP action levels are proposed. A first DAP action level of 125 Gy.cm2 corresponding 
to the dose threshold of 2 Gy would imply an optional radiopathological follow-up depending on 
the cardiologist’s decision. A second DAP action level of 250 Gy.cm2 corresponding to the 3 Gy skin 
dose would imply a systematic follow-up.  
Dose Reference Levels (DRLs): 71.3 Gy.cm2 for diagnostic and 106.0 Gy.cm2 for therapeutic 
procedures were derived from the 75 percentile of the DAP-distributions.  
As a conclusion, we propose that total DAP is registered in patient’s record file as it can serve to 
improve the follow-up of patients for radiation induced skin injuries. 
 
Introduction 
The extensive exposure to X-rays during fluoroscopy guided procedures 
often involves high radiation doses to patient’s skin. Several observed 
radiation induced skin injuries have been reported in the nineties [1, 2] . By 
late 1994, the Food and Drug Administration (FDA) called attention to this 
problem with an advisory that later appeared on its website [3].  The review 
paper of Koenig et al. describes more than 70 skin injuries [4]. These injuries 
varied from erythema, moist desquamation, and ulceration to necrosis. The 
overview of the reported cases shows that the vast majority of the 
overexposures took place in the catheterization room during coronary 
angiography and interventions [5]. This is not unexpected as the number of 
cardiac interventions annually performed exceeds the other interventional 
radiological procedures by an order of magnitude [5].  
Several recommendations for physicians working extensively with X-rays in 
interventional cardiology have been published in order to reduce patient 
doses and to avoid radiation induced injuries [6, 7].  However, due to 
complexity of procedures, still radiation induced skin injuries in patients 
occur, even with contemporary state of the art dose-reducing X-ray systems 
and appropriate training of physicians. 
As stated by the ICRP (International Commission on Radiological 
Protection), the risk of skin injuries has to be estimated in the individual 
patient in order to provide adequate follow-up and treatment of these 
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injuries [8]. Dose thresholds of 2 Gy (onset of transient erythema) and 3 Gy 
for maximum skin dose or even as low as 1 Gy have been proposed [8]. 
Therefore procedures to estimate and monitor patient skin dose in daily 
practice have to be worked out. 
Several studies report skin doses in interventional cardiology mostly 
measured using film or using only a very limited number of TLDs [9-11]. 
However due to the complexity of the irradiation geometries involving often 
two X-ray tubes in a C-arm type setting at different angles, it is not clear in 
advance which location on patient’s skin is going to be most critical. This 
implies that to measure the maximum received skin dose, the total skin dose 
distribution has to be mapped. Similar dose distributions were measured by 
Suzuki et al. [12] using colour-changing radiosensitive indicators, but for a 
restricted number of patients in only one catheterization room. 
Dose-Area Product (DAP) action levels are defined as alarm levels 
indicating a situation in terms of skin exposure necessitating medical follow-
up for possible radiation injuries.  Whereas DAP action levels do not provide 
a guideline for optimisation of the dose versus medical benefit relation, Dose 
Reference Levels (DRLs) do. Initial national values can be derived from the 
75th percentile of the overall DAP distribution of the patients undergoing a 
particular procedure. This method of calculation of DRLs is indicated when 
a low number of rooms is participating in the study [13].  A comparison of 
the local mean values with national proposed DRLs, gives an idea about the 
ranking of the current practice in a hospital, with respect to patient dose.  
In present study, action levels derived from cumulative DAP values are 
proposed as indicator for skin dose. This was possible by the measurement 
of the entire skin dose distribution using a grid of Thermoluminescence 
Dosemeters (TLDs), ensuring the determination of the Maximum Skin Dose 
(MSD)-value. In addition, initial values for national Belgian DRLs of the 
diagnostic and therapeutic DAP distribution are also proposed. 
 
Methods 
Patients  
The patient group comprised 318 adult patients (221 male, 97 female, age 
between 29 and 89 years) who underwent cardiac catheterization in 8 
Belgian hospitals in a period of two years (July 2003 – July 2005). The 
hospitals were selected to be representative for the current Belgian situation.  
As well university hospitals as private hospitals, geographically chosen to 
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cover the Belgian territory and with contemporary x-ray equipment 
participated in present study. Demographic patient data are indicated in 
Table 1.  In each hospital about 40 patients in one catheterization room were 
included in this study. The cardiac interventional procedures were divided 
into two groups. The first group comprises diagnostic coronary angiography 
possibly combined with Pulmonary Capillary Wedge Pressure 
measurements. The second group consists of therapeutic procedures:  single 
or multiple percutaneous transluminal coronary angioplasty (PTCA) with or 
without single or multiple consecutive stenting, single or plural direct 
stenting and combined (diagnostic plus therapeutic) procedures. The 
procedures were performed by experienced cardiologists or medical doctors 
being in training for interventional cardiology, all using their own protocols. 
A total of 200 diagnostic and 118 therapeutic procedures were included in 
this study. 
Table 1. Demographic patient data and measured and calculated radiation dose parameters for 
diagnostic and therapeutic procedures. 
 Diagnostic procedures Therapeutic  procedures 
 Mean (range) Median Mean (range) Median 
Demographic patient data 
N° male  
(avg weight (kg)) 
130 
(81) 
 91 
(82) 
 
N° female 
(avg weight (kg)) 
70 
(71) 
 27 
(71) 
 
Age (years) 67 
(29 - 86) 
 65 
(31 - 89) 
 
BMI (kg/m2) 27 
(19 - 49) 
 28 
(20 - 47) 
 
Measured and calculated radiation dose parameters 
MSD (Gy) 0.31 
(0.03 – 2.62) 
0.20 0.70 
(0.06 – 4.50) 
0.46 
DAP (Gy.cm2) 55.7 
(2.71 - 265) 
43.8 81.5 
(10.3 - 404) 
65.4 
% contribution of 
fluoro  to DAP 
33 
(8 - 90) 
 50 
(9 – 91) 
 
% contribution of 
cine  to DAP 
67 
(8 -90 ) 
 50 
(9 - 91) 
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X-ray equipment and Dose-Area Product meter  
The measurements were performed on different contemporary cardiac X-ray 
systems (Table 2). All tubes had an inherent filtration of 2.5 mm Al. 
Distinction was made between two types of filtration insertion for X-ray 
equipments. X-ray equipment was either provided with ‘fixed filtration’-
insertion or with ‘variable filtration’-insertion. A system with variable 
filtration adapts filtration thickness and material (Al or Cu) according to 
patient’s thickness, without the cardiologist’s involvement. Fixed filtration 
refers to a manual filtration function of the X-ray equipment by which the 
cardiologist has to choose one  filtration-setting out of a limited number of 
possible filtration settings. All possible filtration settings for the different 
hospitals in either fluoroscopy or cinegraphy mode for variable or fixed 
filtration systems are given in Table 2. Generally a combination of an Al 
filtration of a particular thickness and one or more Cu filters of different 
thickness are used. 
All X-ray tubes operated in a pulsed mode and controlled tube voltage and 
anode current with automatic brightness control. All tubes were equipped 
with a PTW DAP meter integrated in the system. The DAP meters were 
calibrated in situ for different tube voltages, filtrations and modes 
(fluoroscopy or cinegraphy) with a  60cc ionisation chamber (Radcal,10X5-
60, Dutoit medical ) and 33x41-cm Kodak X-Omat V films (Eastman Kodak) 
for field size determination. 
 
Acquisition of exposure and procedure parameters  
Each irradiation geometry was determined by a set of two angles per tube, 
using the radiological convention for geometry setting: cranial and caudal 
rotations in the sagittal plane of the patient and left anterior oblique (LAO) 
and right anterior oblique (RAO) for rotations in the transverse plane of the 
patient. 
For each projection used in the cardiovascular intervention, geometry, tube 
potential, filtration settings per mode,  number of frames, source to image 
detector distance, image detector field size, number of frames per second, 
tube current, pulse duration, and mode (fluoroscopy or cinegraphy) were 
registered. Cumulative DAP and DAP rate as a function of time during the 
procedure were registered online (Figure 1) by the PTW DAP meter 
connected to a Diamentor M4 readout unit and a laptop.  This allowed us to 
measure DAP contribution for each mode and projection. 
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Figure 1. Typical output of DAP registration program: cumulated DAP (dark line) and DAP rate 
(light line) as  function of time. This example shows nine cinegraphy-runs and fluoroscopy in 
between. 
After each intervention the following information was recorded : complexity 
of the intervention (subjective score 1 to 3 according to ‘easy’, ‘normal’ and 
‘difficult’) , amount of contrast used, cardiologist’s experience (doctor or 
trainee) and standard protocol used for the intervention and patient’s data 
(gender, age, weight, length and chest circumference).  The three point scale 
for the complexity score was based on the duration of the procedures with 
respect to an equivalent procedure under normal circumstances, the number 
of lesions, the accessibility of the coronary arteries and the number of frames 
in one fixed position. 
 
Skin Dose Measurements  
A two-dimensional array of 70 TLDs (MTS-N type, Poland) covering the 
patient’s chest was used, measuring the skin dose distributions of 318 
patients in 8 cardiologic centres.   In order to attach the TLDs to patient’s 
skin, a ‘wrap-around’ was used, provided with a grid of 30cm by 97.5cm 
divided in squares of 7.5cm by 7.5cm. TLDs were wrapped in a plastic 
protection, labelled together with their positions, in order to be  able to 
reconstruct the patient skin dose distribution. Patient’s chest was covered 
completely with a wrap-around, with the middle centred at the spine and 
the upper end at the height corresponding to the sternum. All patients were 
asked to keep their arms upwards with their hands behind the neck during 
the procedure. The wrap-around with the TLDs did not affect image quality 
as their material (cotton for the wrap-around and LiF:Mg,Ti for the TLDs) 
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are not radio-opaque. Neither the wrap-around nor the individual TLDs 
were visible on the radiographic cardiovascular images. 
 
Figure 2. Three-dimensional representation of patient skin dose distribution (mGy) for a 
coronary angiography in a biplane setting. TLD positions are indicated. Left: viuw from the back 
of the patient. Right: view of the right side of the patient. 
 
All TLDs were calibrated at the Standard Dosimetry Laboratory in Ghent 
(Belgium) at the beginning and at the end of the study at the same beam 
quality that was used in situ.  Read-out was performed with a Harshaw 3500 
reader (Thermo Electron Corp). For the study TLDs were selected with a 
calibration factor within 5 %. The maximum difference between the 
calibration factors at the beginning and the end of the study was less than 
10%, the overall uncertainty on the measured MSD. 
 A graphical representation of the three-dimensional skin dose distribution 
was achieved by plotting TLD data on a mathematical cylindrical  phantom 
representing the patient taking into account the circumference of the wrap-
around around patient’s chest as is shown in  Figure 2. TLD positions are 
indicated.  
DAP was calculated from the measured TLD skin dose and compared with 
measured DAP, multiplied by a factor that takes into account the backscatter 
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of the patient [14].  A very good correlation (r = 0.95) with a conversion 
factor of 1.03 was obtained which confirms the reliability of the DAP and 
TLD measurement sets. 
 
Statistical analysis  
As multiple factors may influence radiation dose measurements and 
calculations, a multifactor analysis of variance (ANOVA) was set up. Factors 
in the ANOVA design included the differences between hospitals, the 
difficulty of the procedure, system of beam filtration insertion and type of 
equipment (bi/monoplane, digital flat panel or conventional image 
intensifier). Levene’s test was used to test the homogeneity of the variances 
between groups. A non-significant result of the Levene’s test assured a 
correct application of the ANOVA analysis. Pillai’s trace was used as a 
robust indicator of significance in the ANOVA analysis [15]. 
In cases where only two groups had to be compared, a non-parametric two-
tailed Mann-Whitney test was performed. Correlations between groups 
were calculated by means of the non-parametric Spearman’s rank 
correlation coefficient (r). To calculate the regression coefficients in the 
relation between two quantities, linear regression analysis was performed 
using the Levenberg-Marquardt algorithm. Fitting of data in figure 6 was 
performed by Weighted Least Squares method, using heteroscedasticity for 
determination of weighting factors. Fitting and p-values in figure 6 were 
calculated using ‘the R-project’ [16]. 
In all statistical calculations a confidence interval of 95% was applied. 
Hence, a p-value < 0.05 was considered as significant. All calculations were 
performed by means of the SPSS 12.0 software (SPSS, Chicago, Ill). 
 
Results 
Maximal Skin Dose  
The results of the radiation dose measurements are summarized in Table 1. 
The mean value of MSD was 0.31 Gy and 0.70 Gy for diagnostic and 
therapeutic procedures respectively. The difference between these mean 
values was significant at a level of p= 0.001. The median values amounted to 
0.20 Gy and 0.46 Gy for diagnostic and therapeutic procedures respectively. 
Figure 3 represents the histograms (interval of 0.25 Gy) of MSD values for 
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both diagnostic and therapeutic procedures with their mean values 
represented by a dotted line. A multifactor ANOVA analysis was performed 
to check whether other factors than the type of procedure (diagnostic or 
therapeutic) affect the MSD. Both flat panel equipment and the use of 
biplane configurations did not contribute to a significant lowering in MSD 
(p=0.828 and p=0.626 respectively). On the other hand, the lowest MSD 
values were found with systems equipped with variable filtration settings 
(p=0.033). The MSD depends also significantly on the difficulty level of the 
procedures (p<0.001). In the 3-point difficulty scale used in this study, level 
2 and 3 resulted in significantly higher MSD values compared to first level 
procedures.   
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Figure 3. Histogram of maximal skin dose (Gy) for diagnostic (full line) and therapeutic (dashed 
line) procedures. Mean values are indicated by a vertical line. 
ANOVA analysis could not reveal significant differences in MSD due to the 
hospital-factor (p= 0.171), partly due to the large variations in the dataset of 
the MSD. However, some clear trends were observed between hospitals. In 
some hospitals higher mean values could be explained by a continuous use 
of the fluoroscopy ‘high’ mode for fluoroscopy filtration setting. This mode 
uses least beam filtration during exposure.  In other hospitals, the 
explanation for high doses could be found in the fact that in the period of the 
dose measurements, different medical doctors were trained in PTCA and 
stenting. Low mean values are related to ‘good practice’ in terms of the 
amount of radiation used on a monoplane system or by  the local cardiology 
clinical practice, where a coronary angiography does not precede directly 
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the therapeutic intervention but is performed a few days earlier, and 
therefore, is not taken into account in the skin dose distribution. 
The angle of the projections under which the MSD was received by the 
patient could be deduced from the TLD measurements. These angles, 
measured in a transverse plane through the patient are plotted as a 
histogram  (interval 30 degrees) in Figure 4.   The sagittal angulations of the 
X-ray beam were not taken into account in this figure. The most sensitive 
projection for receiving the MSD is the pure left lateral geometry of X-ray 
equipment (LAO90), in agreement with Kuon et al. [17]. For this projection, 
there is a closer positioning of the tube to patient’s skin and an increase in 
exposure is induced by the larger patient size in the lateral dimension. The 
probability for the location of the MSD decreases steadily from lateral right 
to the centre of the back with a second prominent peak at the back left to the 
spine from the RAO30 projection. The angular distribution of the MSD 
indicates the necessity to use a large TLD set covering the whole chest for 
MSD determination in interventional cardiology. 
 
Figure  4. Distribution of the angles under which maximal skin dose was received by the patient. 
The coordinate system is centred at the centre of the mathematical cylindrical patient. 0 degrees 
means anterior-posterior projection and 90 degrees means left lateral projection. 
 
For therapeutic procedures, the highest measured MSD was 4.50 Gy, 
whereas for diagnostic procedures this value was 2.62 Gy. 1% of the 
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diagnostic procedures (n=2) and 6 % of the therapeutic procedures (n=7) 
exceeded the threshold of 2 Gy for deterministic skin effects. An overview of 
these cases is given in Table 3. The therapeutic procedures were all 
‘combined procedures’ which means that a diagnostic examination preceded 
a therapeutic intervention, except for case 2, where the procedure was a 
merely therapeutic intervention. In 3 out of the 9 cases a trainee was 
involved. 
Table 3. Summary of the cases for which the maximum skin dose exceeded 2 Gy 
N° 
Proce-
dure 
MSD 
(Gy) 
Angle 
MSD 
(°) 
gender 
Cardio-
logist 
DAP 
(Gy.cm2) 
contribution 
of fluoro to 
MSD (%) 
contribution 
of cine to 
MSD (%) 
1 D 2.1 100 F Tr.+Doc. 194 57 43 
2 T 2.5 -44 M Tr. 298 30 70 
3 T 2.4 66 M Doc 154 77 23 
4 T 3.1 -47 M Doc. 153 40 30 
5 T 2.3 -15 M Doc. 131 27 73 
6 T 3.2 14 F Tr.+Doc. 404 95 5 
7 T 3.4 45 M Doc. 315 98 2 
8 T 4.5 95 M Doc 257 89 11 
9 D 2.6 94 F Doc. 191 79 21 
(D = Diagnostic, T = Therapeutic; Tr = Trainee, Doc. = Doctor-Cardiologist ) 
 
The contributions of fluoroscopy and cinegraphy in terms of percentage to 
the DAP  that was  registered for the geometry that caused the MSD 
exceeding 2 Gy, show that for 5 of the 9 cases a long fluoroscopy projection 
was obviously responsible for the highly measured peak in skin dose 
(contribution > 75 %). Investigation of these exposures in detail shows that 
the main explanation is the complexity level of the examinations 
necessitating automatically more X-rays for guidance of the catheter and 
imaging (p<0.001). All patients with skin peak doses of 2 Gy and higher 
belong to the high difficulty level. According to our study, important 
procedural aspects that lead to high skin doses are large patient weight, 
prolonged use of one and the same projection (both in cinegraphy as in 
fluoroscopy) and a relatively large distance between patient and image 
receptor, reducing the distance between X-ray source and patient in a C-arm 
setting. 
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Dose-Area Product  
The mean value of DAP for diagnostic procedures was  55.7 Gy.cm2 and 
differed significantly (p<0.001) from that for  therapeutic procedures  (81.5 
Gy.cm2). The corresponding 75th percentile values were 71.3 Gy.cm2 and 
106.6 Gy.cm2  for diagnostic and therapeutic procedures respectively. Table 
4 gives an overview of mean DAP values for the different hospitals 
considered in the study, for comparison with the proposed DRLs.  DAP 
values differ significantly among the hospitals where the procedures were 
performed (p<0.001).  Significant differences were also found between 
monoplane and biplane systems with lower values for monoplane systems 
(p= 0.026) (mean DAP values of 59.6 Gycm2 versus mean DAP values of 74.6 
Gycm2). When a variable filtration setting was available, lower DAP 
numbers were recorded (mean DAP values of 49.2 Gycm2 versus mean DAP 
values of 91.4 Gycm2, p<0.001). 
 
Table 4. Mean values for dose-area product values (Gycm2) 
 Diagnostic procedures Therapeutic procedures 
Hospital Mean DAP (Gycm2) Mean DAP (Gycm2) 
1 76.9 120.3 
2 31.2 57.0 
3 74.2 90.8 
4 50.6 75.8 
5 46.2 78.0 
6 83.1 137.7 
7 18.6 41.5 
8 54.9 70.0 
DRL derived from 
this study 71.3 106.0 
 
The installation of a digital flat panel detector generally resulted in lower 
DAP values, as compared to image intensifier systems (mean DAP values of 
57.4 Gycm2 versus 70.0 Gycm2 respectively). However, this finding did not 
reach statistical significance (p= 0.068).  Apart from the factors just 
mentioned the higher DAP values recorded in some hospitals are also due to 
cardiologists in training performing the procedures during the study, a 
continuous use of the fluoroscopy high contrast mode (least possible 
filtration). 
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Figure 5. Histogram of Dose-Area Product (Gycm2) for diagnostic (full line) and therapeutic 
(dashed line) procedures. The third quartile is presented by a dashed line and represents Belgian 
Dose Reference Levels. 
 
The mean contribution of fluoroscopy to DAP in diagnostic procedures was 
33%, whereas this contribution was 50% in therapeutic procedures (p=0.002). 
In general, contributions of fluoroscopy and cine to the total DAP values 
varied significantly depending on the hospital (p=0.017). The level of 
procedure difficulty also had a significant influence (p<0.001) with an 
enhancement of the fluoroscopy contribution for difficult procedures. For 
diagnostic procedures, hospitals with biplane systems have a statistically 
significant (p=0.001) larger contribution of cinegraphy than hospitals with a 
monoplane system (p=0.001). This means that the possibility of acquiring 
two cinegraphy runs simultaneously at two different projections in a biplane 
system is not fully exploited but rather leads to an overuse due to the ease 
and speed of the technique. For therapeutic procedures, these trends are not 
so prominent.  
Figure 5 represents the histograms (intervals of 25 Gycm2) of DAP values for 
diagnostic and therapeutic procedures. The distributions are strongly 
skewed and the 75th percentile values are indicated by vertical lines. In the 
scope of establishment of diagnostic reference levels (DRLs) these values can 
be proposed as initial national Belgian DRLs, taking into account the 
number of catheterization rooms that were considered. 
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Figure 6. Maximal Skin Dose (Gy) versus  Dose-Area Product  (Gycm2) for all procedures.  DAP 
level of 125 Gycm2 and 250 Gycm2 are indicated corresponding to action levels for skin doses of 
respectively 2 Gy and 3 Gy. The different symbols refer to the complexity level of the procedure. 
Outlying points are squared. 
 
Maximal Skin Dose versus Dose Area Product  
The relation between cumulative DAP and MSD was investigated for both 
diagnostic and therapeutic interventions based on all hospital data. These 
data are presented graphically in Figure 6. Different symbols are used to 
highlight the impact of the difficulty of the procedures. The regression line 
for bulk data and a trend line for outlying points are indicated. For bulk 
data, a linear relationship was considered as first approximation and yielded 
a p < 0.001. The mathematical function (c.DAP d) chosen for the outlying 
points was based on their DAP dependence and to fulfil criteria of physical 
relevance (passing through origin and continuously increasing function). p-
values for parameters c (0.113) and d (0.591) were 0.064 (p slightly > 0.05) 
and lower than 0.001.  The fit served as guiding tool for derivation of DAP 
action levels.  DAP values of 125 Gycm2 and 250 Gycm2 corresponding to 2 
and 3 Gy MSD-levels can be deduced from these data. 
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Discussion 
Maximal Skin Dose and Dose-Area Product 
Results of present study for  mean MSD, 0.31 Gy for diagnostic and 0.70 Gy 
for therapeutic procedures, confirm the high values for the MSD reported in  
papers published previously but now at a larger scale: 0.270 Gy [18, 19] for 
diagnostic procedures and 0.760 Gy [20] and 0.980 Gy [19] for therapeutic 
procedures.  On the other hand, mean values for  MSD as low as 0.113 Gy 
[21] and 0.217 Gy [22] for diagnostic procedures and 0.391 Gy [22] for 
therapeutic procedures  have also been reported, but these were measured 
with only a limited number of TLDs, which explains the difference with the 
values of present work. In 9 patients, being  3% of all patients investigated, 
the dose threshold for deterministic effects to the skin, 2 Gy, was exceeded. 
This percentage can be considered to be representative for contemporary 
clinical practice in Belgium. 
Mean and median values for cumulative DAP distributions over all patients 
undergoing diagnostic and therapeutic procedures, as reported in this study, 
are in the range of the data reported in the literature. A comparison with 
literature data can be found in table 5 ([18, 21, 23, 24]). 
 
DAP action levels 
Interpretation of figure 6 shows that cumulative DAP can serve as online 
monitor for the interventionist in terms of action levels for MSD. The trend 
line through the data points of outliers results in DAP action levels of 125 
Gy.cm2 and  250 Gy.cm2 for 2 Gy and 3 Gy MSD levels respectively. The 
trend line is based on the behaviour of outlying MSD values, representing 
the highest skin doses obtained in present study. It serves as a guiding tool 
for derivation of DAP action levels. The function is not applicable as such for 
low DAP values, nor values in extend to the measured data. It does not 
represent a general relationship between MSD and DAP since it was only 
based on outlying points. According to the data set of present study the 
cumulative probability for MSD exceeding the 2 Gy level, amounts to 30% 
when the DAP exceeds the action level of 125 Gy.cm2. Analogously, the 
cumulative probability for MSD exceeding the 3 Gy level is 60%, when the 
DAP exceeds 250 Gy.cm2. As these DAP readings can be considered as DAP 
action levels for both diagnostic and therapeutic procedures, systematic 
registration of the DAP-value at the end of the procedure in patient’s record 
is indicated.  
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In case DAP exceeds 125 Gy.cm2, registration in patient’s record of the entry 
site of the beam being responsible for the highest skin dose, according to the 
cardiologist on a body map (together with the DAP value) is indicated. The 
cardiologist can also decide that the patient has to be followed up for 
radiation skin effects based on the difficulty of the procedure and the total 
fluoroscopy time especially in single projection directions. This decision has 
to be based on a comparison with the local reference procedure.   
 
Table 5. Mean and median Dose-Area Product (DAP) values for diagnostic and therapeutic 
procedures in interventional cardiology and literature data 
Reference procedure 
Mean 
DAP 
(Gycm2) 
Median 
DAP 
(Gycm2) 
procedure 
Mean 
 DAP 
(Gycm2) 
Median  
DAP 
(Gycm2) 
Zorzetto et al. (17) 39  CAa 55.9 52.5 19 PTCA 91.8 82.6 
Vaño et al. (20) 288 CA 66.5 45.7 45 PTCA 87.5 66.7 
Padovani et al. (22) 76  CA-LVb 55.9  54 PTCA 101.9  
Karambatsakidou (23) 20  CA 49  40 PTCA 40  
Present work 200 CA 55.7 43.7 118 therapc 81.5 65.4 
a CA = Coronary Angiography 
b CA-LV = Left catheterism + Coronary Angiography + left ventriculography + 1-2 other 
acquisitions 
c therap = therapeutic procedures as defined in present work. 
 
At the 3 Gy action level (250 Gy.cm2), the patient and his personal physician 
should be informed on the possible radiation effects. Of course, in view of 
the higher probability of skin-overexposures in therapeutic interventions, 
this action level is indicated for therapeutic interventions. In our multicentre 
study four interventions (all were therapeutic) resulted in skin doses 
exceeding 3 Gy, being 1% of all procedures or 3% of the therapeutic 
interventions. In our study one patient with a DAP value of 153 Gy.cm2 and 
a skin dose of 3.1 Gy can be considered as a false negative. The DAP action 
level resulting from our study, 250 Gy.cm2, is somewhat lower than the level 
resulting from the European DIMOND III project, 300 Gy.cm2 [25]. 
According to ICRP publication 85 [8], an additional level of 1 Gy for 
procedures, likely to be repeated should be considered. This is applicable to 
patients undergoing PTCA, since a significant number of them need a repeat 
PTCA or additional coronary procedures later on. According to us, a 1 Gy 
action level is not relevant as this is only half of the threshold dose and the 
skin site with the MSD can only be estimated by the cardiologist. A 1 Gy 
action level would be applicable to a larger fraction of the treated patients: in 
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our study 25% of the therapeutic procedures. Also, a difference in action 
level between diagnostic and therapeutic procedures, as stated by the ICRP, 
is not relevant as in some hospitals a diagnostic procedure precedes a 
therapeutic intervention a few days earlier. 
 
Dose Reference Levels 
At the end of the EC DIMOND II project in 1999 the following DRLs were 
proposed: 67 Gy.cm2 for coronary angiography and 110  Gy.cm2 for PTCA  
[26]. The 75th percentile data obtained in present study, 71.3 Gy.cm2 and 
106.0 Gy.cm2 for respectively diagnostic and therapeutic procedures, as 
shown in Figure 5, support these DRLs. When applying these reference 
levels to the mean DAP values of the Belgian hospitals five of the cardiologic 
centres pass for diagnostic interventions and six for therapeutic 
interventions. However, the following EC project (DIMOND III, 2003) 
proposed new DRLs based on the 75th percentiles: 45 Gy.cm2 for coronary 
angiography and 75  Gy.cm2 for PTCA [25]. When applying these more 
stringent DRLs, only three of the Belgian cardiologic centres in our study 
would pass for diagnostic interventions and four for therapeutic 
interventions.  
0
10
20
30
40
50
60
70
80
90
GR SP IT IRL FIN ENG BEL*
a) Mean values 
DAP(Gy.cm2)
diagn therap
 
Figure 7.  a) Comparison of the mean values for Dose-Area Product (Gycm2) for diagnostic and 
therapeutic procedures for Belgium (* = this work) and other EU countries [25]. b) Comparison of 
the third quartile values for dose-area product (Gycm2) for diagnostic and therapeutic procedures 
for Belgium (* = this work) and other EU countries [25]. 
In Figure 7 a and b,  the mean and the 75th percentile values for the DAP for 
diagnostic and therapeutic cardiac interventions obtained in present work 
for Belgium are compared to the data reported by Neofotistou et al. [25] for 
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different European countries as a result of the European DIMOND III 
project.  From this figure it is apparent that DAP values in Belgium are 
relatively high in comparison with DAP values obtained in other European 
countries as well for CA as for therapeutic interventions. 
 
Training Programs and Quality Control  
The lower reference values of DIMOND III compared to the previously 
proposed ones were explained by the continued education and training of 
personnel involved in interventional cardiology procedures and the increase 
of constancy checks of the X-ray systems. The skin dose distribution data 
obtained in present study support practical training programs dedicated to 
patient skin dose reduction in interventional cardiology. Besides the 
emphasis on dose reduction techniques (such as use of pulsed fluoroscopy at 
low frame rate, last image hold, beam collimation, variable filtration, use of 
‘store-fluoro’ mode, use of the largest image intensifier field size and 
variable C-arm orientation), these programs should also focus on the 
relevance of DAP values as guideline in optimisation of procedure protocols 
in terms of radiation protection and in prediction of radiation induced skin 
injuries. Furthermore, an annual quality control of the X-ray equipment 
should be performed. The systematic registration of DAP for interventional 
procedures imposed by present Belgian legislation will allow a comparison 
of hospital DAP values with the DRLs proposed in this paper and lead 
towards optimization in terms of radiation exposure. The impact of training 
programs and quality control on patient dose will emerge from the follow 
up of the database of patient DAP values. This will allow an update of the 
DRLs, very probably lower than the values presented now and closer to the 
DRLs proposed in DIMOND III. 
It must be kept in mind that DAP action levels and DRLs are not a dose 
constraint nor a dose limit. It is a kind of investigation tool to identify 
unusually high levels of radiation that call for investigation if substantially 
exceeded [27]. 
 
Conclusion 
Cumulative DAP can serve as online monitor to provide the interventionist 
with an immediately readable dose display representative for the MSD. 
Therefore, systematic registration of this DAP at the end of the procedure in 
patient’s record is necessary.  In case DAP exceeds 125 Gy.cm2 
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(corresponding to a MSD of 2 Gy), registration in patient’s record of the 
entry site of the beam being responsible for the highest skin dose is 
indicated. A possible follow up of the patient for radiation skin effects is to 
the cardiologist’s decision. In case DAP exceeds 250 Gy.cm2 (corresponding 
to a MSD of 3 Gy) the patient and his personal physician should be informed 
on the possible radiation effects. A systematic follow-up should be 
performed. 
In present study, 71.3 Gy.cm2 and 106.0 Gy.cm2 are proposed as national 
DRLs for diagnostic and therapeutic procedures respectively in Belgium. 
Local mean values should be compared to these values in view of 
optimisation in terms of patient dose. 
Present study supports practical training programs in interventional 
cardiology. Beside the emphasis on dose reduction techniques (such as use 
of pulsed fluoroscopy at low frame rate, last image hold, beam collimation, 
variable filtration, use of ‘store-fluoro’ mode, use of the largest image 
intensifier field size and variable C-arm orientation), these programs should 
also focus on the relevance of DAP as guideline in optimisation of procedure 
protocols with respect to radiation protection and in prediction of radiation 
induced skin injuries. 
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Abstract 
In this paper, a large-scale multicentre patient dose study performed in eight Belgian interventional 
cardiology departments is presented. Effective dose (E) was calculated based on a detailed dose–
area product (DAP)-registration during each procedure and by using conversion coefficients 
generated by the Monte Carlo-based computer program PCXMC. Conversion coefficients were 
found to be 0.177 mSv Gy-1cm-2 for systems that do not use any additional copper filtration in 
cineradiography and 0.207 mSv Gy-1cm-2 for systems that use additional copper filtration in 
cineradiography. Mean E values of 9.6 and 15.3 mSv for diagnostic and therapeutic procedures, 
respectively, were obtained. DAP distributions were investigated in order to derive dose reference 
levels: 71 and 106 Gycm2 for diagnostic and therapeutic procedures, respectively, are proposed. 
Significant differences were observed in DAP distributions taking into account whether additional 
copper filtration was used in the cineradiography mode. Apart from the skin, the organs most at 
risk are lungs and heart. The probability of fatal cancer for the studied population amounted to 1.1 
x 10-4 and 2.1 x 10-4 for diagnostic and therapeutic procedures, respectively, for the age distribution 
of the patients considered in this multicentre study. 
 
Introduction 
Effective dose (E), introduced by the International Commission on 
Radiological Protection (ICRP) in publication 60(1), represents the risk of late 
radiation-induced effects such as malignancies and genetic effects.    
During cardiac procedures in the catheterization laboratory carried out 
under fluoroscopic control, such as coronary angiography (CA) and 
percutaneous transluminal coronary angioplasty (PTCA), the radiation 
doses received by the patient can be high(2-5). The hazards associated by the 
use of X-rays must therefore be justified by the procedure’s benefits.  
Adaptation of the clinical protocols and knowledge of  E  or other dose 
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related quantities such as dose-area product (DAP) of a procedure can lead 
to optimisation of patient safety and image quality in fluoroscopically 
guided invasive cardiovascular procedures(6). 
In order to determine E for a certain X-ray examination, knowledge of 
specific organ doses is essential. Unfortunately, specific organ doses cannot 
be measured directly during the procedure. Therefore Monte Carlo-based 
computer simulation codes are available, providing organ doses as a 
function of DAP or entrance surface dose (ESD) for certain irradiation 
geometries, X-ray spectra and clinical examination parameters. Thus, the 
problem of determination of organ doses in order to find  effective dose has 
shifted towards the calculation of accurate DAP to E conversion factors. 
The National Radiological Protection Board (NRPB) has published  
conversion factors for E, referring to both DAP and ESD measurements for 
68 common radiographic projections and 9 complete X-ray examinations(7). 
Tapiovaara et al.(8), of the Finnish Centre for Radiation and Nuclear Safety 
(STUK), developed a Monte Carlo-based computer program PCXMC in 
order to define specific E conversion factors in freely adjustable X-ray 
projections and other examination conditions used in projection radiography 
and fluoroscopy.  
For a number of types of interventional procedures, used in cardiology, 
conversion coefficients can be found in literature. Reported values are 
mainly restricted to a total conversion coefficient for E owing to a complete 
procedure. For instance, for PTCA values of 0.18(9) and 0.27 mSv Gy-1cm-2 (10) 
were reported for conversion of DAP to E.  
This study was undertaken in catheterization rooms in eight different 
Belgian hospitals, covering 318 patients of which 200 underwent a diagnostic 
procedure and 118 underwent a therapeutic procedure. Equivalent organ 
doses and effective dose were calculated based on DAP values recorded 
during the whole procedure.  The goal of this study was to determine 
DAP/E conversion coefficients using the Monte Carlo code PCXMC, and the 
information gathered in the catheterization rooms. Dependency of 
conversion factors of additional copper (Cu) filtration used in 
cineradiography was examined.  DAP distributions were interpreted in 
terms of dose reference levels (DRLs) and mean values of  each hospital 
specific distribution were compared with the proposed DRLs. 
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Materials and Methods 
Population and interventional procedures   
E was calculated for a total number of  318 patients (221 male, 97 female, age 
between 29 and 89) who underwent cardiac catheterization over a period of 
2 y (July 2003 – July 2005) in  eight hospitals in Belgium, selected to be 
representative for the whole territory.  Mean BMI was found to be 27.5 kg m-
2, ranging from 19 to 49 kg m-2. In each hospital about  40 patients in one 
catheterization room were included in this study. Patients were asked to 
keep their arms behind their neck during the procedure.  
The cardiac interventional procedures were divided into two groups. The 
first group comprises diagnostic CA possibly combined with Pulmonary 
Capillary Wedge Pressure measurements. The second group consists of  
therapeutic procedures:  single or multiple PTCA with or without single or 
multiple consecutive stenting, single or plural direct stenting and combined 
(diagnostic plus therapeutic) procedures. The procedures were performed 
by experienced cardiologists or medical doctors being in training for 
interventional cardiology. A total of 200 diagnostic and 118 therapeutic 
procedures were included in this study. 
 
X-ray equipment and DAP-meters  
The measurements were performed on different contemporary cardiac X-ray 
systems. Table 1 gives detailed information about the systems and describes 
the possible filtration combinations used in fluoroscopy and 
cineradiography mode. 
Most frequently a combination of an aluminium (Al) filtration of a particular 
thickness and one or more Cu filters of different thickness are used in 
addition to an inherent filtration of 2.5 mm Al. If we look into detail at the 
filtration for the two modes, we see, as indicated in Table 1, that systems 2, 5, 
7 and 8 have additional Cu filtration available for cineradiography mode 
and that for systems 1, 3, 4 and 6 this is not the case. For the fluoroscopy 
mode, all systems have the possibility to use extra Cu filtration. All X-ray 
tubes operated in a pulsed mode and controlled tube voltage and anode 
current with automatic brightness control. 
As calculation of E was based on the DAP values of the different projections 
used in the procedure, all X-ray tubes are equipped with a DAP meter. 
These DAP meters (PTW, Freiburg), were all integrated in the system and 
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were calibrated in situ for different tube voltages, filtrations and modes 
(fluoroscopy or cineradiography) with a  60cc ionisation chamber 
(Radcal,10X5-60, Dutoit medical ) and 33x41-cm Kodak X-Omat V films 
(Eastman Kodak) for field size determination. 
Image quality was checked for all systems, at normal clinical conditions 
using a Leeds FG18 phantom to comply with  the minimum criteria, defined 
in Radiation Protection 91 report of the European Commission (RP91)(11).  
According to this report, the contrast threshold under automatic brightness 
control should be ≤ 4%. With respect to resolution, the requirements to be 
met for field sizes of 23 – 25 cm are 1.0 lp mm-1 and 1.4 lp mm-1 for field sizes 
of 15 – 18 cm.  
 
Acquisition of data and exposure parameters  
Each projection used in a clinical protocol, can be characterised by a set of 
two angles per tube, using the radiological convention for geometry setting: 
cranial and caudal rotations in the sagittal plane of the patient and left 
anterior oblique (LAO) and right anterior oblique (RAO) for rotations in the 
transverse plane of the patient. For each projection used in the 
cardiovascular intervention, geometry, tube potential, filtration settings per 
mode, source to image detector distance, image detector field size, number 
of frames per second and the mode (fluoroscopy or cineradiography) were 
registered. Cumulative DAP and DAP rate as a function of time during the 
procedure were registered online by the PTW DAP meter connected to a 
Diamentor M4 readout unit and a laptop. An in-house written software 
made the measuremenof the DAP contribution for each mode and projection 
possible, based on the large difference in DAP rate (cGycm2 s-1)(12).  After 
each intervention, the following information was also recorded: complexity 
of the intervention (score 1 to 3), cardiologist’s experience (doctor or trainee) 
and patient’s data (gender, age, weight and length). 
 
Calculation of equivalent organ doses  and effective dose  
Using the recorded data, equivalent organ doses and E were calculated. 
Values for E were derived using two different methods for determination of 
conversion coefficients (mSv Gy-1cm-2), converting DAP into E. The first 
method used the Monte Carlo-based computer simulation program PCXMC, 
developed at the Medical Radiation Laboratory of the Finnish Radiation and 
Nuclear Safety Authority(8). The user defines, via a graphical interface, beam 
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parameters such as focus to skin distance, rotation geometry in transverse 
and sagittal plane, skin entry point and field size at this position. According 
to the practical set-up of this study, the arms were left out of the 
hermaphrodite phantom of the program.  
The second method used the tables of conversion factors, published by the 
NRPB(7). These factors were derived for certain filtrations and irradiation 
geometries for radiological examinations of different organs. The calculation 
of the coefficients in the NRPB-report was based on the Monte Carlo 
technique as described by Jones and Wall(13).  Specific factors for 
examinations of the heart are listed for four specific irradiation geometries. 
The calculation of E with PCXMC was practically performed taking into 
account a set of standard projections describing the irradiation geometry. 
These standard projections are adapted to the local clinical protocol used for 
diagnostic procedures and are specific for each hospital. For therapeutic 
procedures, the cardiologist selects a projection used in the diagnostic 
procedure where the lesion is most clearly visible. As a consequence, the 
standard projections used for diagnostic procedures can also be used to 
describe the geometry for therapeutic procedures. Practically, each standard 
projection can be characterized by two angles (θ and ϕ). Each projection in 
the cardiac intervention of a patient was decoded in the same way by θ’ and 
ϕ’ . A study of the differences between θ and θ’ and between ϕ and ϕ’ 
allowed to determine  the standard projection closest to each patients 
projection.  The data on the geometry for the standard protocols of each 
hospital are summarized in Table 2. These standard projections include 
geometries for frontal and lateral tubes in case of biplane systems. 
Contrary to cineradiography where the projections are fixed during 
imaging, fluoroscopy implies rotation of the tube resulting in multiple 
projections for guidance of the catheter. However, a very logical assumption 
about the irradiation geometry for fluoroscopy can be made taking into 
account the fact that fluoroscopy always precedes cineradiography in order 
to have the optimal view of the heart and the catheter during the following 
cineradiography run. Therefore, the different fluoroscopy projections were 
reduced to one covering projection chosen to be the same as that used in the 
following cineradiography run.   
66 
C
in
e
ra
d
io
g
ra
p
h
y
 
(m
m
A
l 
/ 
m
m
C
u
) 
(0
 /
 0
) 
(0
 /
 0
.2
 -
 0
) 
(0
 /
 0
) 
(0
 /
 0
) 
(0
 /
 0
 -
 0
.1
 -
 0
.2
 -
 0
.3
 -
 0
.6
) 
(0
 /
 0
) 
0 
/
 0
.2
 -
 0
) 
0 
/
 0
 -
 0
.1
 -
 0
.2
 -
 0
.3
 -
 0
.6
) 
F
lu
o
ro
sc
o
p
y
 
(m
m
A
l 
/ 
m
m
C
u
) 
(1
.5
 /
 0
 -
 0
.3
 -
 0
.5
) 
(0
 /
 0
.2
) 
(1
.5
 /
 0
.1
- 
0.
2 
- 
0.
4)
 
(1
.5
 /
 0
.1
 -
 0
.4
 -
 0
.9
) 
(0
 /
 0
 -
 0
.1
 -
 0
.2
 -
 0
.3
 -
 0
.6
) 
(1
.5
 /
 0
.1
- 
0.
2 
- 
0.
4)
 
(0
 /
 0
.2
) 
(0
 /
 0
 -
 0
.1
 -
 0
.2
 -
 0
.3
 -
 0
.6
) 
M
a
n
u
fa
ct
u
-
ri
n
g
 d
a
te
 
19
99
 
19
98
 
19
96
 
20
04
 
20
04
 
19
97
 
19
96
 
20
04
 
Im
a
g
e
 
R
e
ce
p
-
ti
o
n
 
II
 
II
 
II
 
F
D
 
F
D
 
II
 
II
 
F
D
 
Im
a
g
e
 
F
ie
ld
 
(c
m
) 
23
, 1
7,
 1
4 
23
, 1
7,
 1
3 
23
, 1
8,
 1
4 
25
, 2
0,
 1
5 
25
, 2
0,
 1
6 
23
, 1
7,
 1
4 
23
, 1
7,
 1
3 
25
, 2
0,
 1
6 
F
lu
o
ro
sc
o
p
y
 
(p
/s
) 
a
n
d
 
C
in
e
ra
d
io
g
ra
p
h
y
 
(f
/s
) 
12
.5
 -
 2
5 
12
.5
 -
 2
5 
12
.5
 -
 2
5 
12
.5
 -
 2
5 
15
 -
 3
0 
12
.5
 -
 2
5 
12
.5
 -
 2
5 
15
 -
 3
0 
M
o
n
o
/ 
b
ip
la
n
e
 
b
i 
m
o
n
o
 
b
i 
m
o
n
o
 
b
i 
m
o
n
o
 
m
o
n
o
 
m
o
n
o
 
X
-r
a
y
  
sy
st
e
m
 
P
h
il
ip
s 
In
te
g
ri
s 
B
H
 5
00
0 
S
ie
m
en
s 
C
o
ro
sk
o
p
 
P
h
il
li
p
s 
B
H
 3
00
0 
P
h
il
ip
s 
A
ll
u
ra
 F
D
 
S
ie
m
en
s 
A
x
io
m
 A
rt
is
 
P
h
il
ip
s 
In
te
g
ri
s 
H
M
 3
00
0 
S
ie
m
en
s 
C
o
ro
sk
o
p
 
S
ie
m
en
s 
A
x
io
m
 A
rt
is
 
T
a
b
le
 1
. 
D
e
ta
il
s 
a
b
o
u
t 
th
e
 X
-r
a
y
 e
q
u
ip
m
e
n
t 
 
H
o
s-
p
it
a
l 
1 2 3 4 5 6 7 8 II
, I
m
ag
e 
In
te
n
si
fi
er
; F
D
, f
la
t 
d
et
ec
to
r 
67 
 
Beside irradiation geometry represented in the standard projections, other 
parameters such as field size, filtration and tube voltage, specific for a 
hospital’s equipment and/or clinical protocol have to be taken into account. 
The source to image receptor distance (SID) was kept systematically 98 cm 
for monoplane systems and 105 cm for biplane systems with a distance from 
patient’s skin to  image intensifier of 10 cm. For projections with an angle in 
the cranial direction that was larger than or equal to 40° the SID was 
increased with 5 cm and the distance from patients skin to  image intensifier 
with 10 cm. It is necessary to simulate the real clinical situation for this kind 
of projections.  
Table 2. Standard  projections for each hospital 
 Hospital 1 
(bipl.) 
Hospital 2 
(monopl.) 
Hospital 3 
(bipl.) 
Hospital 4  
(monopl.) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
LAO 10 CRAN 10 
RAO 30 CAUD 30 
RAO 30 CRAN 30 
RAO 0 CRAN 40 
RAO 45 CRAN 25 
RAO 30 CAUD 0 
LAO 90 CAUD 0 
LAO 50 CRAN 20 
LAO 50 CAUD 30 
LAO 90 CRAN 10 
LAO 45 CRAN 25 
LAO 45 CAUD 0 
LAO 10 CRAN 10 
RAO 30 CAUD 0 
RAO 30 CRAN 20 
RAO 30 CAUD 20 
LAO 50 CRAN 10 
LAO 40 CRAN 30 
LAO 90 CAUD 0 
LAO 70 CAUD 20 
LAO 40 CAUD 30 
LAO 45 CAUD 0 
RAO 45 CAUD 0 
 
RAO 0 CAUD 0 
RAO 30 CAUD 0 
RAO 30 CAUD 30 
RAO 20 CRAN 30 
RAO 15 CRAN 40 
RAO 0 CAUD 35 
RAO 30 CRAN 20 
LAO 90 CAUD 0 
LAO 60 CAUD 0 
LAO 50 CRAN 20 
LAO 50 CAUD 20 
LAO 60 CRAN 20 
RAO 30 CAUD 0 
RAO 20 CAUD 20 
RAO 10 CRAN 40 
LAO 50 CRAN 20 
LAO 90 CAUD 0 
LAO 20 CRAN 20 
LAO 0 CRAN 0 
LAO 40 CAUD 0 
 
 Hospital 5 
(bipl.) 
Hospital 6 
(monopl.) 
Hospital 7 
(monopl.) 
Hospital 8  
(monopl.) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
RAO 30 CAUD 0 
RAO 30 CAUD 20 
RAO 30 CRAN 20 
RAO 0 CRAN 25 
RAO 0 CAUD 25 
RAO 0 CRAN 15 
RAO 45 CAUD 0 
LAO 50 CRAN 10 
LAO 90 CAUD 0 
LAO 70 CAUD 20 
LAO 45 CAUD 0 
RAO 30 CAUD 30 
RAO 30 CAUD 0 
RAO 30 CRAN 30 
LAO 40 CRAN 30 
LAO 45 CAUD 0 
LAO 45 CAUD 30 
LAO 90 CAUD 0 
LAO 0 CAUD 30 
LAO 0 CAUD 0 
LAO 30 CAUD 0 
RAO 30 CAUD 20 
RAO 30 CRAN 20 
RAO 5 CRAN 20 
RAO 5 CAUD 20 
LAO 40 CRAN 20 
LAO 40 CAUD 0 
LAO 40 CAUD 20 
RAO 30 CAUD 0 
RAO 30 CAUD 0 
RAO 25 CAUD 25 
RAO 10 CRAN 40 
LAO 45 CRAN 25 
LAO 90 CAUD 0 
LAO 35 CAUD 15 
LAO 10 CRAN 30 
LAO 60 CAUD 0 
monopl.,  monoplane system; bipl.,  biplane system. 
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Factors were calculated for the three different image receptor field sizes 
possible for each hospital (e.g. 23cm, 17cm and 13 cm) and the different 
filtrations used in each hospital were taken into account. 
For a certain standard projection with appropriate geometry, field size and 
filtration, conversion factors were calculated using PCXMC for tube voltages 
between 50kV and 120 kV in steps of 10kV. This implied calculation of a 
total of 5328 conversion factors.  For tube voltages in-between, interpolation 
of the conversion factors was applied. 
Figure 1 gives an example of the kV dependence of the DAP to E conversion 
factors for a standard projection of hospital 1 characterised by LAO 10  
CRAN 10 and a field size of 17 cm.  
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Figure 1. Conversion factor for effective dose from Dose-Area Product-values (mSv Gy-1cm-2) for 
field size of 17 cm and for projection LAO10 CRAN10 (hospital 1). 
DAP values of the individual patients were used together with the 
conversion factors calculated for an adult hermaphrodite phantom with 
reference dimensions which is essentially based on the phantom of Cristy(14).  
As the program only allows a scaling in height and weight of the phantom 
including its organs, without adding any additional layers of adipose tissue, 
this would lead to a simulation that is not realistic. As a consequence, the 
dimensions of the individual patients were not used as input in the program. 
Moreover, as a very large number of patients was considered in present 
study (318) the average dimensions of the patient group approached the 
reference dimensions. Therefore, no size correction(15)  was applied.  
Summarising, calculation of effective dose for each patient using PCXMC 
implies multiplication of the correct conversion factor defined by field size, 
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filtration, tube potential and geometry with the DAP contribution for each 
consecutive mode (fluoroscopy, cineradiography) in the procedure of that 
patient. This results in an effective dose contribution for each projection 
used in the cardiac intervention. Summing these effective dose contributions 
gives the effective dose for a specific patient. 
Athough, for the procedure of dose calculation with PCXMC, a set of 
standard projections was derived from the clinical protocol for each hospital, 
only four standard projections are available in the NRPB-tables, implying a 
reduction of the number of conversion coefficients.  The coefficients are 
given for spectra with peak potential ranging from 50 to 120 kV and total 
beam filtrations of 2 to 5 mm Al. Cu is not considered as filtration material in 
the tables.  For the dose calculations based on the NRPB tables, each 
projection during a catheterization procedure of a patient was reduced to 
one of the four available standard projections. The same method for 
assessment of the fluoroscopy projection as explained for E calculation with 
PCXMC was applied here. Interpolation was performed for tube voltages 
when necessary.  
Recent X-ray tubes for interventional cardiology are equipped with Al and 
Cu filtration, while the NRPB tables only consider Al filtration. In case of the 
procedures with Cu filtration the maximum value of Al filtration of the 
tables, 5 mm, is used. The standard focus-to-skin distance (FSD) applied in 
the NRPB-tables is 45 cm.  Calculated from the SID, the FSD used for the 
PCXMC calculations ranged from 63 to 75 cm, taking into account 
projections with angulations larger than or equal to CRAN 40. 
Equivalent organ doses were be calculated using PCXMC. The simulation 
resulted in conversion factors for DAP to equivalent dose (mSv Gy-1cm-2) for 
different organs together with the DAP to E conversion factors for the 
different standard projections, field-size, filtration and tube voltage as 
described above. Equivalent organ doses were considered for diagnostic and 
therapeutic procedures separately. 
 
Effect of patient support table 
The effect of the patient support table being in the beam at frontal 
projections had to be considered when calculating effective dose, both with 
the PCXMC program and NRPB-tables. Patient support table induces beam 
hardening but influences to a greater extend the photon fluence in the beam. 
Beam hardening implies an increase in effective dose contribution for frontal 
projections whereas a decrease of photon fluence implies a decrease in 
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effective dose contributions. Both effects will only partially compensate, 
resulting in a decrease in effective dose contribution for frontal projections.  
Beam hardening effect was simulated by PCXMC and the decrease in 
fluence, due to presence of patient support table, was measured. We found 
all patient support tables, except for the patient support table in hospital 7, 
to have an equivalent of 0.8 mm Al,  which caused an increase of effective 
dose contribution for frontal projections of 11.5 %. The patient support table 
of hospital 7 had an equivalent of 0.5 mm Al, causing and increase of  7.4% 
in effective dose contribution for frontal projections. Decrease in photon 
fluence was measured to be 32.6 % for all hospitals except for hospital 7 
where the decrease in photon fluence was 19.4%. The resulting factor for the 
decrease of effective dose contribution for projections with patient support 
table in the beam was 0.751 for all hospitals, except for hospital 7 where the  
factor was 0.866.  For all frontal and inclined projections for which the 
patient support table was located in the beam, these factors were applied.  
 
Statistical Analysis  
Because multiple factors may influence radiation dose measurements and 
calculations, a multifactor analysis of variance (ANOVA) was set up. Factors 
in the ANOVA design included the differences between hospitals, the 
difficulty of the procedure, system of beam filtration insertion and type of 
equipment (bi/monoplane, digital flat panel or conventional image 
intensifier). Levene’s test was used to test the homogeneity of the variances 
between groups. A non-significant result of the Levene’s test assured a 
correct application of the ANOVA analysis. Pillai’s trace was used as a 
robust indicator of significance in the ANOVA analysis(16). 
In cases where only two groups had to be compared, a non-parametric two-
tailed Mann-Whitney test was performed. Correlations between groups 
were calculated by means of the non-parametric Spearman’s rank 
correlation coefficient (r). To calculate the regression coefficients in the 
relation between two quantities, linear regression analysis was performed 
using the Levenberg-Marquardt algorithm. The difference between 
regression lines was calculated using the general linear model. 
In all statistical calculations, a confidence interval of 95% was applied. 
Hence, a p-value <0.05 was considered as significant. All calculations were 
performed by means of the SPSS 12.0 software (SPSS, Chicago, IL, USA). 
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Results 
Mean values of DAP and E for diagnostic and therapeutic interventions in 
the different hospitals of present study are listed in Table 3 . Mean DAP 
values were found to be 56 and 82 Gycm2 for diagnostic and therapeutic 
procedures, respectively. Overall distributions of diagnostic and therapeutic 
procedures resulted in DRL values (75 percentile) for DAP of 71 and 106 
Gycm2 respectively. Overall mean values for E are 9.6 mSv for diagnostic 
procedures and 15.3 mSv for therapeutic procedures. 
Figures 2 and 3 represent the histograms of DAP values for diagnostic and 
therapeutic procedures respectively, taking together the hospitals that use 
additional Cu filtration in cineradiography mode in their cardiac X-ray 
equipment, and hospitals that do not. A striking reduction in the mean 
value, indicated by the vertical lines, is observed as well in diagnostic as in 
therapeutic procedures, when additional Cu filtration is used in 
cineradiography. A mean value of 38 Gycm2  (60 Gycm2)  was observed for 
systems that use additional Cu filtration in cineradiography mode and  71 
Gycm2  (108 Gycm2) for systems that did not have that option, for diagnostic 
(and therapeutic) procedures. 
Figures 4 and 5 compare the mean values of the DAP distribution of each 
hospital (full line) with the proposed DRLs (dashed line)  for diagnostic and 
therapeutic procedures, respectively (71 and 106 Gycm2).  The histograms 
and the ANOVA statistical analysis performed, show that DAP depends 
significantly on the hospital (p < 0.001).   
 
Table 3. Mean effective dose values calculated with the Monte Carlo simulation program 
PCXMC and dose-area-product values, both for diagnostic and therapeutic procedures.    
 Diagnostic procedures Therapeutic procedures 
 E (mSv) DAP (Gycm2) E (mSv) DAP (Gycm2) 
1 13.4 76.9 21.7 120.3 
2 6.5 31.2 12.9 57.0 
3 11.2 74.2 13.9 90.8 
4 8.3 50.6 13.2 75.8 
5 8.4 46.2 15.2 78.0 
6 14.0 83.1 24.9 137.7 
7 4.3 18.6 9.8 41.5 
8 9.1 54.9 13.1 70.0 
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Figure 6 shows the correlation between total DAP values and calculated E. 
An excellent overall correlation between the effective dose and DAP was 
found, resulting in a conversion factor of 0.185 mSv Gy-1cm-2  (dashed line) [r 
= 0.966, p < 0.001,  95% confidence interval for the slope (0.182 - 0.188)]. 
When analysing diagnostic and therapeutic procedures separately, similar 
correlations and regression lines were found (slope 0.179 mSv Gy-1cm-2,  r = 
0.968, p < 0.001 and slope 0.190 mSv Gy-1cm-2, r = 0.974, p < 0.001 
respectively). The difference in slope of the regression lines did not reach 
statistical significance (p = 0.723). However, a significantly lower conversion 
factor for the systems that do not have extra Cu filtration implemented in 
cineradiography was found compared to the systems that do have this 
option. The resulting conversion factor was 0.177 mSv Gy-1cm-2  (r = 0.976, p 
< 0.001) for systems that do not use any extra Cu filtration in 
cineradiography versus a conversion factor of 0.207 mSv Gy-1cm-2  (r = 0.979, 
p < 0.001) for other systems. The  p-value  for the distinction of the slope of 
both regression lines was smaller than 0.001. 
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Figure 2. Comparison of histograms of dose-area product values for diagnostic procedures, 
taking into account the availability of additional copper filtration in cineradiography mode.  
 
Relative contributions of fluoroscopy and cineradiography to E were 
calculated.  Fluoroscopy contributions for both diagnostic and therapeutic 
procedures are represented in Figure 7. Mean values were 39% for 
diagnostic and 56% for therapeutic procedures. Of all hospitals, hospital 6 
has a very large contribution of fluoroscopy to E for both types of 
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procedures. This is due to the continuous use of high fluoroscopy mode, 
with the lowest filtration in the X-ray beam in this hospital. 
Besides the use of the Monte Carlo simulation program PCXMC, E was also 
calculated using the NRPB tables and the measured DAP values. E 
calculated based on the  NRPB tables is, in general, 12% lower. 
Equivalent doses for all organs defined in ICRP 60(1) are calculated with 
PCXMC. Organs that received the highest dose are listed in Table 4. As can 
be expected, the lungs and the heart are exposed to the highest level and 
receive mean equivalent doses in the range of 40 and 60 mSv for diagnostic 
and therapeutic procedures respectively. Doses for liver, breasts, pancreas 
and muscle were calculated to be below 15 mSv for both diagnostic and 
therapeutic procedures. Stomach, thyroid, kidneys, spleen and gall bladder 
received doses lower than 5 mSv while ovaries, testes, intestine, urinary 
bladder, brain and uterus receive a low dose level (< 0.5 mSv). 
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Figure 3. Comparison of histograms of dose-area product values for therapeutic procedures, 
taking into account the availability of additional Cu filtration in cineradiography mode. 
Imaging performance tests were carried out for all X-ray systems and were 
checked to comply with RP91(11). Concerning contrast visibility, all systems 
fulfilled the criteria (contrast threshold under automatic brightness control ≤ 
4%). Average values for contrast threshold at normal operation mode are 2.4 
% (10% variation in terms of percentage) for fluoroscopy and 1.5% (8% 
variation in terms of percentage) for cineradiography. This difference is 
statistically significant (p < 0.001). With respect to resolution, all systems 
except for two fulfilled the requirements of RP 91 (for field sizes of 23 – 25 
cm resolution should be at least 1.0 lp mm-1 and for field sizes of 15 – 18 cm 
at least 1.4 lp mm-1). The elder image intensifiers of hospitals 3 and 6 did not 
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comply with the criteria for magnification (smallest fields). Average values 
for resolution for fluoroscopy and cineradiography at normal operation 
mode are 2.00 lp mm-1 (18% variation in terms of percentage) and 2.16 lp 
mm-1 (18% variation in terms of percentage) respectively. This difference is 
not significant (p =0 .236). 
 
Figure 4. Comparison of histograms of DAP values for diagnostic procedures for the different 
hospitals. The general third quartile, is indicated by a dashed line. The local mean values and 
the local distribution are indicated by a full line. 
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Figure 5. Comparison of histograms of DAP values for therapeutic procedures for the different 
hospitals. The general third quartile, is indicated by a dashed line. The local mean values and 
the local distribution are indicated by a full line. 
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Figure 6. Correlation between DAP values  (Gycm2) and effective dose (mSv) for the studied 
patient population. Distinction is made for the hospitals where additional copper filtration was 
available in cineradiography mode and for hospitals where this was not the case. 
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Figure 7. Contribution  in terms of percentage to effective dose due to fluoroscopy for diagnostic 
and therapeutic procedures. 
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Table 4. Mean equivalent doses (mSv) for the organs mostly exposed during diagnostic and 
therapeutic procedures. 
 Mean equivalent organ doses (mSv) 
 Diagnostic 
procedures 
Therapeutic 
procedures 
Active Bone marrow 9.7 16.8 
Skeleton 18.1 29.5 
Lungs 43.3 67.2 
Oesophagus 25.5 48.1 
Adrenals 13.0 16.2 
Thymus 14.4 22.9 
Heart 35.9 64.5 
 
 
Discussion and Conclusion 
In this study, detailed DAP registration made determination of overall DAP 
distributions possible. Third quartile values led to national DRLs for 
interventional cardiovascular diagnostic and therapeutic procedures. The 
proposed values are 71 and 106 Gycm2 for diagnostic and therapeutic 
procedures respectively.  
These correlate well with DRLs proposed in  Refs. (17) and (18) as a result of 
the DIMOND II and the DIMOND III project:  67 and 57 Gycm2, respectively 
for diagnostic procedures and 110 and 94 Gycm2 respectively for therapeutic 
procedures.  DRL values of  122, 84 and 67 Gycm2 were derived by Aroua et 
al.(19) for cardiac catheterization, stent insertion and PTCA, respectively, in a 
national survey in Switzerland. They attribute the large difference with the 
literature in DRL for diagnostic procedures (CA) to the variability in 
techniques used, particularly in the case of complex examinations. The lower 
values found bij Aroua et al. for stent insertion and PTCA in comparison 
with the present work can be explained by the fact that ‘therapeutic’ 
procedures, as defined in this study, also contain combined procedures 
where a therapeutic intervention immediately follows a diagnostic 
examination.   
Figures 2 and 3 show a significant difference in DAP distribution depending 
on the availability of additional Cu filtration. Lower DAP values can be 
attributed at least partly to higher filtration of the X-ray equipment in 
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cineradiography mode, and might be lowered even more by dose conscious 
action or training of the cardiologists. The data support that additional Cu 
filtration is a very helpful tool for dose reduction if correctly installed or 
upgraded and implemented in clinical practice. Dose saving tools such as 
additional Cu filtration can be implemented on an existing X-ray system to 
lower mean values of a local distribution in order to comply with 
established DRLs. Additional filtration will lower not only DAP values but 
also skin doses and E. 
A good correlation was found between E and DAP, providing an overall 
conversion factor between these two quantities of 0.185 mSv Gy-1cm-2. 
Statistical significance was not observed for the difference in DAP/E 
conversion factors between diagnostic and therapeutic procedures.  
 
Table 5. Comparison of the different conversion factors from dose-area product to effective dose 
(mSv/Gycm2) for the different systems in the hospitals corresponding to whether extra copper 
filtration was available in cineradiography mode or not. 
 
Conversion factor  
(mSv  Gy-1cm-2) 
All systems 0.185 
Systems with Cua 0.207 
Systems without extra Cub 0.177 
aSystems that use extra Cu filtration in 
cineradiography mode 
bSystems that do not use any extra Cu filtration in 
cineradiography mode 
 
However, distinction based on filtration used in cineradiography mode in 
terms of the availability of extra Cu material in the beam does make sense. A 
conversion factor of 0.207 mSv Gy-1cm-2  for systems that use extra Cu 
filtration in cineradiography was found, whereas the conversion factor 
amounts to 0.177 mSv Gy-1cm-2  for the other systems. The beam hardening 
as a consequence of the additional Cu filtration leads to a higher  mean E-
value for the same DAP value.   
Although conversion factors were calculated for each hospital individually, 
taking into account the X-ray set up and the clinical protocol, as stated by 
Schultz and Zoetelief(20), geometry related factors did not result in significant 
differences in conversion factor. The standard projections derived from the 
clinical protocol and presented in Table 2 show that more geometries are 
used in biplane than in monoplane systems and that different hospitals 
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indeed use different projections. The lateral projection LAO 90 CAUD 0, for 
instance, is not included in the standard clinical protocol of hospital 7. 
Instead of influencing E, this fact affects mostly maximum skin dose, as 
highest values for this dose quantity can be found under this projection, as 
shown in a complementary study in the same 8 hospitals(21).  Considering 
the different standard projections of the hospitals, we see that only hospitals 
3, 4 and 6 use the pure frontal (AP) projection (LAO 0 CAUD 0) to make a 
cineradiography run, whereas the other hospitals use this projection only 
during  fluoroscopy at the beginning of the procedure for guidance of the 
catheter.   
Effective doses were calculated for 318 cardiovascular procedures taking 
into account the X-ray set up and the clinical protocol in each participating 
hospital using the Monte Carlo Code PCXMC and also using conversion 
coefficients  of the NRPB-tables. As a result of the PCXMC calculations, a 
mean value of 9.6 mSv was obtained for effective dose of diagnostic 
procedures but with individual outliers up to 60.7 mSv. The UNSCEAR 2000 
report indicates as mean value for health care level I countries 7.3 mSv. With 
this effective dose, CA is among the medical applications of diagnostic X-
rays with a high patient radiation burden. Computed tomography of the 
thorax and the abdomen induces similar doses of 9.7 mSv and 12.0 mSv 
respectively (22).  
For patients undergoing therapeutic interventions the mean effective dose of 
our study was 15.3 mSv with outliers up to 79.8 mSv. For comparison, the 
mean effective dose for a PTCA intervention reported in the UNSCEAR 2000 
report is 22 mSv. In the study of Neofotistou et al. (23) individual patient data 
range from 7.5 up to 57 mSv.  Dose values of  5.6 mSv for diagnostic 
procedures and of 13.0 mSv for therapeutic procedures were reported by 
Betsou et al.(9). 
Dose ranges of 4.6 – 15.8(23) and 2.7 – 8.8 mSv(24) for diagnostic procedures 
and of  5.4 – 41.0(23) and 5.7 – 15.3 mSv(24)  for therapeutic procedures were 
reported before. Both dose values and dose ranges present slightly lower 
mean E values than observed in our study. It should be mentioned that 
Betsou et al.(9) based E determination on phantom (RANDO) measurements, 
that Neofotistou et al.(23) based their E determination on effective dose 
conversion factors published by NRPB and that only Stisova(19) based E 
determination on PCXMC calculations. 
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Figure 8. Age distribution of the patients included in this study and age dependency of the life-
time risk for males and females in per cent per Sv(1). 
 
In this study, Comparing the E determined using the NRPB tables with E 
calculated by means of PCXMC revealed a systematically lower value  
(12%). This can be explained by the fact that NRPB only provides conversion 
factors for beam filtration in millimeters of Al, which cannot always be 
applied in contemporary equipment for interventional cardiology. Cu filters 
are often inserted into the beam as skin-dose saving tool. A higher filtration 
implies beam-hardening and thus a higher E value to be expected.  
When we look at the organs at risk, certainly the skin is the most important 
tissue. However, in contrast with maximal skin dose, mean skin doses are of 
no interest. The skin is only partially exposed and only hot spots of high 
doses can relatively easy pass the threshold for deterministic effects: 2 Gy(1). 
With respect to the skin, PCXMC is able only to calculate mean doses. If one 
wants to know what the maximal skin doses amounts to we should perform 
in situ measurements using thermoluminescent dosimeters. This was 
performed in a complementary study in the same 8 hospitals(21).  Organs 
directly in the beam apart from the skin that receive highest equivalent dose 
are the lungs and the heart.  
The risk for late effects is strongly dependent on patient’s age and is 
different for males and females. In Figure 8, the age dependence of the 
attributable life-time risk in per cent per Sievert according to the ICRP 
publication 60(1) following the multiplicative model is depicted graphically 
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for males and females. On the same figure the age distribution of the 
patients considered in our multicenter study is presented. Using these data 
together with the effective doses of the patient population, the average risk 
for late effects for a diagnostic cardiologic intervention amounts to 1.1 x 10-4 
for both males and females and 2.1 x 10-4 for a therapeutic cardiologic 
intervention also for both genders, for the age distribution of the patients 
considered in this multicenter study. In view of these values all measures 
have to be taken to reduce cumulative DAP value and consequently also the 
effective dose leading to a reduced risk for late effects especially when 
treating relatively young patients. 
In conclusion,  From this study  national DRLs for Belgium for diagnostic 
and therapeutic cardiovascular interventional procedures could be derived 
for DAP values. Proposed conversion factors for E differed significantly for 
systems that used additional Cu filtration in cineradiography mode and 
systems that did not.  
Additional Cu filtration is a very effective dose saving tool on X-ray systems 
used for fluoroscopy-guided procedures and has its influence on the dose 
registered to the patient through lower DAP and E values. Therefore, 
comparison of local mean values with DRLs, together with specific practical 
training for cardiologists leading towards dose conscious action and 
towards practical use of dose saving tools in X-ray equipment, make dose 
reduction possible. 
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Abstract 
Effective dose (E), representing the risk of late radiation-induced effects can be estimated by the use 
of conversion factors (CF), converting direct measurable quantities such as Dose-Area-Product 
(DAP) into E. Eight Belgian hospitals participated in the study with a total number of 318 
procedures. E-values, calculated with PCXMC, were compared for the different hospitals for 
diagnostic and therapeutic procedures separately. E varied significantly depending on the hospital 
where the procedure was performed (p < 0.001), on filtration insertion (p < 0.001), on whether a 
centre is a training centre or not, the dose conscious action of the cardiologists and the complexity 
of the procedure (p < 0.001). Hospital specific CF were calculated. An average CF of 0.185 mSv     
Gy-1cm-2 was obtained with a satisfactory correlation (r = 0.966, p < 0.001). The differences in CF 
between hospitals were due to a large extent to the availability of additional filtration in cinegraphy 
mode (p < 0.001) and not to differences in irradiation geometries in the clinical protocol of the 
interventional procedures.   
 
Introduction 
As stated in the draft recommendations of the ICRP (2007)(1), Effective Dose 
(E) can be of value for comparing the use of similar technologies and procedures in 
different hospitals and countries as well as the use of different technologies for the 
same medical examination, provided the patient population is similar with regard to 
age and sex.  Determination of E is very important for high dose examinations 
as cardiovascular procedures carried out under fluoroscopic control. 
Moreover, in recent years the number of fluoroscopy-guided procedures in 
interventional cardiology has increased substantially. Typical annual figures 
for Percutaneous Transluminal Coronary Angioplasty (PTCA) in developed 
countries are 500-1000 per million inhabitants(2) . Comparing literature data, 
E-values range from 5 to 9 mSv for  Coronary Angiography (CA) and from 6 
to 15 mSv for PTCA (3-6).   
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Yet, determination of E being defined in ICRP 60(7) as the sum of the 
weighted equivalent doses in twelve critical organs is quite complex since 
direct organ dose measurements are not possible in patients undergoing a 
cardiovascular procedure. Therefore, several indirect methods have been 
proposed to allow for a practical estimation of E. Based on the use of Monte 
Carlo modelling of radiological exposures, these methods only require the 
measurement of the incident radiation, e.g. Dose Area Product (DAP), to 
estimate patient E(8) .  
The goal of this study was to calculate E based on detailed DAP registration 
during the procedures and by the use of specific conversion factors (CF), for 
eight catheterization rooms in Belgian hospitals representing the situation of 
the Belgian territory. Differences in mean E-values were analysed in terms of 
protocol- or equipment-related parameters. Hospital specific conversion 
factors converting DAP into E, generated by the Monte Carlo simulation 
code PCXMC [9], were compared to each other. The influence of different 
factors on the CF such as clinical protocol (orientation of the fluoroscopy and 
cine views), equipment (filtration) and procedure (diagnostic or therapeutic) 
was investigated. 
 
Materials and Methods 
Eight Belgian hospitals participated in this study, providing a population of 
221 male and 97 female patients, between 29 and 89 years of age. An average 
of 40 patients per catherisation room was followed for both diagnostic CA 
and therapeutic procedures. Therapeutic procedures comprised both single 
or multiple balloon or stent dilatation as combined procedures. In the latter 
the therapeutic part follows immediately the diagnostic part (CA) of the 
procedure. A total number of 200 diagnostic and 118 therapeutic procedures 
were included in this study. 
The X-ray equipment in the participating hospitals, all manufactured by 
either Philips or Siemens, consisted of three biplane and five monoplane 
systems. Three of the systems had flat detectors for image capture. The 
others used conventional image intensifiers. All X-ray systems can be 
considered as contemporary state of the art equipment with pulsed mode for 
X-ray generation. All systems inserted aluminium (Al) and copper (Cu) 
filtration into the beam in fluoroscopy mode, but only for four of them 
additional Cu filtration was available in cinegraphy mode. All systems were 
provided with a build-in DAP-meter that was calibrated in situ, using a 60cc 
ionisation chamber (Radcal Corporation, Monrovia, USA) and a 
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radiographic film (Eastman Kodak) for field size determination. Online 
computer registration of cumulative DAP and DAP rate made interpretation 
in terms of fluoroscopy and cinegraphy mode possible.  
During a cardiovascular procedure, following parameters were recorded: 
field size, tube potential, filtration, mode (fluoroscopy or cinegraphy), 
irradiation geometry, number of frames per second, complexity score of the 
procedure according to the cardiologist and patient characteristics (gender, 
age, height and weight). A three-point scale for the complexity score was 
based on the duration of the procedures with respect to an equivalent 
procedure under normal circumstances, the number of lesions, the 
accessibility of the coronary arteries and the number of frames in one fixed 
orientation.   
For calculation of E and CF, the Monte Carlo-based computer program 
PCXMC(9) was used. For each hospital the irradiation geometry of the 
clinical protocol was described in ’standard projections’. For calculation of E, 
the irradiation geometry of each procedure was described in terms of the 
standard projections. Field size, filtration and tube voltage recorded during 
the procedure and a fixed source to image receptor distance (SID) were used 
as input in the program. SID was 98 cm for monoplane systems and 105 for 
biplane systems. The distance from patient’s skin to the image receptor (PID) 
was 10 cm. For geometries with an angle in cranial direction larger than 40 
degrees, SID was increased with 5 cm and PID with 10 cm, according to the 
realistic clinical situation.  
Statistical analysis was based on a multifactor ANOVA. In cases were only 
two groups had to be compared, a non-parametric two-tailed Mann-
Whitney test was performed. A p-value < 0.05 was considered as significant. 
 
Results and Discussion 
Effective Dose values  
E was calculated for each procedure taking into account the CF for the 
hospital where the procedure was performed. Overall histograms of E are 
represented for diagnostic and therapeutic procedures separately in Figure 
1. The vertical lines represent the median values of these distributions and 
amount to 7.3 mSv for diagnostic procedures and 11.6 mSv for therapeutic 
procedures. Both distributions are strongly skewed, with E values reaching 
up to 79.8 mSv for therapeutic interventions. Overall mean values for E are 
9.6 mSv for diagnostic procedures and 15.3 mSv for therapeutic procedures.  
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E distributions were also calculated for the different hospitals, for diagnostic 
and therapeutic procedures respectively and are represented in Figures 2 
and 3. The median values of the overall distribution for diagnostic and 
therapeutic procedures respectively are taken as a guidance for comparison 
of local median E values. In figures 2 and 3, the local distributions and their 
median values are indicated by a full line and the overall median values are 
represented by a dashed line. Based on these histograms and on the 
ANOVA statistical analysis performed, we can conclude that E varies 
significantly depending on the hospital where the procedure was performed 
(p < 0.001), on filtration insertion (p < 0.001), on whether a centre is a training 
centre or not, the dose conscious action of the cardiologists and the 
complexity of the procedure (p < 0.001).  
 
Figure 1. Histogram of effective dose E (mSv) for diagnostic (full line) and therapeutic (dashed 
line) procedures. The median values are indicated by a vertical line. 
A comparison of the E histograms for the different hospitals revealed 
significant differences between the hospitals with respect to E for the patient 
(p < 0.001). This means that in some hospitals doses are significantly higher 
or lower than the average for both diagnostic and therapeutic procedures. In 
hospital 6, higher E-values and in hospitals 2 and 7, lower E-values are 
obtained.  
In hospital 1 (training facility for cardiologists), we should take into account 
that, at the moment our measurements were carried out, different assistant 
cardiologists in training performed PTCA and stenting procedures. This 
explains the high E-values for therapeutic procedures related to this 
hospital. For both diagnostic and therapeutic procedures, mean E numbers 
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of hospital 6 were considerably higher than the overall figures. Although 
hospital 6 is a also training centre, the high values could mainly be 
attributed to the poor attention of some cardiologists with respect to 
radiation burden of the patient and the continuous use of the fluoroscopy 
’high’ mode for fluoroscopy filtration setting. 
 
Figure 2. Comparison of histograms of effective dose for diagnostic procedures for the different 
hospitals. The overall median value is indicated by a dashed line. The median value of the local 
distribution is indicated by a full line. 
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Figure 3. Comparison of histograms of effective dose for therapeutic procedures for the different 
hospitals. The overall median value is indicated by a dashed line. The median value of the local 
distribution is indicated by a full line. 
In hospital 7, diagnostic and therapeutic procedures are performed with the 
lowest E, which can be explained by the very low tube-current setting in 
comparison to the tube currents of the other hospitals. Highest doses were 
recorded in hospital 1 , 3 and 6. These were the only departments where a 
manual filtration methodology was used. Hence, using automatic filtration 
insertion will generally result in lower E-values. It is, however, worthwhile 
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to mention that only very little filter variability was implemented in the 
systems of hospital 2 and 7. Therefore, in the latter centres, low E-values can 
be more attributed to the good practice in terms of the amount of radiation 
used by the cardiologist.  
In conclusion, with respect to technical parameters, automated variable 
filtration settings result in significantly reduced effective patient doses (p < 
0.001). This relates to hospitals 2, 4, 7 and 8.  
In centers where flat-panel technology was introduced (hospitals 4, 5, 8), 
lower E-values were obtained. However, this effect did not reach 
significance (p = 0.068). A similar conclusion could be drawn for the 
comparison of E-values obtained in rooms equipped with a biplane and with 
a monoplane system. The use of biplane systems resulted in higher dose 
values.  
The complexity of the procedure had a significant influence on E (p < 0.001). 
In the 3-point difficulty scale used in this study, level 2 and 3 resulted in 
significantly higher median E-values compared to the first level (4.1 versus 
10.6 mSv). 
 
Conversion Factors 
An excellent overall correlation between E and DAP was found (r = 0.966, p 
< 0.001). When analysing diagnostic and therapeutic procedures separately, 
similar correlations were found (r = 0.965, p < 0.001 and r = 0.964,  p < 0.001 
respectively). Table 1 describes the different hospital specific CF from DAP 
to E. The average value for the CF is 0.185 mSv Gy-1cm-2. Statistical 
significance was not observed for the difference in CF between diagnostic 
(0.179 mSv Gy-1cm-2) and therapeutic (0.190 mSv Gy-1cm-2) procedures (p = 
0.723).  
However, distinction based on filtration used in cinegraphy mode in terms 
of the availability of additional Cu material in the beam does make sense. A 
CF of 0.207 mSv Gy-1cm-2 for systems that use extra Cu filtration in 
cinegraphy was found, whereas the CF amounts to 0.177 mSv Gy-1cm-2 for 
the other systems. The beam hardening as a consequence of the additional 
Cu filtration leads to a higher mean E-value for the same DAP value.  
Although CF were calculated for each hospital individually, taking into 
account the X-ray set up and the clinical protocol, as stated by Schultz and 
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Zoetelief(10), geometry related factors did not result in significant differences 
in CF. 
Table 1. Conversion Factor from DAP to E, for the different hospitals involved in this study. The 
last column mentions whether additional Cu filtration is available in cinegraphy mode or not. 
Hospital CF (mSv Gy-1cm-2) Additional Cu? 
1 0.184 No 
2 0.225 Yes 
3 0.157 No 
4 0.170 No 
5 0.203 Yes 
6 0.183 No 
7 0.235 Yes 
8 0.211 Yes 
 
For practical use of CF for calculation of E, the availability of additional Cu 
filtration can be taken into account. The CF factors derived in present work 
can be used for both diagnostic and therapeutic procedures. 
 
Conclusion 
Local E-distributions show statistical significant differences between 
different hospitals. This means that further dose reduction is possible for 
interventional cardiovascular procedures in Belgium. The importance of 
additional Cu filtration in clinical practice should be stressed. It is a very 
helpful tool that not only lowers E but also the Entrance Skin Dose (ESD), as 
shown in a complementary study in the same 8 hospitals(11). ESD easily 
exceeds the threshold of 2 Gy(7) for deterministic effects in these high-dose 
procedures. The use of conversion factors provides a very practical 
methodology to calculate E from DAP. In present work separate CF are 
proposed for X-ray systems that use additional Cu filtration in cinegraphy 
mode and systems that do not: 0.207 versus 0.177 mSv Gy-1cm-2. 
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Abstract 
Background—Because of the higher radiosensitivity of infants and children compared with adults, 
there is a need to evaluate the doses delivered to pediatric patients who undergo interventional 
cardiac procedures. However, knowledge of the effective dose in pediatric interventional 
cardiology is very limited. 
Methods and Results—For an accurate risk estimation, a patient-specific Monte Carlo simulation of 
the effective dose was set up in 60 patients with congenital heart disease who underwent diagnostic 
(n=28) or therapeutic (n=32) cardiac catheterization procedures. The dose-saving effect of using 
extra copper filtration in the x-ray beam was also investigated. For diagnostic cardiac 
catheterizations, a median effective dose of 4.6 mSv was found. Therapeutic procedures resulted in 
a higher median effective dose of 6.0 mSv because of the prolonged use of fluoroscopy. The overall 
effect of inserting extra copper filtration into the x-ray beam was a total effective dose reduction of 
18% with no detrimental effect on image quality. An excellent correlation between the dose-area 
product and effective patient dose was found (r=0.95). Hence, dose-area product is suitable for 
online estimation of the effective dose with good accuracy. With all procedures included, the 
resulting median lifetime risk for stochastic effects was 0.08%. 
Conclusions—Because of the high radiation exposure, it is important to monitor patient dose by 
dose-area product instrumentation and to use additional beam filtration to keep the effective dose 
as low as possible in view of the sensitivity of the pediatric patients. 
 
Introduction 
Interventional cardiology procedures are known to give high radiation 
doses to patients because of prolonged use of fluoroscopy, multiple cine 
runs, and the complexity of the procedures (1–8). The radiation exposure issue 
in cardiac catheterizations is particularly relevant for infants and children 
because of their higher radiosensitivity compared with adults, the large 
fraction of the body irradiated by the x-ray beam, and the probable need to 
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repeat the procedure (9,10). In addition, cardiac catheterizations are being 
increasingly used for therapeutic purposes, possibly resulting in higher 
patient radiation doses (9–11). When these facts are taken into account, there is 
a strong need to evaluate the doses delivered to pediatric patients who 
undergo such high-dose x-ray examinations (12).  
Most of the radiation dosimetry studies performed in pediatric patients are 
based on measurements with thermoluminescence dosimeters (TLDs) for 
estimating the dose to the skin, thyroid, and gonads (12–16). Other studies 
have indicated the dose-area product (DAP) (10,12,17,18,21). However, to assess 
the potential risk for stochastic effects such as cancer and leukemia resulting 
from cardiac catheterization procedures, the effective dose should be 
calculated (19). The limited published results are based mainly on phantom 
measurements or calculated conversion factors and do not take into account 
the real exposure settings and geometry (9,20,21 ). 
Therefore, the aim of the present study was to find a patient-specific 
determination of the effective dose in pediatric heart catheterization 
procedures and to investigate whether previously reported results on risk 
estimates are comparable to this patient-specific dosimetry. Furthermore, 
radiation doses of diagnostic procedures are compared with those of 
common therapeutic interventions. Because dose reduction in pediatric 
settings is of great importance, we also investigated the dose-saving effect of 
using extra copper filtration in the x-ray beam. 
 
Materials and Methods 
Patients 
The patient population included 60 consecutive pediatric patients with 
congenital heart disease (age ≤ 10 years). The study group comprised 33 
male and 27 female patients with a median age of 2.0 years (range, 1 month 
to 10 years) and a median weight of 11.7 kg (range, 3.0 to 43 kg). Nineteen 
patients were < 1 year of age. Of the 60 patients, 28 underwent cardiac 
catheterization procedures for diagnostic purposes (Table 1). Thirty-two 
patients were referred for a therapeutic catheter procedure: 11 for patent 
ductus arteriosus occlusion, 10 for atrial septal defect (ASD) closure, and 11 
for balloon dilatation. All examinations were carried out by an experienced 
pediatric cardiologist.  
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Table 1: Lesions studied in the diagnostic catheterization patient group 
Lesions Patients, n 
Univentricular heart 
Double aortic arch 
Truncus arteriosus 
Aortopulmonary collaterals 
Pulmonary atresia and intact septum 
Total anomalous pulmonary venous drainage 
Double discordance 
Pulmonary atresia and VSD 
Coronary artery fistula 
Swiss cheese VSD 
RV aneurysma 
AVSD   
15 
1 
1 
1 
2 
1 
1 
2 
1 
1 
1 
1 
VSD indicates ventricular septal defect; RV, right ventricular; and AVSD, 
AV spetal defect 
 
X-Ray System  
All studies were performed with an Integris BH5000 biplane x-ray system 
(Philips) consisting of a frontal Poly Diagnost C2 and a lateral L-arc 2 U. 
Tube settings such as peak voltage and anode current are controlled by the 
automatic brightness control. Pulsed fluoroscopy (12.5 frames per second) 
and cineangiography (25 frames per second) were used.  
For fluoroscopy, 2 x-ray beam filtrations were available. The standard 
setting consisted of a filtration of 1.5 mm Al, combined with 0.2 mm Cu. The 
low-dose fluoroscopy setting had an extra filtration of 0.2 mm Cu. The half-
value layers of the x-ray tubes for both fluoroscopy settings were measured 
at 80 kVp with a NE2571 Farmer ionization chamber (Thermo Electron, UK). 
For both tubes, values of 6.2 and 7.3 mm Al were obtained for the standard 
and low-dose fluoroscopy settings, respectively.  
For the measurement of the dose-area product (DAP) at the frontal and 
lateral tubes, 2 transmission ionization chambers (PTW) were attached to the 
tube housing of each x-ray tube and connected to a Diamentor M4 readout 
unit (PTW). DAP meters were calibrated in situ with the NE2571 Farmer 
ionization chamber and 33x41-cm Kodak X-Omat V films (Eastman Kodak). 
The calibration factor was taken as the ratio between the actual DAP, 
calculated as the dose in the centre of the field multiplied by the field size 
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measured from the film, and the DAP reading from the Diamentor M4. The 
calibration was performed for both beam filtration settings, with a peak 
potential ranging from 50 to 125 kV (Figure 1). 
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Figure 1. Calibration factor of the dose-area product monitors for the frontal X-ray tube.                
R represents the uncalibrated read-out of the DAP monitor. 
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Figure 2. Typical output of the DAP registration program: the registered DAP (solid line) and 
DAP rate (dashed line)  as a function of time. The example shows output for the frontal tube. 
99 
Effect of Extra Filtration on Image Quality and Dose 
To investigate the dose reduction when an extra 0.2 mm of copper filtration 
(low-dose setting) was used, patients were randomized to the standard or 
the low-dose fluoroscopy setting. From the 28 diagnostic catheterizations, 13 
were performed with low-dose fluoroscopy and 15 with standard settings. 
In half of the therapeutic interventions, low-dose fluoroscopy was used. Skin 
and effective doses were calculated in both groups as described below.  
For an objective image quality analysis of the effect of the additional 
filtration, a CDRAD 2.0 (University of Nijmegen) contrast-detail phantom 
study was set up (22). The phantom was used to assess the minimum contrast 
required to visualize objects of different sizes above the noise threshold.  
The phantom was placed between 2 layers of 5-cm PMMA to simulate 
patient scatter. For both filtration settings, images were acquired in the same 
conditions as used for patients. All images were scored by 5 independent 
readers using the methodology as described by the manufacturer (22). The 
results are presented in contrast-detail curves. 
 
Acquisition of Exposure Parameters 
For each projection used in the cardiac intervention, tube potential, filtration 
settings, fluoroscopy times, and position of the x-ray tubes  were recorded 
for all patients. The x-ray tube position (rotation and skew), tube potential, 
source-to-image-intensifier distance, and image intensifier field size were 
registered automatically for every cine run by the system.  
DAP data were gathered by connecting the Diamentor M4 readout unit to a 
laptop and using software written in-house. In this way, DAP values could 
be analyzed as a function of time. A distinction could be made between the 
fluoroscopy and the cine run contributions based on the large difference in 
DAP rate (cGycm2/s) between fluoroscopy and cine mode (Figure 2). DAP 
calibration factors were applied according to the tube potential and the 
filtration settings of an exposure. Thus, the variation in the DAP calibration 
factor with beam quality was taken into account.  
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Skin Dose Measurements 
To measure the entrance skin dose from the frontal tube, an array of 14-LiF 
TLD meters (Harshaw TLD-100, Thermo Electron) was attached to a 33x41 
cm Kodak X-Omat V dosimeter film. Afterward, the film was placed on the 
table underneath the patient’s back, near the frontal x-ray tube. The lateral 
entrance skin dose was assessed by placing 3 TLDs at the right armpit of the 
patient.  
TLDs were analyzed by a Harshaw 3500 reader (Thermo Electron Corp). 
Optical density readings from the film were obtained with a digital 
densitometer-scanner (Vidar System Corp). All TLDs were calibrated at the 
same beam quality that was used in situ. The SD within the set of TLDs was 
minimized to 2%. The X-Omat V film dosimeter was calibrated as described 
elsewhere (23).  
Film dosimetry was used to verify whether the maximum skin dose 
measured by TLD corresponded to the maximum skin dose assessed by film. 
If there was a good correspondence, TLD readings were preferred over film 
results because of their better accuracy. In addition, the measured skin dose 
distribution by film dosimetrie served as a verification of the results of the 
dose distributions obtained by Monte Carlo simulation.  
 
Patient-Specific Effective Dose Simulation  
The effective dose, introduced by the International Commission on 
Radiological Protection (ICRP), representative of the risk of late radiation-
induced effects as malignancies, is defined by the following expression (19): 
∑=
T
TT HwE ,  
where HT is the equivalent dose to tissue T and wT is the weighting factor 
representing the relative radiation sensitivity of tissue T. Organ equivalent 
doses were calculated with the Monte Carlo code MCNP4b2 (24).   
The simulations take into account the irradiation geometry of the x-ray tubes 
and the x-ray spectral distribution used for a particular projection in a 
patient. X-ray spectra were calculated with an analytical program (25,26). Field 
size at the patient’s skin level was calculated by measuring the focus-to-skin 
distance and by using the recorded source-to-image-intensifier distance and 
the image intensifier field size. The field geometry for fluoroscopy was 
copied from the first cine run after a series of fluoroscopy. This technique is 
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acceptable because most of the fluoroscopy is used to position the catheter 
for the next cine run, which is done with the same tube incidence.  
 
Table 2. Demographic Patient Data and Exposure Parameters for diagnostic catheterizations  
Diagnostic Catheterizations   
Standard Fluoroscopy 
(n=15) 
Low-Dose Fluoroscopy 
(n=13) p 
Demographic patient data 
Age, y 
BMI, kg/m² 
 
2.4 (0.1-8.8) 
14.6 (12.6-21.6) 
 
1.3 (0.1-9.2) 
14.9 (12.6-21.0) 
 
0.695 
0.945 
Exposure parameters    
Peak voltage frontal tube, kV 77.0 (58.3-79.6) 76.6 (71.2-80.3) 0.818 
Peak voltage lateral tube, kV 84.9 (59.5-100.0) 85.7 (74.6-102.0) 0.773 
Fluoroscopy time, s 294 (30-870) 234 (96-1992) 0.316 
Total DAP, cGycm² 548 (114-1461) 337 (96-1399) 0.510 
Fluoroscopic DAP rate, cGycm²/s 0.61 (0.53-0.92) 0.46 (0.22-0.94) 0.042 
PA cine runs, n 4.0 (1-9) 3.0 (1-7) 0.293 
LAT cine runs, n 3.0 (0-9) 2.0 (0-6) 0.356 
BMI indicates body mass index; PA postanterior; and LAT lateral. Values represent the median 
(range). 
 
Table 3. Demographic Patient Data and Exposure Parameters for therapeutic catheterizations 
Therapeutic Catheterizations   
Standard Fluoroscopy 
(n=16) 
Low-Dose Fluoroscopy 
(n=16) p 
Demographic patient data 
Age, y 
BMI, kg/m² 
 
2.0 (0.2-10.0) 
15.6 (10.1-23.7) 
 
2.0 (0.3-7.8) 
16.3 (13.4-30.1) 
 
0.401 
0.258 
Exposure parameters    
Peak voltage frontal tube, kV 75.0 (56.0-84.8) 79.1 (77.0-91.8) 0.041 
Peak voltage lateral tube, kV 83.0 (60.0-96.5) 89.7 (77.0-116) 0.024 
Fluoroscopy time, s 401 (182-3612) 300 (42-2466) 0.267 
Total DAP, cGycm² 472 (282-2044) 272 (41-1800) 0.079 
Fluoroscopic DAP rate, cGycm²/s 0.71 (0.42-1.11) 0.55 (0.30-0.91) 0.039 
PA cine runs, n 3.5 (2-7) 3.0 (2-14) 0.376 
LAT cine runs, n 3.5 (0-6) 3.0 (2-13) 0.249 
Abbrevitiations as in Table 2. Values represent median (range). 
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Because of the broad differences in body length and weight between the 
standard pediatric mathematical phantoms of 0, 1, 5, 10, and 15 years, (27) we 
developed a Visual Basic (Microsoft) program, allowing us to generate a 
more refined patient-specific phantom based on the gender and the length of 
the patient. Phantom calculation was based on the interpolation between the 
standard pediatric phantoms. In all cases, the arms were removed from the 
body phantom, simulating the normal clinical practice in which the patients 
have to move their arms along their head so as not to obstruct the lateral 
projection. The patient table was also included in the model to compensate 
for additional attenuation. The x-ray simulation was based on the 
assumption that the heart lies in the isocentre of the x-ray beams of the C 
arms.  
The computer phantom, the geometry of the x-ray tube, and the x-ray 
spectrum were used as input for the Monte Carlo simulations. Then, for 
every tube incidence and for each exposure mode, the effective dose per unit 
DAP was calculated using the ICRP60 organ weighting factors (19). For the 
remainder dose, the mass-weighted average of the remainder organs listed 
in the latter report was taken. The dose to the bone marrow was calculated 
with the method of Rosenstein (28) and the published kerma-to-dose 
conversion factors (29). The dose to the bone surface was taken as the dose to 
the skeleton excluding the marrow. By multiplying the effective dose per 
unit DAP by the corresponding recorded DAP, we could calculate the total 
effective patient dose. As a verification of the Monte Carlo calculations, the 
dose distribution at the location of the X-Omat V film was simulated and 
compared with the distribution derived from the film. 
 
Risk Estimation 
The lifetime mortality risk resulting from stochastic effects such as cancer 
and leukemia was determined by multiplying the effective dose by the 
appropriate risk factor. In this study, we used the ageand gender-dependent 
risk factors from the multiplicative model recommended in the ICRP 60 
publication: 13%/Sv for boys and 16%/Sv for girls (19) 10 years of age.  
 
Statistical Analysis 
Correlations in scatterplots were investigated by calculating the Pearson 
correlation (r). Differences between 2 independent (not normally 
distributed) populations were tested for significance with the 2-tailed Mann-
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Whitney test (95% confidence level). All statistical calculations were 
performed with the SPSS 10.0.5 program.  
 
Results 
Exposure Data 
Demographic patient data and exposure parameters used during the cardiac 
catheterization procedures are summarized in Tables 2 and 3 for the 
diagnostic and therapeutic interventions, respectively. The data for the 2 
patient groups receiving standard and low-dose fluoroscopy are indicated 
separately. There was no statistical difference in age and body mass index 
between the patient groups; hence, no bias was introduced as a result of 
differences between the groups.  
The median fluoroscopy time during the cardiac catheterizations was 372 
seconds (range, 30 to 3612 seconds). More fluoroscopy was used in 
therapeutic procedures (median, 456 seconds; range, 42 to 3612 seconds) 
compared with diagnostic catheterizations (median, 261 seconds; range, 30 
to 1992 seconds), but the difference was not statistically significant at the 
95% confidence level (p=0.089).  
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Figure 3. Correlation between maximum lateral and back skin dose, measured by TLD, and DAP. 
With extreme value for lateral dose taken out (hot spot > 250mGy), the correlation of lateral skin 
dose and DAP remains good (r = 0.78, slope = 0.203). 
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Use of the frontal and lateral tubes for cineangiography acquisitions was 
well balanced. The median measured cumulative DAP was 453 cGycm2 
(range, 41 to 2044 cGycm2). As a result of the longer fluoroscopy times and 
slightly higher number of cineangiographies, the median DAP was found to 
be higher in therapeutic interventions (463 cGycm2; range, 41 to 2044 
cGycm2) compared with diagnostic procedures (409 cGycm2; range, 96 to 
1461 cGycm2). However, differences were not statistically significant 
(p=0.568). 
The use of 0.2 mm extra copper filtration for fluoroscopy reduced the 
fluoroscopy DAP rate from a median of 0.71 to 0.51 cGycm2/s. This 29% 
reduction was significant (p=0.041). 
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Figure 4. Median effective dose for diagnostic and therapeutic catheterizations. A, Median 
contributions of fluoroscopy and cineangiography in total effective dose. B, Median contribution 
of frontal and lateral exposure in effective dose. Error bars represent the 25% and 75% 
percentiles. 
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Skin Dose 
Peak entrance skin doses measured with the TLD array on the patient’s back 
showed very good agreement with the X-Omat film doses (r=0.98). 
Correspondence between the 2 measurement techniques showed that the 
TLD array accurately detects the maximum skin dose. The median peak skin 
dose at the patient’s back was 34.2 mGy (range, 12.1 to 144 mGy). The 
median lateral peak skin dose, measured near the patient’s armpit, was 23.9 
mGy (range, 1.49 to 297.5 mGy).  
A strong correlation was found between DAP and maximum skin dose 
(Figure 3). This was the case for the frontal (r=0.90) and lateral (r=0.91) skin 
exposure. In 4 cases, the lateral TLD dosimeters were clearly not located at 
the peak skin dose positions. 
 
Effective Dose Simulation 
Comparison of the dose distributions measured on film and simulated with 
MCNP resulted in differences of <7% in all patients.  
Median effective doses for diagnostic and therapeutic cardiac interventions 
are shown in Figure 4. Contributions of cineangiography and fluoroscopy in 
the total effective dose are indicated in Figure 4A. Figure 4B illustrates the 
contributions of the frontal and lateral tube exposures to the effective dose.  
For the diagnostic cardiac catheterization, the median effective dose was 4.6 
mSv (range, 0.6 to 23.2 mSv). The cine contributed a median of 69% to the 
dose, and 49% of the effective dose was due to exposure of the lateral tube.  
The therapeutic cardiological procedures resulted in a median effective dose 
of 6.0 mSv (range, 1.0 to 37.0 mSv). The cine had a median contribution of 
45%, whereas 47% of the effective dose was due to the lateral exposure. ASD 
closure procedures were subject to a significantly lower effective dose 
(median, 2.8 mSv; range, 1.8 to 7.4 mSv) compared with the patent ductus 
arteriosus occlusions (median, 7.6 mSv; range, 2.1 to 37 mSv) and the balloon 
dilatations (median, 8.1 mSv; range, 2.9 to 20 mSv).  
 
106 
 
y = 0.00556x
R2 = 0.81786
y = 0.00824x
R2 = 0.92296
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
0 500 1000 1500 2000 2500 3000 3500 4000
fluoroscopy time (s)
Fl
u
o
ro
sc
o
py
 
pa
rt
 
o
f t
he
 
ef
fe
ct
iv
e 
do
se
 
(m
Sv
)
1.5mmAl+0.4mmCu
1.5mmAl+0.2mmCu
 
r = 0.96 
 
r = 0.90 
 
y = 0.0159x
R2 = 0.9173
y = 0.0131x
R2 = 0.8905
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
0.0 500.0 1000.0 1500.0 2000.0 2500.0
DAP (cGycm²)
To
ta
l E
ffe
ct
iv
e 
do
se
 
(m
Sv
)
1.5mmAl+0.4mmCu
1.5mmAl+0.2mmCu
 
 
r = 0.96 
r = 0.94 
 
Figure 5. A, Correlation between effective dose resulting from fluoroscopy and fluoroscopy time. 
B, Correlation between total effective dose and DAP for 2 filtrations considered in this study. 
 
In Figure 5A, the fluoroscopy part of the effective dose is plotted versus 
fluoroscopy time for standard and low-dose fluoroscopy settings. 
Application of low-dose fluoroscopy resulted in a mean reduction of the 
fluoroscopy part of the effective dose of 33%. The overall effect of inserting 
an extra 0.2 mm copper filtration in the x-ray beam was a total effective dose 
reduction of 18% (Figure 5B). An excellent correlation between the DAP and 
A 
B 
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the effective patient dose was found for both normal (r=0.96) and low-dose 
(r=0.94) fluoroscopy.  
 
Image Quality of Low-Dose Fluoroscopy  
The contrast-detail study showed no statistically significant difference in 
low-contrast performance of the standard filtration compared with the low-
dose fluoroscopy settings (p=0.437). The contrast-detail curves, averaged 
over the 5 independent readers, are presented in Figure 6.  
 
Risk Estimation 
Including all procedures, the median lifetime risk for stochastic effects was 
0.08% (range, 0.007% to 0.481%). The risk estimates for male and female 
patients did not differ significantly. No significant risk difference was found 
between therapeutic (median, 0.09%) and diagnostic (median, 0.06%) 
catheterizations.  
The highest effective doses and corresponding risk estimates were found for 
the youngest patients (<1 year of age). The median lifetime risk for the latter 
group was 0.10% (range, 0.007% to 0.481%). For the age groups of 2 to 5 
years and 6 to 10 years, the median risk was 0.08% (range, 0.016% to 0.431%) 
and 0.05% (range, 0.030% to 0.320%), respectively.  
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Figure 6. Contrast-detail curve for standard and low-dose filtration settings. 
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Discussion 
Cardiac catheterizations are among the radiological x-ray procedures with 
the highest patient radiation dose and therefore are of great concern in 
pediatric settings because of the higher tissue radiosensitivity of infants and 
children (9–15). Moreover, in children with congenital heart disease, there is 
often a need to perform multiple examinations, increasing the radiation risks 
(9,10). About 7% of all cardiac angiography procedures are carried out in 
children 0 to 15 years of age (30). 
Over the last few years, an increasing number of therapeutic catheterization 
procedures have been performed in children (9–11). In general, the justification 
of these procedures is evident because they avoid complicated invasive 
surgery. However, the complexity of these procedures results in higher 
radiation exposures caused by the longer fluoroscopy times (9–11). The high 
patient doses and the introduction of new interventional procedures stress 
the need for an inventory of the doses delivered to pediatric patients who 
undergo these high-dose x-ray examinations (9,12) . 
The risk for a skin injury is related to the maximum skin dose value (7). The 
maximum skin dose measured in this study (297.5 mGy) was far below the 
2-Gy threshold level for transient erythema. The median peak skin dose of 
34.2 and 23.9 mGy for the anterior-posterior and the lateral exposures, 
respectively, may be compared with previous (mean) values of 126.2 mGy 
(12), 149 mGy (13), and 74 mGy (14). Only one study reported a mean entrance 
skin dose of 481 mGy for children <10 years of age (15). Because of the 
moderate values of skin doses in pediatric catheterizations, radiation-
induced skin injuries are unlikely. On the other hand, skin dose has to be 
monitored so that the cardiologist knows the maximum skin  dose delivered 
during the procedure. Because the DAP correlates very well with peak skin 
dose (r=0.90) for the posterior-anterior and lateral exposures, DAP 
measurement is suitable for online skin dose estimation and may avoid 
radiation-induced skin injuries in any case. This finding corresponds with a 
similar correlation found by Boothroyd et al. (12). 
In contrast with TLD measurements, DAP monitoring is easily performed, 
even for very complex procedures. As a result, DAP measurements from 
pediatric cardiac catheterizations were published in different studies.  In our 
study, the overall measured DAP varied from 41 to 2044 cGycm2, and the 
median value of 453 cGycm2 is in good agreement with the results of others  
(10,12,17,18,21). 
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To assess the potential risk for stochastic effects such as cancer and 
leukemia, the effective dose should be calculated (19). Unfortunately, 
determining the effective dose in catheterization procedures is not 
straightforward, mainly because of the complexity of the x-ray beam 
geometry (beam direction and field size variations during the catheterization 
procedure). Moreover, individual anatomy should be taken into account. 
Anatomy is very important for child dose estimations because patient 
weights and lengths may be subject to large variations. As a result of these 
dosimetric complications, data in the literature on the effective dose in 
pediatric interventional cardiology are scarce. The published results are 
based mainly on phantom measurements or a restricted number of existing 
conversion factors without taking into account the real exposure settings 
and geometry (9,20,21). Furthermore, using only the standard pediatric 
mathematical phantoms of 0, 1, 5, 10, and 15 years (27) could result in errors 
as large as 25%. In the present study, a patient-specific Monte Carlo 
calculation of the effective dose was set up, taking into account the exact 
irradiation geometry of the x-ray tubes and x-ray exposure settings used for 
a particular projection in a patient. Patient anatomy was simulated by an 
anthropomorphic phantom that was based on the gender and length of the 
patient.  
For diagnostic cardiac catheterizations, a median effective dose of 4.6 mSv 
was found. Therapeutic procedures resulted in a higher median effective 
dose of 6.0 mSv because of the prolonged use of fluoroscopy and the larger 
number of cine runs. The reported values are as high as those for a typical 
adult cardiac angiography (30).  In ASD closure procedures, a significantly 
lower effective dose (median, 2.8 mSv) was found compared with the patent 
ductus arteriosus occlusions (median, 7.6 mSv) and balloon dilatations 
(median, 8.1 mSv). This can be attributed to the higher degree of difficulty 
for the cardiologist in those 2 procedures (11).  Moreover, for ASD closure, the 
cardiologist relied more on transesophageal imaging than on cine, resulting 
in a low effective dose. Overall, large variations in effective doses were 
found for diagnostic and therapeutic procedures, mostly because of 
differences in the difficulty level among individual patients. In only ≈10% of 
the cases, the effective dose was >20 mSv.  Similar variations were found by 
Rassow et al. (21) who reported effective doses varying from ≈2 mSv (25th 
percentile) to ≈18 mSv (90th percentile) in infants. The same authors state 
that at least 50% of the effective dose was due to cineangiography. Schueler 
et al. (10) calculated that cine made up 44% of the total exposure. Results from 
both studies are confirmed in our study, in which a median of 69% and 45% 
of the effective dose was attributed to cineangiography for diagnostic and 
therapeutic procedures, respectively. In both diagnostic and therapeutic 
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procedures, the lateral and frontal tube exposures each contributed ≈50% to 
the total effective dose. An excellent correlation between the effective dose 
and  the DAP was found (r=0.95), indicating that using a simple conversion 
coefficient (mSv/cGycm2) to estimate effective dose is an acceptable way to 
calculate effective doses. Even when raw DAP data (without additional 
corrections) are used, the correlation remains good (r=0.87). Hence, a DAP 
meter is suitable for online estimation of the effective dose with good 
accuracy.  
Using the risk factors from the multiplicative model of the ICRP (19),  we 
calculated an overall median risk of 0.08% (range, 0.007% to 0.481%). 
Because of the large variations in effective doses, no significant difference in 
risk could be shown between therapeutic and diagnostic procedures. The 
overall correlation between radiation risk and patient age was poor (r=0.22). 
However, a much higher median risk estimate was found for patients 0 to 1 
year of age (0.10%) compared with patients 2 to 5 years (0.08%) and 6 to 10 
years (0.05%) of age. Similar conclusions were presented by Rassow et al. (21), 
who found a significant increase in effective dose with decreasing age.  
Because effective doses in pediatric cardiac catheterizations are high, dose 
reduction techniques should be applied to keep the dose as low as 
reasonably achievable and to reduce the radiation risks. Today, several 
techniques are available to decrease radiation exposure. Techniques that do 
not deteriorate image quality are of particular interest.  
The introduction of pulsed fluoroscopy in the late 1980s resulted in a 
reduction in the radiation exposure rate of 30% to 50% (10). In addition, the 
use of increased x-ray tube filtration removes lower-energy x-ray photons 
from the beam, thus reducing the amount of x-rays absorbed by the patient. 
In the present study, the dose-saving effect of an extra 0.2 mm copper beam 
filtration was demonstrated. With this low-dose  fluoroscopy, a significant 
reduction in the fluoroscopy dose was measured. The overall effect was an 
effective dose reduction of 18%. Contrast-detail analysis showed that this 
dose reduction was not detrimental to image quality.  
Similar results were obtained by Baldazzi et al. (9), who used a foil of 0.1 mm 
of gadolinium. In their experimental setting, a mean reduction in effective 
dose/frame of 14% was reported while image quality was maintained. Other 
attempts to reduce the radiation dose such as the use of digital zooming 
(acquisition zoom) also resulted in a dose reduction. However, a significant 
deterioration in image quality was observed with this technology (17).  
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In conclusion, skin doses are not problematic in pediatric interventional 
cardiology, but the calculated effective doses are as high as those for adult 
interventional cardiology, resulting in higher radiation risks. Therefore, it is 
important to monitor the patient dose by DAP instrumentation and to use 
additional beam filtration to keep the effective dose as low as possible in 
view of the age-related sensitivity of pediatric patients. Being a simple 
quantity, DAP readings can easily be included in patient records, especially 
those of young patients. The cumulative DAP (and hence effective dose) can 
be useful in decisions on the clinical management of the patient in case of 
follow-up examinations. Moreover, diagnostic reference levels of DAP could 
be useful for keeping the dose as low as possible and would be very 
valuable in training new interventional cardiologists. 
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Abstract 
As dynamic flat-panel detectors (FD) are introduced in interventional cardiology (IC), the relation 
between patient dose and Image Quality (IQ) needs to be reconsidered for this type of image 
receptor.  On one hand this study investigates IQ of a FD system by means of a threshold contrast 
detail analysis and compares it to an image intensifier (II) system on a similar X-ray setup. On the 
other hand patient dose for coronary angiography (CA) procedures on both systems is compared 
by Dose-Area Product (DAP)-registration of a patient population. The comparative IQ study was 
performed for a range of entrance dose rates (EDR) covering the fluoroscopy and cinegraphy 
working mode. In addition the IQ investigation was extended to a similar study under Automatic 
Brightness Control (ABC).  As well the systematic study of IQ as a function of EDR as the study 
performed under ABC point to a better IQ for FD in cinegraphy mode and no difference between 
both systems in fluoroscopy mode. The patient population study resulted in mean DAP values of 31 
Gycm2 (II system) and 33 Gycm2 (FD system) (p=0.68) for CA procedures. As well total DAP as 
contributions of fluoroscopy and cinegraphy on both systems are not significantly different. 
To conclude, we could state that profit was taken from the intrinsic better performance of the FD for 
cinegraphy mode in producing higher quality images in this mode but without any effect on patient 
dose for CA procedures. 
 
Introduction 
Ever since the use of X-rays in medical applications, equipment developers 
have aimed for new techniques and refinement for better image quality  (IQ) 
for both static and dynamic examinations. Nowadays, flat detectors (FD) 
have gained field in both radiography and fluoroscopy, replacing screen-
film combinations, digital storage phosphor systems or image intensifiers 
(II) (1-4). In comparison with conventional II, FDs have shown convincing 
advantages of better ergonomics with better patient access, lack of geometric 
distortion, little or no veiling glare, no vignetting, insensitivity to magnetic 
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fields and wider dynamic range (2, 3, 5, 6). However, questions regarding 
the  capabilities of FD have not been answered completely, particularly as it 
pertains to IQ at low exposure levels. In interventional cardiology, real–time 
viewing of vascularisation of the heart and tiny devices such as stents and 
guidewires impose stringent requirements on the imaging techniques used.  
Up to now, IIs achieve essentially ‘noiseless’ gain at low exposure rates, due 
to their characteristics of high electronic brightness gain and minification 
gain (5). For FDs, on the other hand, system noise becomes a limiting factor 
in determining system performance at low exposure rates (7-9).    
Within this scope the question for dose optimisation is complex but urgently 
demanding clarification. Investigations whether the introduction of FD 
technology into the cardiac laboratory will result in an increase in clinical IQ 
or improved dose efficiency compared to II systems, need to be performed. 
Literature data report on IQ assessment under automatic brightness control 
(ABC) circumstances by use of the Leeds TOR 18-FG phantom placed into 
the X-ray  beam together with a certain amount of PMMA (Polymethyl 
Methacrylate) (10-12).  Other studies calculate modulation transfer function 
(MTF), point spread function (PSF), signal-to-noise ratio (SNR), contrast-to-
noise ratio (CNR), noise power spectra (NPS) or Detective Quantum 
Efficiency (DQE) (7, 13, 14) for digital detectors for fluoroscopy, cardiac 
implementation or radiography. However, this is the first study comparing 
IQ of an II based and a FD based cardiac system, assessed by four-alternative 
forced-choice measurement to find the threshold contrast-detail 
detectability.  
The goal of this study was to compare the performance of a FD based 
cardiac X-ray system with a contemporary X-ray II system by  assessment of  
IQ under equal exposure circumstances and under ABC in exposure ranges 
of clinical practice. At the same time we investigated whether the use of a 
FD system resulted in a higher sensitivity for fluoroscopy and cinegraphy 
mode and in a reduction in patient dose in clinical practice. 
  
Materials and Methods 
Imaging Systems 
The II based and the FD based cardiac systems for this study were both 
Siemens Axiom Artis monoplane modalities, with ABC-function and three 
field sizes for magnification of the image. X-ray tube configuration and 
filtration were identical for both systems. Details are listed in Table 1. 
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Although the size indications for the large, medium and small imaging 
fields are different for both systems (compare e.g. 23 cm with 25 cm), the 
dimensions of the corresponding actual radiation fields are the same. 
Measurement of the (diagonal) diameter of the radiation fields, as presented 
in Table 1 was performed using 33x41-cm Kodak X-Omat V films (Eastman 
Kodak) at the receptor entrance plane at reference distance (100 cm) from the 
focus. The explanation for the different figures for indication of the imaging 
fields lies in the geometry of the image receptors: circular for II and 
rectangular for FD. Manufacturers indicate the actual visible field diameter 
(diagonal) and for II, this diameter is smaller than for FD due to loss of 
image information at the corners of the circular field. 
 
Table 1. Measurement of the diameter of radiation field at the entrance plane of the image 
intensifier and the flat detector. 
 
 
 
 
The II of the conventional system contains CCD-technology for digitalisation 
of the image. The FD of the more recent system is of the indirect amorphous 
silicon (a-Si) type, consisting of an active matrix size of  960 x 960 pixels, 
with a pixel size of 184 µm (Trixell, Moirans, France). Conversion of the 
energy of the X-ray photons into light occurs in a scintillation phosphor 
layer consisting of a CsI:Tl needle-shape crystalline structure. The light 
photons are subsequently detected by pixel photodiodes on a thin film 
transistor (TFT) array and stored in the form of electronic charge in the 
capacitors associated with each pixel. Extensive description of FD systems of 
the indirect (and the direct) conversion type can be found elsewhere (2, 3, 5). 
In order to compare IQ in a correct way, the same magnification factor for 
image capture and storage is necessary. To this end a grid positioned at the 
isocentre of the system was used. An arbitrary distance on the grid was 
compared with the distance measured at the monitor in the catheterization 
room.  A magnification factor of 2.78 and 2.73 for medium field size was 
obtained for the II system and the FD system respectively, which is a 
satisfactory result. 
 
 
 Large 
field 
Medium 
field 
Small 
field 
II system 25.9 20.0 15.5 
FD system 24.7 20.1 15.7 
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Test object details and images  
IQ was evaluated using the commercially available CDRAD 2.0 contrast-
detail phantom (Instrumentale Dienst, Nijmegen, The Netherlands (15)). 
This phantom is designed to perform four-alternative forced-choice 
measurements (4-AFC). The advantage of this method is that there is no 
need for the observer to set any subjective thresholds as is the case with e.g. 
the Leeds TOR 18-FG  phantom (16). Moreover, with 4-AFC the detection 
errors by the observer are controlled by the correction scheme described in 
the manual of the test object (15). Nevertheless, as in all psychophysical 
measurements, variations among observers cannot be neglected (17). For 
averaging purposes, each image was scored by five independent readers. 
Based on these measurements, contrast-detail curves are obtained, reflecting 
the visibility limitations by the noise properties of the imaging system. A 
numerical value, the inverse Image Quality Figure (IQFinv) can be calculated 
as the sum of the products of hole depth and hole diameter for the objects in 
the phantom at the limit of visualisation. 
Scoring of the images was performed for both II and FD systems on the same 
monitor, a 19” TFT-LCD Avidav monitor (Jetway Computer Corporation, 
USA). For this scoring the freely available medical viewer software 
ezDICOM (18) was used, allowing dynamical presentation of all runs. Use 
was made of the ‘Contrast Autobalance’ function, meaning that readers were 
not allowed to change window and level of the images. Scoring was 
performed in a darkened room and no restrictions were implied on viewing 
distance or viewing time. 
 
Image Quality measurements 
The first set of measurements concerned IQ evaluation by IQFinv 
determination of both II and FD systems for a range of  EDR used in clinical 
practice. For this study a tube potential setting of 70 kV and a fixed filtration 
of 0.2 mm Cu at small focus were chosen on both imaging systems (Table 2). 
Image receptor EDR was gradually increased from 23 nGy/p up to 240 
nGy/p (manufacturer settings). A phantom of 20 cm PMMA (with the 
CDRAD 2.0 phantom in the middle) was used to simulate the patient. 
Measurements were performed at a reference distance of 100 cm from source 
to image receptor entrance plane. The distance between exit of the phantom 
and the image receptor housing was kept 5 cm, in order to simulate clinical 
practice. All measurements were performed for the medium field size. All 
images were recorded and phantom EDR was measured with a standard 
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60cc ionisation chamber (Radcal Corporation, Monrovia, USA) for each 
radiation setting chosen. 
Table 2. Exposure parameters during phantom (20 cm PMMA) measurements in cinegraphy and 
fluoroscopy mode at 15 f/s and large focus, under automatic brightness control for II- and FD-
system. 
 
 field 
size 
(cm) 
tube 
potential 
(kV) 
tube 
current 
(mA) 
additional 
filtration 
(mmCu) 
pulse 
duratio
n (ms) 
phantom 
entrance 
dose rate 
(mGy/min) 
Cinegraphy mode 
  
II-system 23 65 800 0.3 6.4 60.1 
 17 68 703 0.1 6.2 130.4 
 13 74 800 0.1 6.4 176.3 
FD-system 25 65 715 0.2 7.8 81.1 
 20 68 692 0.2 7.6 102.3 
 16 68 800 0.2 8.0 132.5 
Fluoroscopy mode 
  
II-system 23 70 50 0.2 9.1 11.0 
 17 68 92 0.3 13.3 16.7 
 13 73 100 0.2 12.4 28.2 
FD-system 25 67 158 0.6 13.5 12.2 
 20 67 156 0.6 13.2 18.4 
 16 69 170 0.6 13.8 20.1 
 
A second set of measurements was performed to provide a numerical value 
for the IQ under ABC settings, for the three different field sizes by IQFinv 
determination. This means that different X-ray spectra were generated 
according to the ABC settings of the systems. The X-ray systems were set to 
their default clinical values and EDR was measured. Exposure parameters 
are summarized in Table 3. Images of the CDRAD 2.0 phantom, positioned 
in between two layers of 9.5 cm PMMA (resulting in a total thickness of 20 
cm PMMA) were registered and scored afterwards by the same five readers 
of the first set of measurements. 
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Table 3. Exposure parameters for imaging of CDRAD 2.0 test object  for increasing phantom 
entrance dose rate (mGy/min) for medium field, 15 f/s, additional filtration of 0.2 mm Cu and 
small focus. 
 
 tube 
potential 
(kV) 
tube 
current 
(mA) 
pulse 
duration 
(ms) 
phantom 
entrance 
dose rate 
(mGy/min) 
II-system 
  
 70 67 9.1 13.5 
 70 106 11.2 26.1 
 70 138 12.4 37.2 
 70 160 13.1 45.7 
 69 305 9.2 60.6 
 76 332 9.6 79.9 
 83 254 8.9 91.6 
FD-system 
  
 70 80 7.8 14.2 
 70 109 9.0 22.3 
 70 127 9.7 27.7 
 70 145 10.3 33.3 
 70 163 11.0 39.7 
 66 361 10.0 67.7 
 72 373 10.0 92.4 
 79 324 9.7 106.8 
 
Patient dose measurements 
Patient dose measurements consisted of real-time DAP registration during 
diagnostic cardiac interventions (CA) performed on both systems. In order 
to avoid large variations in procedure protocol, therapeutic procedures as 
Percutaneous Transluminal Coronary Angioplasty (PTCA) were not 
included in the study. The same team of cardiologists and nursing staff 
operated at both imaging systems, to minimize variation in clinical protocol. 
 Eighteen procedures were followed on the II system, while this number was 
26 for the FD system. The average age of the patients was 66y (range: 35y - 
86y)  for the II system and  67y (range: 44y - 83y) for the FD system. Both 
populations had an average weight of 73 kg (II: range 55 kg – 100 kg and FD: 
range 55kg – 88kg). This indicates that there was no bias with respect to 
patient population characteristics.  DAP was registered for fluoroscopy and 
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cinegraphy mode separately, allowing us to investigate the contributions of 
both modes. For each run, exposure parameters (tube potential, tube current 
and filtration) and tube angulations were also registered. 
 
Statistical analysis 
Statistical significance of differences between the two digital systems was 
assessed with the two-factor analysis of variance (ANOVA) using system-
type (II or FD) and hole depth as independent variables and the observed 
threshold diameter as dependent variable.  
For DAP patient data analysis a non-parametric two-tailed Mann-Whitney 
test was performed. Correlations between groups were calculated by means 
of the non-parametric Spearman’s rank correlation coefficient (r). To 
calculate the regression coefficients in the relation between two quantities, 
linear regression analysis was performed using the Levenberg-Marquardt 
algorithm.  
In all statistical analyses a confidence interval of 95% was applied. Hence, a 
p-value < 0.05 was considered as significant. All statistical tests were 
performed with a statistical application package (S-PLUS software – 
Insightful Corporation, Seattle, WA, USA).  
  
Results 
Assessment of IQ was performed by calculation of IQFinv, based on the 
scoring of images of the CDRAD 2.0 test object. Figure 1 shows the relation 
between IQFinv and the EDR at the 20 cm PMMA phantom, with the CDRAD 
2.0 test object in the middle, resulting from the first set up of measurements.  
The error bars represent the standard deviations between the scores of the 
five independent readers.  A linear regression curve was plotted for both 
systems. The dose rate at the entrance of the phantom ranged from 14 
mGy/min to 107 mGy/min (Table 2). When we compare these values with 
the settings selected by the ABC system for a phantom of total thickness of 
20 cm PMMA presented in Table 3, we notice that the EDR range of the data 
is clinically relevant both for fluoroscopy and cinegraphy mode.   
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Figure 1. Image Quality Figure inverse (IQFinv) versus phantom entrance dose rate (mGy/min) for 
medium field size at the II and the FD system, for a radiation quality of 70 kV with 0.2 mm Cu 
filtration. 
 
Figures 2 and 3 compare contrast-detail curves representing phantom 
threshold hole diameter versus hole depth for equivalent phantom EDR 
used in fluoroscopy and cinegraphy mode. This type of curves is used to 
deduce the IQFinv values represented in Figure 1. The curves were obtained 
at the following phantom EDR values: 37.2 mGy/min (II) and 39.7 
mGy/min (FD) for fluoroscopy mode (Figure 2) and 91.6 mGy/min (II) and 
92.4 mGy/min (FD) for  cinegraphy mode (Figure 3). Error bars correspond 
again to the standard deviations between the results of the readers. 
 
fluoroscopy
0.1
1
10
0.1 1 10Depth (mm)
Di
am
et
er
 
(m
m
)
II-system 37,2 mGy/min
FD-system 39,7 mGy/min
 
Figure 2. Contrast-detail curves for the II and FD system for equivalent phantom entrance dose 
rates used in fluoroscopy mode. 
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Figure 3. Contrast-detail curves for the II and FD system for equivalent phantom entrance dose 
rates used in cinegraphy mode. 
 
Application of the clinically used ABC of both systems for imaging of the 
test object, resulted in IQFinv values shown in Figure 4.  Exposure conditions 
for these images in both fluoroscopy and cinegraphy mode can be found in 
Table 3.   A difference in additional filtration and tube current can be 
attributed to differences in ABC settings of both systems. However, with 
respect to dose-settings, the image receptor EDR was programmed to be 170 
nGy/p in cinegraphy mode for both systems. For fluoroscopy mode, the 
ABC settings for dose were 36 nGy/p for the FD system and 32 nGy/p for 
the II system. This implies other filtration, tube potential, tube current and 
pulse duration restrictions to produce the same (or equivalent) image 
receptor EDR. Figures 1-4 support a better image quality for the FD system 
at EDR values used in cinegraphy mode while not statistically significant 
differences were observed at low EDR values typical for fluoroscopy.  
The DAP data obtained from the patient dose measurements are 
summarized in Figure 5. A comparison of DAP histograms for diagnostic 
procedures followed on both systems allows an assessment of image 
receptor influence on patient dose. For the DAP histogram reconstruction an 
interval op 25 Gycm2 was used. Mean DAP values of 31 Gycm2 and 33 
Gycm2 were obtained for the II and FD system respectively, resulting in no 
statistically significant difference in patient dose between the two systems 
(p=0.68).  
 
 122 
0.75
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
large field medium field small field
IQ
F i
n
v
FD-system cinegraphy
II-system cinegraphy
FD-system fluoroscopy
II-system fluoroscopy
 
Figure 4. Image Quality Figure inverse (IQFinv) versus field size for the II and the FD system, for 
fluoroscopy and cinegraphy mode.  Images were taken under Automatic Brightness Control 
(ABC). 
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Figure 5. Distribution of patient DAP values for diagnostic coronary angiography procedures, 
performed with the II system (dashed line) and FD system (full line). Mean values are indicated 
by vertical lines. 
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Discussion 
A first set of measurements focussed on image receptor performance as a 
function of increasing phantom EDR (Figure 1). The same X-ray radiation 
quality, tube current, field size and frame rate were used to visualize the 
CDRAD 2.0 test object either on II or FD. A linear relationship (r=0.99 for FD 
and r=0.98 for II) between EDR and IQFinv was obtained for both systems, in 
accordance with the characteristic linear response curve  for FD (4).  The left-
lower part of the graph with EDR ranging from 10 to 35 mGy/min, is 
representative for fluoroscopy mode which is supported by the EDR values 
obtained under ABC conditions in this study (Table 3).  Similar EDR values 
were used in comparative studies between II and FD for fluoroscopy also on 
a Siemens Axiom Artis system: 22 mGy/min by Vaño et al. (11) and 9 
mGy/min by Nickoloff et al. (19). The right-upper part of Figure 1, with 
rates ranging up to 107 mGy/min is representative for cinegraphy mode. 
Under ABC-conditions EDR values of 102 mGy/min and 130 mGy/min 
were measured for medium size field for this mode (Table 3). The higher 
EDR values in the ABC study can be explained by the fact that a large focus 
is programmed in ABC settings according to clinical protocol while a small 
focus is applied in service mode of the equipment used for the IQFinv versus 
EDR study.   Vaño et al. (11) used EDR values of 151 and 86 mGy/min in 
cinegraphy mode studies with  Siemens Axiom Artis II and FD systems 
respectively, while Nickoloff et al. (19) applied 53 mGy/min in a similar 
study.  Figure 1 shows very clearly that within the EDR fluoroscopy range 
IQFinv of FD does not differ significantly from that of II. On the other hand, 
for the higher EDR range corresponding to cinegraphy mode the FD system 
shows a significantly better IQFinv than the II system. As within the frame of 
measurements all exposure parameters were the same, the higher IQFinv 
values reflect the intrinsic better imaging performance of FD with respect to 
II when higher EDR are considered (cinegraphy mode).  Figures 2 and 3, 
representing a comparison of the contrast-detail curves of the II and FD 
systems for typical fluoroscopy and cinegraphy EDR values, also support 
these observations. Figure 2 shows overlapping curves for fluoroscopy mode 
resulting in a p-value of 0.56 for system dependency for an EDR of 37.2 
mGy/min (II) and 39.7 mGy/min (FD). Thus, no difference in imaging 
performance between II or FD technology in the fluoroscopy mode is 
observed. On the contrary, the situation is notably different in the 
cinegraphy mode. The comparison of contrast-detail curves results in a p-
value of 0.001 for EDR of 91.6 mGy/min (II) and 92.4 mGy/min (FD) 
supporting significance in technology dependency for IQ, with advantage 
for the FD system. From Figure 3 we can conclude that the gain in IQ for the 
FD system compared to the II system is due to both better contrast and 
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better resolution, reflected by the entire shift of the FD contrast-detail curve 
towards the lower left corner of the graph.  
The IQ conclusions of present study based on phantom measurements are in 
agreement with reports regarding DQE(f) (f : spatial frequency lp/mm) (7, 
14, 20). For high exposures in the cinegraphy range (80 to 400 nGy – entrance 
dose per pulse at image receptor), the DQE(0) is superior for the FD systems 
while in the fluoroscopy range (5 – 80 nGy) DQE(0) values of FD and II are 
overlapping. For II the DQE(0) remains almost constant over the whole 
exposure range covered in fluoroscopy and cinegraphy while for FD the 
DQE(0) increases steadily for receptor entrance doses from 1 to 100 nGy. The 
low DQE(0) of FD for low dose is a consequence of the low SNR of low dose 
images.  
Based on the results obtained in the first set of measurements we could 
expect a better dose-IQ relationship for the FD system, in cinegraphy mode. 
This means that in cinegraphy mode the same IQ as for the II system could 
be obtained for lower dose settings, resulting in a net patient dose reduction.   
To investigate whether exposure parameters of the system were optimised 
towards dose reduction or towards better IQ we performed a contrast-detail 
study under ABC - settings for both modes and for different field sizes 
(Figure 4).  From this figure, a better IQ for smaller fields and for cinegraphy 
compared to fluoroscopy is apparent. For the fluoroscopy mode, data do not 
reveal a significant difference in IQ between FD and II (p=0.26). On the 
contrary a statistically significant better IQ for the FD system is observed in 
the cinegraphy mode (p=0.02). Together with a same EDR (at image 
receptor) of 170 nGy/p programmed for both the II and FD system, this 
shows that the dose versus IQ relationship was not optimised towards dose 
reduction. Rather profit was taken from the intrinsic better performance of 
the FD for cinegraphy mode to produce images of higher quality for similar 
entrance doses. 
Finally, DAP measurements were performed in order to investigate the 
influence of FD technology on patient dose in clinical practice. Mean values 
of 31 Gycm2 (II system) and 33 Gycm2 (FD system), are in agreement with 
previously published values for both conventional and digital technology: 
mean values of 31.2 Gycm2  (II) and  33.4 Gycm2 (FD) were reported by 
Trianni et al. (10) and median values of 30 Gycm2 (II) and 31 Gycm2 (FD) 
reported by Tsapaki et al. (12). The measurements (Figure 5) could not reveal 
a significant dose reduction by introduction of the FD system (p=0.68).  
Analysis of the DAP data according to the fluoroscopy and cinegraphy 
contribution did also  not highlight a difference in patient dose (p=0.15 and 
0.82).  Similar findings were reported by Tasapaki et al. (12) and Trianni et al. 
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(10).  None of them could show a significant patient dose reduction for 
neither FD nor II technology. Combining the patient dose results with the 
phantom IQ measurements we can state that for procedures performed on 
patients in daily practice, a better IQ is obtained with the FD system in 
cinegraphy mode. This better IQ is appreciated by the cardiologists but 
apparently does not lead towards dose reduction by e.g. a decrease in 
procedure exposure time. This would have become clear in reduced DAP 
values, which was not the case.  
Whereas in cinegraphy an optimisation towards dose reduction is possible 
with the use of FD technology, this is not directly the case for fluoroscopy. 
To this end further evolution of FD technology is necessary by reducing 
system noise for low exposures. 
 
Conclusions 
Image Quality related to the introduction of FD in interventional cardiology, 
has been evaluated and compared to the IQ of an II imaging system in a 
similar X-ray set up. At low exposure rates used in fluoroscopy, no 
significant difference in IQ was found. Contrarily, at high exposure rates 
used in cinegraphy a remarkably (statistically significant) better IQ could be 
attributed to the presence of FD imaging technology.  Mean DAP values, as 
estimates for patient dose, resulted to be the same for diagnostic (CA) 
procedures performed on either the FD system or the II system. No 
differences were noted not even when the fluoroscopy or the cinegraphy 
contribution was considered separately. The implementation of FD imaging 
technology was appreciated by the cardiologists for better IQ in cinegraphy 
mode, but did not involve a lowering of patient dose. Optimisation of ABC 
towards lower patient dose is possible in cinegraphy mode. In fluoroscopy 
mode further evolution of FD technology with respect to system noise at low 
exposure rates is necessary to improve IQ and/or reduce patient dose. 
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Chapter  4  
General discussion and conclusions 
4.1 IC: Importance and population 
Catheterization of coronary arteries, shortly denoted by IC in medicine, is 
highly appreciated for its non-invasive character in comparison to surgery 
and because it is fast, straightforward and safe. Both adults and children can 
benefit of the technique, most frequently for diagnosis and/or treatment of 
CAD and CHD respectively. Annual numbers (2004) of around 4000 
diagnostic CA procedures per million inhabitants and around 1500 PTCA 
interventions per million inhabitants are still increasing [5]. Statistics 
regarding IC in Belgium (2005) documented in MIRA-T report show a 
number of two to three procedures (diagnostic and therapeutic) per 1000 
inhabitants [1]. 
As viewing of the coronary arteries is performed through dynamic x-ray 
imaging the radiation burden to the patient can be important. The 
procedures belong to those involving ‘high doses’ to patients [7-9] and the 
effects of these possibly high doses were classified by the ICRP and the 
ICRU into deterministic (short-term) and stochastic (long-term). Considering 
deterministic effects, the skin is the most exposed tissue and in 1994, the 
Food and Drug Administration (FDA) called attention on the problem of 
radiation burden to the skin in an advisory that later appeared on its website 
[7]. In the year 2000, Koenig et al. reported more than 70 cases of skin injuries 
[53, 55]. With respect to late term effects, it is mostly the youngest generation 
i.e. the paediatric population that is of highest risk. Due to their larger 
radiosensitivity and the longer post-exposure life expectance, possible 
radiation induced sequelae are more likely to occur. Moreover, about  7% of 
all cardiac angiography procedures are carried out in children 0 to 15 years 
of age [36]. Paediatric procedures may even involve longer fluoroscopy 
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times than adult interventions, because of higher heart rates, smaller 
cardiovascular structures and smaller body size [15, 46].  
4.2 Direct skin effects: discussion of nine cases with 
Maximum Skin Dose > 2 Gy 
As reported in Publication 1, MSD  in nine cases exceeded 2 Gy, which is the 
threshold level for onset of transient erythema, appearing a few hours after 
irradiation [51, 53]. For two of them, the maximum measured TLD value was 
not the MSD, received by the patient, because of missing parts of the 
reconstructed peak. This means that MSD is higher than measured. 
 
Table 6. Summary of the cases for which the maximal skin dose exceeded 2 Gy 
N° 
Proce
-dure 
MSD 
(Gy) 
Angle  
MSD 
(°) 
gen
der 
Cardio-
logist 
DAP 
(Gycm2) 
contrib 
of fluoro 
to MSD 
(%) 
Contrib 
of cine 
to MSD 
(%) 
1 D 2.1 100 F Ass+Doc 194 57 43 
2 T 2.5 -44 M Ass 298 30 70 
3 T 2.4 66 M Vis+Doc 154 77 23 
4 T 3.1 -47 M Doc 153 40 30 
5 T 2.3 -15 M Doc 131 27 73 
6 T 3.2 14 F Ass+Vis 404 95 5 
7 T 3.4 45 M Vis+Doc 315 98 2 
8 T 4.5 95 M Doc 257 89 11 
9 D 2.6 94 F Vis 191 79 21 
 (D = Diagnostic, T = Therapeutic; Ass = Doctor-Assistant, Vis. = Visitor, Doc. = Doctor-Cardiologist ) 
 
A summarised description of these cases is given in Table 6. Whether the 
procedure was diagnostic (D) or therapeutic (T), the MSD (Gy), the angle 
under which the MSD was measured (degrees), gender of the patient, the 
professional status of the cardiologist, DAP (Gy.cm2) and contribution of 
cinegraphy and fluoroscopy to the contribution of DAP in the geometry that 
caused the MSD, are listed. The cardiologist is specified as Assistant (Ass), 
when he/she is in training. Visitor (Vis) represents a cardiologist who 
catheterises a limited amount of days a week and Doctor (Doc) is an 
experienced cardiologist. Therapeutic procedures were all ‘combined 
procedures’ which means that a diagnostic examination preceded a 
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therapeutic intervention, except for case 2, where the procedure was a 
merely therapeutic intervention. Mostly a supervising doctor performs the 
therapeutic part (especially when the case turns out to be difficult) after the 
diagnostic examination, performed by the assistant doctor or the visiting-
doctor. 
The contributions of fluoroscopy and cinegraphy in terms of percentage to 
the DAP that was registered for the geometry that caused the MSD, show 
that for 5 of the 9 cases fluoroscopy mode was obviously responsible for the 
highly measured peak in skin dose. A detailed description for each of the 
cases is given below.  
Body Mass Index (BMI) was also calculated for the patients. Table 7 gives 
classification with respect to BMI. 
Table 7. Classification of BMI index 
BMI Classification 
BMI < 18.5 Underweight 
18.5 < BMI< 25 Optimal body weight 
BMI > 25 Overweight 
BMI > 30 Obese 
 
4.2.1 Case 1 
A diagnostic procedure (coronary angiography, CA) was performed by a 
doctor-assistant, supervised by an experienced cardiologist on a biplane 
system and was classified as difficult because of the use of 3 different 
catheters in order to find the right coronary.  The patient was a 79 years old 
woman of normal weight (BMI = 23). The procedure contained 10 
cinegraphy-runs, simultaneous on the two x-ray tubes of the system, with an 
average  cinegraphy radiation time (time that the doctor pushed the treadle) 
of 7.5 seconds and at a frame rate of 12.5 frames per second. This means that 
all cinegraphy-runs were taken simultaneously with frontal and lateral tube.  
This is equivalent to 20 cinegraphy runs on a monoplane system. For one 
cinegraphy-run a frame rate of 25 frames per second was taken (for both 
frontal and lateral tube), when a ventriculogram was registered. The pulse 
rate for fluoroscopy mode was 12.5 pulses per second.  The II imaging field 
was switched between 23 and 17 cm for both frontal and lateral tube. The 
MSD was 2.1 Gy and was measured in lateral position due to the tube 
geometry of the lateral tube (LAO90, CAUD1) (Figure 17). The Source to 
Image Receptor Distance (SID) was rather large at that projection: 115 cm. A 
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rather large distance between patient’s skin and II was observed, whereas 
the distance from the x-ray tube focus to patient’s skin was rather small. The 
contribution of fluoroscopy to DAP, registered for the projection LAO90, 
CAUD1 was slightly more than the contribution of cinegraphy. Five 
cinegraphy-runs were taken at that projection (57% versus 43 %). With 
respect to the filtration used in fluoroscopy mode, fluoroscopy ‘normal’ 
filtration setting was used, which implies an additional filtration of 0.3 mm 
Cu (with an inherent filtration of 2.5 mm Al). This setting was selected by 
the cardiologist. 
  
Figure 19.  Three-dimensional representation of skin dose distribution for case 1. 
4.2.2 Case 2 
A therapeutic procedure (PTCA + direct or primary stenting) was performed 
by a doctor-assistant on a biplane system and was classified as difficult 
because of difficult positioning of balloon- and stent-catheters. The patient 
was a 52 years old obese man (BMI = 30). The procedure contained 14 
cinegraphy-runs, simultaneous on the two x-ray tubes of the system, with an 
average cinegraphy radiation time (time that the doctor pushed the treadle) 
of 8 seconds and at a frame rate of 12.5 frames per second. This means that 
all cinegraphy-runs were taken simultaneously with frontal and lateral tube 
which is equivalent to 28 cinegraphy runs on a monoplane system. The 
pulse rate for fluoroscopy mode was 12.5 pulses per second.  The II imaging 
field was kept on 17 cm for both frontal and lateral tube. Two pairs of peaks 
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were visible in the distribution (Figure 18). One pair could be attributed to 
the combined geometry of frontal and lateral tube in the following 
projections: RAO25, CAUD30 for the frontal tube and LAO35, CAUD30 for 
the lateral tube. These projections were both responsible for the 2 hot spots 
in patient’s skin dose distribution, observed at the upper side on the wrap-
around, which means near to patient’s neck. This position can be explained 
by the highly caudal directions (CAUD30) used. Both hot spots reached the 
value of 2.5 Gy, representing the 9 cinegraphy-runs that were taken in the 
frontal projection and the 8 cinegraphy-runs in the lateral position of this 
biplane geometry. The reason that cinegraphy is mostly responsible for this 
MSD lies in the predominate contribution of cinegraphy to the DAP-values 
of these projections. (70% for the frontal projection and 93% for the lateral 
projection).  The filtration for cinegraphy is 2.5 mm Al as inherent filtration 
without any additional filters. The filtration of fluoroscopy mode used is an 
additional filtration of 0.3 mm Cu with an inherent tube-filtration of 2.5 mm 
Al, which corresponds to fluoroscopy ‘normal’ filtration setting of that x-ray 
equipment. This setting was selected by the cardiologist. The SID was rather 
large at the frontal and lateral projection (114 cm and 109 cm) and a rather 
large distance between patient’s skin and II was observed. 
 
 
Figure 20.   Three-dimensional representation of skin dose distribution for case 2. 
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A second pair of peaks could be attributed to the combined geometry of 
frontal and lateral tube in the projections RAO9, CRAN14 and LAO61, 
CAUD3.  Here, 5 and 6 runs were taken in the frontal and respectively 
lateral projection of the biplane geometry. Both peak-values were measured 
below 1 Gy. 
 
4.2.3 Case 3 
A therapeutic procedure (RL-CA+PTCA+(PTCA-ST)) was performed by a 
visiting doctor and an experienced doctor on a monoplane system. A RL-CA 
(right-left catheterization) procedure, which is a measurement of the 
pressure in lung blood vessels, coronary arteries and the heart chambers, 
followed by a coronary catheterization, was performed by the visiting 
cardiologist. An experienced cardiologist did the therapeutic intervention. 
This procedure was classified as difficult because of difficult positioning of 
the balloon-catheters, trying different catheterising techniques. Two 
different lesions had to be treated. The patient was a 74 year old overweight 
man (BMI = 29).  The procedure contained 34 cinegraphy-runs, a frame rate 
of 12.5 frames per second. No information was available on the number of 
frames taken per cinegraphy-run. The pulse rate for fluoroscopy mode was 
12.5 pulses per second.  The II field was switched between 17 for the 
diagnostic part (23 cm for the ventriculography) and 13 cm for the 
therapeutic part of the intervention. The MSD was 2.4 Gy and was measured 
in left anterior oblique position due to the following tube geometry LAO41, 
CAUD4 (Figure 19). The SID had a normal value for this projection: 100 cm. 
The contribution of fluoroscopy to DAP, registered for this projection was 
predominate (77% versus 23% for contribution of cinegraphy). Sixteen 
cinegraphy runs were taken at that projection. With respect to the filtration 
used in fluoroscopy mode, an additional filtration of 0.2 mm Cu (with an 
inherent filtration of 2.5 mm Al) was selected by the x-ray system. No 
additional filtration (Cu) and an inherent filtration of 2.5 mm Al was 
selected by the system for cinegraphy mode. 
A second, much lower (skin dose <1 Gy) peak was measured at a projection 
of LAO45, CRAN19, which means at the right corner of the first, most 
important peak. This peak was also caused by fluoroscopy (93 % versus 7%).  
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Figure 21. Three-dimensional representation of skin dose distribution for case 3. 
 
4.2.4 Case 4 
A therapeutic procedure (CA-PTCA) was performed by an experienced 
doctor on a monoplane system and was classified as difficult because of 
difficult positioning of the 3 different  balloon-catheters, without any result. 
None of them passed the lesion. The patient was a 57 year old man of 
normal weight (BMI = 24). The procedure contained 26 cinegraphy-runs, 
with an average cinegraphy radiation time (time that the doctor pushed the 
treadle) of 9.1 seconds and at a frame rate of 12.5 frames per second. One 
cinegraphy-run had a duration of 50 sec (628 images), due to overheating of 
the x-ray tube. The x-ray tube switched in safety mode, which implies a 
restriction of the mode to cinegraphy, even when pushing the fluoroscopy 
treadle. The cardiologist was not aware of the consequences of the 
overheated x-ray tube. The median value of cinegraphy radiation time for 
this procedure was 6.6 seconds. The pulse rate for fluoroscopy mode was 
12.5 pulses per second. The filtration used in this mode was 3.5 mm Al (of 
which 2.5 mm Al is inherent tube filtration) with an additional filtration of 
0.4 mm Cu. This corresponds to the fluoroscopy ‘low’ filtration setting for 
this x-ray equipment.  This setting was selected by the cardiologist. There 
was no additional filtration used in cinegraphy mode (2.5 mm Al inherent). 
The FD imaging field was kept on 20 cm. The MSD observed was 3.1 Gy and 
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was measured in right anterior oblique position due to the following tube 
geometry: RAO11, CAUD24 (Figure 20). Twelve cinegraphy runs were taken 
at this projection. The SID was of normal value at this projection: 104 cm. 
The contribution of cinegraphy to DAP, registered for this projection, was 
slightly more than the contribution of fluoroscopy (60 % versus 40 %), due to 
the cinegraphy in the safety mode of the x-ray equipment, meant to be 
fluoroscopy. 
 
 
Figure 22. Three-dimensional representation of skin dose distribution for case 4. 
4.2.5 Case 5 
A therapeutic procedure (CA+PTCA+(PTCA-ST)) was performed by an 
experienced doctor on a monoplane system and was classified as difficult 
because of difficult positioning of the balloon-catheters at a lesion located at 
a bifurcation. One balloon thorn open after one inflation, and thus another 
had to be positioned. Secondly, a busy nurse passed by mistake a catheter of 
wrong shape/size to the cardiologist.  The patient was a 61 year old obese 
man (BMI = 32). The procedure contained 31 cinegraphy-runs, with an 
average cinegraphy radiation time (time that the doctor pushed the treadle) 
of 6.8 seconds and at a frame rate of 12.5 frames per second.  
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Figure 23. Three-dimensional representation of skin dose distribution for case 5. 
There was a good application of the 1-frame function installed on the x-ray 
equipment. By selection of this setting, only one frame is taken as an image 
when pushing the treadle. This setting is suitable for making calibration-
images for calculation of cardiac ejection fraction from ventriculography. 
The pulse rate for fluoroscopy mode was 12.5 pulses per second. The 
filtration used in this mode was 3.5 mm Al (of which 2.5 mm Al is inherent 
tube filtration) with an additional filtration of 0.4 mm Cu. This corresponds 
to the fluoroscopy ‘low’ filtration setting for that x-ray equipment. This 
setting was selected by the cardiologist. There was no additional filtration 
used in cinegraphy mode (2.5 mm Al inherent). The FD imaging field was 
kept on 25 cm for the diagnostic part of the procedure and on 20 cm for the 
therapeutic intervention. The MSD was 2.3 Gy and was measured in right 
anterior oblique position due to the following tube geometry RAO22, 
CAUD22 (Figure 21). This peak was marked at the upper side on the wrap-
around, which means near to patient’s neck. This can be explained by the 
rather high caudal directions (CAUD22) used. The SID was of normal value 
at that projection: 101 cm. The contribution of cinegraphy to DAP, registered 
for this projection, was predominate 73 % versus 40 % contribution of 
fluoroscopy to DAP for that projection. The plot of the skin dose distribution 
shows that the MSD-peak was not fully measured. The value of 2.3 Gy was 
registered on the increasing side of the peak, which means that the actual 
MSD can even be higher.  
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4.2.6 Case 6 
A therapeutic procedure (CA-PTCA-ST) was performed by a doctor-
assistant and a visiting doctor on a monoplane system. The CA was done by 
the cardiologist in training. The therapeutic intervention was done by the 
visiting cardiologist. This procedure was classified as difficult because of 
trying to position an aspirator-tool, without any result and with alternative 
of PTCA and stenting. The patient was a 72 year old woman suffering from 
obesity (BMI = 47).  The procedure contained 25 cinegraphy-runs, at a frame 
rate of 12.5 frames per second (except 25 frames per second for the 
ventriculography), with an average duration of cinegraphy-runs of 4.8 
seconds. The pulse rate for fluoroscopy mode was 12.5 pulses per second.  
The II imaging field was kept on 17 cm during the whole intervention 
(except for 23 cm for the ventriculography). The MSD was 3.2 Gy, with 
neighbouring values of 2.4 and 1.2 Gy and was measured in a vertically 
spread out AP position due to fluoroscopy mode (Figure 22). The SID was of 
normal value at this projection: 100 cm. The contribution of fluoroscopy to 
DAP, registered for this projection was predominate 95%). Five cinegraphy 
runs were taken at this projection.  
With respect to the filtration used in fluoroscopy mode, no additional 
filtration with an inherent filtration of 2.5 mm Al was used, corresponding to 
the filtration setting fluoroscopy ‘high’. Image Quality at this x-ray 
equipment was found to be insufficient at low dose fluoroscopy mode.  
Fluoroscopy ‘high’ mode was set as ‘default’ value for clinical practice, but 
could, however, be changed when judged necessary.  No additional 
filtration (Cu) and an inherent filtration of 2.5 mm Al was used for 
cinegraphy mode.  
A second, lower skin dose peak with value of 1.4 Gy was measured at a 
projection of LAO31, CAUD0. Fourteen cinegraphy runs were taken at this 
position, with a relative contribution of cinegraphy to DAP in this projection 
of 58%.   
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 Figure 24.  Three dimensional representation of skin dose distribution for case 6. 
 
4.2.7 Case 7 
A therapeutic procedure (CA-PTCA) was performed by a visiting doctor 
and an experienced cardiologist on a monoplane system. The CA was done 
by the visiting cardiologist. The therapeutic intervention was done by the 
experienced cardiologist. This procedure was classified as difficult because 
of a difficult lesion: 90% stenosis at a bifurcation. The patient was a 76 year 
old overweight man (BMI = 27). The procedure contained 18 cinegraphy-
runs, at a frame rate of 12.5 frames per second (except 25 frames per second 
for the ventriculography), with an average duration of cinegraphy-runs of 
3.7 seconds. The pulse rate for fluoroscopy mode was 12.5 pulses per second.  
The II imaging field was kept on 17 cm during the diagnostic part of the 
intervention (except for 23 cm for the ventriculography) and was switched 
between 23 cm, 17 cm and 14 cm for the therapeutic part.  
The MSD was 3.4 Gy, with a long tail in a spread out AP and left anterior 
oblique projection in cranial direction (LAO0, CRAN30 to LAO40, CRAN30), 
containing values below 1 Gy, due to fluoroscopy mode (98% of fluoroscopy 
to DAP contribution) (Figure 23). The SID was of normal value at that 
projection: 100 cm. The cardiologist used collimation and used different 
geometries during fluoroscopy. The II was kept close to the patient. 
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Notwithstanding the fact that good practice was applied, high doses were 
measured. Five cinegraphy runs were taken at that projection. With respect 
to the filtration used in fluoroscopy mode, no additional filtration with an 
inherent filtration of 2.5 mm Al was used, corresponding to the filtration 
setting fluoroscopy ‘high’. Image Quality at this x-ray equipment was found 
to be insufficient at low dose fluoroscopy mode.  Fluoroscopy ‘high’ mode 
was set as ‘default’ value for clinical practice, but could, however, be 
changed when judged necessary. No additional filtration (Cu) and an 
inherent filtration of 2.5 mm Al was used for cinegraphy mode.  
 
 
Figure 25. Three dimensional representation of skin dose distribution for case 7. 
 
A second skin dose peak with value of 1.9 Gy was measured at a projection 
of LAO50, CAUD0. Three cinegraphy runs were taken at this position, with 
a relative contribution of cinegraphy to DAP in this projection of 78%. The 
plot of the skin dose distribution shows that the MSD-peak was not fully 
measured. The value of 3.4 Gy was registered on the increasing side of the 
peak, which means that the actual MSD can be assessed to be a value even 
higher.  
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4.2.8 Case 8 
A therapeutic procedure (CA-2(PTCA-ST)+primST) was performed by an 
experienced cardiologist and on a monoplane system. This procedure was 
classified as difficult because of multiple difficult lesions. During PTCA and 
stenting, different subsequent inflations were performed. The patient was an 
84 year old man of normal weight (BMI = 23). The procedure contained 45 
cinegraphy-runs, at a frame rate of 15 frames per second (except 30 frames 
per second for the ventriculography), with an average duration of 
cinegraphy-runs of 2.8 seconds. The pulse rate for fluoroscopy mode was 15 
pulses per second.  The FD field was kept on 20 cm during the whole 
intervention. The MSD was 4.5 Gy, with a neighbouring value of 3.7 Gy at 
lateral projection (LAO90, CAUD0). The SID was of normal value at that 
projection: 104 cm. Twenty-four cinegraphy runs were taken at the 
projection corresponding to MSD of 4.5 Gy (Figure 24). With respect to the 
filtration used in fluoroscopy mode, the system chose filtration according to 
variable filtration settings:  no additional Cu-filtration or an additional Cu-
filtration of 0.1, 0.2, 0.3, 0.6 mm with an inherent filtration of 2.5 mm Al was 
used. Variable additional filtration (0, 0.1, 0.2, 0.3 mm Cu) was chosen by the 
system (with an inherent filtration of 2.5 mm Al) for cinegraphy mode. The 
contribution of fluoroscopy to DAP, registered for this projection was 
predominate. (89% versus 11% for contribution of cinegraphy) 
 
Figure 26.  Three-dimensional representation of skin dose distribution for case 8. 
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A second spread out skin dose spot with peak value of 1.2 Gy was measured 
at a spread out left anterior oblique projection of LAO30-40, CRAN0-16. 
Twelve cinegraphy runs were taken at this position, with a relative 
contribution of fluoroscopy to DAP in this projection of 72%.  
 
4.2.9 Case 9 
 
Figure 27.  Three-dimensional representation of skin dose distribution for case 9. 
 
A diagnostic procedure (CA) was performed by an experienced cardiologist 
and on a monoplane system. This procedure was classified as difficult 
because of the use of various catheters in order to find the right coronary 
artery. The patient was a 73 year old woman, suffering from obesity (BMI = 
31). The procedure contained 21 cinegraphy-runs, at a frame rate of 15 
frames per second (except 30 frames per second for the ventriculography), 
with an average duration of cinegraphy-runs of  5.6 seconds. The pulse rate 
for fluoroscopy mode was 15 pulses per second.  The FD imaging field was 
kept on 20 cm during the whole intervention (except for the 
ventriculography where the II field had a size of 25 cm). The MSD was 2.6 
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Gy, at lateral projection (LAO90, CAUD0) (Figure 25). The SID was rather 
large at that projection: 111 cm. A rather large distance between patient’s 
skin and FD was observed, whereas the distance from the x-ray tube focus to 
patient’s skin was rather small. Twenty-one cinegraphy runs were taken at 
that projection. With respect to the filtration used in fluoroscopy mode, the 
system chose a filtration according to variable filtration settings: no 
additional Cu-filtration or an additional Cu-filtration of 0.1, 0.2, 0.3, 0.6 mm 
with an inherent filtration of 2.5 mm Al. For cinegraphy mode, variable 
additional filtration (0, 0.1, 0.2, 0.3 mm Cu) was also chosen by the system 
(with an inherent filtration of 2.5 mm Al). The contribution of fluoroscopy to 
DAP, registered for this projection was predominate. (79% versus 21% for 
contribution of cinegraphy)  
4.3 Direct skin effects: General discussion 
The basis of radiographic imaging is the difference in attenuation of an 
incident x-ray beam, by the different tissues and contrast compounds. This 
inevitably causes absorbed dose in patient’s tissues. The first 4.5 cm of the 
body removes half of the beam (measured in a water phantom, for beam 
characteristics of 75 kVp and 3 mm Al filtration); hence most of the 
deterministic damage is found in the superficial tissues, with the skin as 
most important and sensitive one [52].  
As is clear from the introduction section, procedures in IC are likely to 
involve high  skin doses [53, 55]. In previous section, the cases in present 
work with skin doses exceeding 2 Gy were described.  2 Gy is considered the 
threshold value for onset of transient erythema (ICRP60). Parameters with 
the strongest effect on high MSD-values in this work are:  
• overweight of the patients (6 out of 9 patients with overweight, 3 of 
them even suffering from obesity) 
• difficulty of the procedure (all procedures were scale ‘3’ procedures) 
• prolonged use of fluoroscopy mode (5 out of 9 cases presented  a 
fluoroscopy contribution > 75%) 
• fixed geometry for both fluoroscopy and cinegraphy 
• large distance between patient and entrance plane of the IR (distances 
between 20 and 40 cm), related to a short distance of patient’s skin to 
the x-ray tube 
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From this list, only the last two determinants can be actively controlled 
during a procedure. Body mass index of a patient and the fact that a 
procedure turns out difficult are unchangeable. The latter aspect influences 
at least partly fluoroscopy time. An extensive list of general dose-reducing 
techniques is given in paragraph 4.5. The proposed measures are in favour 
of decreased overall tissue dose, including skin. Taking these measures and 
the discussion above in mind, a cardiologist can optimise its catheterization 
technique in order to prevent increased skin damage. Furthermore, he will 
recognize with more ease procedures suspected to cause MSD > 2 Gy, so 
that necessary follow-up can be provided. 
One aspect has not been taken into account in the discussion of this work: 
influence of multiple procedures. In most of the cases with radiodermatitis 
reported in literature, multiple (prolonged) procedures lie at the basis of the 
skin injury [53, 57-59, 62]. Therefore, resulting total value of MSD is reported 
to be a lot higher than 2 Gy. MSD values were estimated retrospectively 
from clinical outcome and nature of the injury and ranged from 2 to 10 Gy 
[62] to values as high as 20 Gy [59, 63]. It is of major importance that DAP 
values, and preferably interpreted in terms of DAP action levels, are 
included in patient’s records. Patients often do not remember how many 
catheterization procedures they were submitted to. They often are not aware 
of the radiation burden involved with the procedure and they evidently 
cannot be aware of the magnitude of exposure of their individual 
examination if they are not told so. It is advised that from a certain number 
of procedures on, the personal physician of the patient is informed.  Actual 
diagnosis of skin injuries is often difficult and initially missed because the 
problem generally presents two to three weeks following the causative 
exposure. Moreover a pronounced variability in onset time, clinical features 
and outcome are reported [57, 59]. Therefore, both the patient and the 
patient’s physicians mostly do not correlate the developing skin lesion to the 
earlier radiation exposure [57, 58]. Some indications when examining the 
skin of patients, sometimes presenting with a painful cutaneous ulceration 
can help to identify radiodermatitis, induced by IC. The lesions are typically 
found in the  (upper) back or at the right trunk side, under the axilla. Chest 
side or left trunk side practically do not appear as location for skin injury, 
related to IC. Sometimes lesions appear on the right upper arm, when 
procedures were performed careless, leaving the arms in the beam or when 
another reason prevented the arms to be removed from the primary beam. 
Radiation induced skin lesions also appear to be of well-defined shape, in 
accordance with the shape of the entrance beam. Moreover, the occurrence 
of ‘spontaneous’ ulceration in skin regions of atrophy and scarring is highly 
suggestive of radiodermatitis. Moreover, when local treatment to resolve 
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skin lesions is not successful and when excruciating pain persists at the 
lesion, the possibility of a chronic radiodermatitis should strongly be 
considered [58]. 
In more moderate cases, or for patients with a single only or restricted 
history of IC, erythema may occur very shortly after exposure, being a 
matter of hours or less and peaking at about 24 hours. Afterward it fades. 
Therefore, and for reason of being located at a location that is difficult to be 
seen by oneself, early and transient erythema probably pass by unnoticed in 
many cases.  
Mean MSD values as reported in paragraph 3.1 (publication 1) are 0.3 Gy 
and 0.7 Gy, respectively for diagnostic and therapeutic procedures. It has to 
be recalled that therapeutic procedures comprise single or multiple PTCA 
with or without single or multiple stenting, single or plural direct stenting 
and combined procedures (diagnostic procedures). Median values, however, 
amounted to 0.2 and 0.5 Gy for diagnostic and therapeutic procedures 
respectively and indicating the influence of the large tail of the distribution 
(recall figure 3, paragraph 3.1, publication 1). Lower and similar mean 
values for skin dose have been reported in literature: 0.3 Gy [89, 90], 0.1 Gy 
[91], 0.2 Gy  [28] for diagnostic procedures and 0.8 Gy [65], 1 Gy [90] and 0.4 
Gy [62] for therapeutic procedures. It has to be mentioned that the lower 
values were measured only with  a limited number of TLDs [62, 91].  
The fact that the entire primary exposed skin was covered during 
measurements is of great value. By use of the grid of TLDs and the 
accompanied reconstruction of the skin dose distribution, we were sure to 
have included the maximum peak values for skin dose. In publication 1, 
MSD was found to be significantly depending on procedure (diagnostic or 
therapeutic), variable filtration and difficulty of the procedure. Trends were 
visible according to the hospital where the procedures were performed, 
representing overall attention to radiation burden of the patient 
(catheterization methods and attitudes, equipment, … ). Significance was not 
expressed, due to large variations in data distributions. 
Skin entrance doses and peak dose values can be roughly estimated, using 
exposure parameters of the performed IC procedure. Research by Morell et 
al. [92] has lead towards a model for patient skin dose assessment in IC, 
based on data stored in DICOM headers. den Boer et al.  described a novel 
modality-feature for real-time quantification and display of skin dose 
distribution [93]. However, these tools are not  always available on x-ray 
equipment. Therefore, it is advised to make use of DAP action levels, as 
described in paragraph 3.1 (publication 1). Practically this means that if DAP 
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exceeds 125 Gycm2 (assigned to a MSD value of 2 Gy), the entry site of the 
beam that is responsible for the highest skin dose should be included in 
patient’s record. A possible follow-up of the patient for radiation skin effect 
is to the cardiologist’s decision. In case DAP exceeds 250 Gycm2, (assigned to 
a MSD value of 3 Gy), the patient and his personal physician should be 
informed on the possible radiation effects, and a systematic follow-up 
should be performed. This is of great concern in the patient population that 
needs recurrent catheterizations, with possibly the same projections as used 
on beforehand to visualise the lesion(s). 
However DAP action levels are a very helpful tool in adult IC, the concept is 
not applicable in paediatric IC. As exposure geometry during paediatric IC 
procedures is not that variable as with adult cardiac catheterizations, one 
and the same skin area is more likely to be exposed. This is represented in a 
relative good correlation between DAP and MSD (chapter 3, Part IV, figure 
3). In contradiction with adult cardiac catheterization where necessarily 
DAP action levels had to be derived due to a minor correlation between 
these two quantities, we can now simply use the MSD-DAP relation to 
predict on skin dose values. Doing so, a DAP value of 174 Gycm2 would 
correspond with a MSD value of 2 Gy for the child’s back (frontal tube). A 
DAP value of 97 Gycm2 would equivalently correspond with a MSD value of 
2 Gy at the armpit (lateral tube).  With median cumulative DAP values of 4.5 
Gycm2 mentioned in chapter 3, Part IV, for a paediatric IC procedure, it is 
unlikely that the MSD threshold for transient erythema (2 Gy) is passed after 
one intervention. However, from the point of view of repeated procedures in 
young children, who receive easily four to five cardiac catheterizations in the 
first three years of their lives for treatment of one and the same lesion, total 
cumulative MSD may pass this 2 Gy threshold. Therefore it is certainly 
advised not only to interpret the recorded DAP values in  patient’s medical 
file in terms of long term effects but also in terms of possible deterministic 
skin effects. Thus, formulation of DAP action levels for a paediatric 
population interpretable for one single IC procedure, as is the case for adult 
cardiac catheterization, does not make sense.  But, as said, storage and 
summation of cumulative DAP values over multiple procedures (preferably 
for frontal and lateral tubes separately) in patient’s files is strongly 
recommended. Dermatological follow-up based on total cumulative DAP 
values of (rounded) 100 Gycm2 (armpit) and/or 175 Gycm2 (back) should be 
included in the clinical IC protocol. 
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4.4 Late effects and Dose Reference Levels (DRL) 
Risks for late effects (cancer induction) are especially important for 
paediatric patients. As mentioned in paragraph 3.4 (publication 4), the risk 
for these effects for the paediatric population followed in the study amounts 
to 0.1% for the youngest patients (<1 year of age) to 0.05% for children 
between 6 and 10 years of age, with no significant difference between 
diagnostic and therapeutic examinations. The calculated risk in paragraph 
3.2 (publication 2) amounted to 0.01 % for diagnostic and 0.02 % for 
therapeutic procedures for an adult population, meaning roughly a factor of 
10. These estimations were based on the attributable life-time risk versus age 
from the ICRP report 60 [8]. The risk- values were obtained through patient-
specific effective dose simulations by use of the software package MCNP. 
This patient-specific dose calculation is of great value, taking into account 
the large anatomical variations in body length and weight in young children 
(0-10 years in  the study we performed). However, recently Smans et al.  [94] 
showed that calculations for premature babies could also be performed 
using a downsized mathematical phantom (PCXMC). 
A practical dose measure for risk estimation, which is in good correlation 
with E, is DAP. Paragraph 3.3 (Publication 3) derived CF for E calculation. 
There is a significant difference in CF for systems using additional Cu 
filtration in cinegraphy mode and systems that do not was noted. A CF of 
0.207  mSv Gy-1cm-2 was derived for the first group and a factor of 0.177 mSv 
Gy-1cm-2 for the second group. The defining factor for this difference was not 
the radiation geometry of the standard clinical protocol in the different 
centres. The explanation was rather found in the beam hardening as a 
consequence of the additional filtration. This results in a higher E for the 
same DAP value. 
Within practical interpretation of E as the multiplication of DAP and a 
conversion factor (CF): 
E=CF*DAP, 
both CF and DAP are influenced by the additional beam filtration. This 
additional filtration induces beam hardening but influences to a greater 
extend the photon fluence. Beam hardening implies an increase in 
conversion factor for the same DAP value, whereas a decrease of photon 
fluence means a direct decrease of DAP. Both effects will only partially 
compensate, resulting in a decrease in effective dose when additional Cu 
filtration is used. However, it should be stressed that the effect of additional 
filtration will mainly influence on ESD. Since the fractional reduction in 
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incident dose is greater than the fractional reduction in exit dose, when 
additional filtration is added, ESD will be reduced proportionally more than 
E. 
In view of the ALARA principle, a constant review of mean dose values (and 
dose distribution) of patients who undergo high dose x-ray examinations is 
needed. Comparison of the local mean values with nationally proposed so-
called ‘reference doses’, gives an idea about the ranking of the current 
practice in a hospital, with respect to patient dose.  ICRP 73 states that 
‘reference doses are intended to act as investigation levels triggering a local 
investigation if the typical dose for a specific type of diagnostic procedures is found 
consistently to exceed the relevant reference level. Unless this can be justified by 
sound clinical judgement, appropriate corrective action should be taken to improve 
practice; this could involve changes in procedures or equipment to reduce doses to 
below the reference level without compromising the quality of the diagnostic 
information.’ [95]. Essentially, DRLs act as a simple test for identifying 
situations where patient doses are becoming unusually high and action is 
most urgently required. With this function in mind, we understand that they 
are not an ‘optimum’ or ‘minimum achievable’ level but more at a 
borderline between acceptable and unacceptable practice. A pragmatic way 
of setting this level uses the third quartile values observed in large surveys 
of typical doses for common procedures. Indeed,  ICRP 73 recommends that  
‘… initial values (be chosen) as a percentile point on the observed distribution of 
doses to patients. The values should be selected by professional medical bodies and 
reviewed at intervals that represent a compromise between the necessary stability 
and the long-term changes in the observed dose distributions.’ Different proposals 
and considerations about derivation of DRLs for different procedures can be 
found in literature [95-98]. Specific DRLs for diagnostic and therapeutic 
examinations in IC, were derived in chapter 3.1 (publication 1).  Proposed 
values are 71 Gycm2 and 106 Gycm2 respectively. It  should be stressed that 
the availability of additional copper (Cu) filtration pulls the entire DAP 
distribution of a followed patient population towards lower values, with a 
lower mean DAP as a consequence (see paragraph 3.3) (publication 3).  
Being aware of this will contribute to an accurate comparison with  DRLs. 
In view of the above discussion, it is strongly advised to save dose indicators 
(e.g. DAP) in patient’s records. An effective framework for measuring doses 
and saving dose values in patient’s record is necessary. 
The Belgian situation regarding radiation burden in cardiovascular 
catheterization in terms of DAP, represented in figure 7 in paragraph 3.1 
(publication 1), shows reported values are rather high. The values for other 
countries than Belgium, derived in DIMONDIII project, included data from 
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100 examinations per country [97]. The procedures included in the 
DIMOND III project are CA and PTCA. The authors stated that in some 
interventions the diagnostic part could not be split from the therapeutic part.  
Therefore, the dose was considered as the value for the PTCA procedure. In 
paragraph 3.1 (publication 1), therapeutic procedures almost never 
consisted of a single PTCA, but were almost always made up of different 
therapeutic interventions, combined with a foregoing CA. This can explain 
the higher dose values in the Belgian study. Within the DIMOND III project, 
Finland also scores rather high with respect to DAP values. A possible 
explanation, given in the paper, is the high value of dose rate in fluoroscopy 
or the dose per frame. However, numbers were not given. In present study, 
physical technical quality control showed average entrance dose rates (20 cm 
PMMA) for the systems of 24 mGy/min at a distance of 1m for normal 
fluoroscopy settings and a medium field size. Values of 0.38 µGy/pulse at 
the entrance plane of the IR were measured for cinegraphy for different 
filtration settings, according to the ABC of the systems. Hopefully, when the 
recommendations for dose lowering in IC, listed below, are taken to heart, a 
lowering of mean and third quartile DAP values can be expected. 
4.5 Recommendations for dose optimisation in IC 
As described in detail in the Introduction section (paragraph 1.5) IC can 
involve high doses to patients (both adults and children) and may result in 
either deterministic or stochastic effects [36, 50]. Regarding short–term (or 
deterministic) effects, the skin is the tissue at greatest risk. Regarding long-
term (or stochastic) effects, the youngest - and therefore most radiosensitive 
- population is at highest risk. Moreover, it is seen that  IC procedures are by 
far the most frequent interventions performed in industrialised countries 
and with a relative high frequency of repetition on the same patient in a 
short period of time [36, 53, 55, 56, 58, 59]. In view of the ALARA-principle, 
dose saving handling and techniques have to be emphasized, whenever x-
ray-based (and more specific interventional) techniques are used. Because of 
the intrinsic compromise between radiation dose and image quality, proper 
imaging techniques can only be described in view of these two parameters 
(see paragraph 1.4). It is obvious that no dose lowering at the expense of 
relevant diagnostic information loss, or overspill of imaging detail at the 
expense of an unacceptable high radiation dose, can be allowed.  
The following paragraph discusses and bundles different dose saving 
techniques based on the recommendations formulated in several 
publications [10, 13, 15, 18, 47, 52, 53, 84-87, 92, 93, 95, 99-117] and on our 
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findings during measurements in catheterization rooms. It was my goal to 
give an overview of all possible techniques and to encourage application in 
daily practice. Therefore, I also provided a short version of this list in the 
appendix. Some of the techniques are specifically applicable to paediatric 
catheterization, while others may emphasize on skin dose. Implementation 
of all possible dose reduction techniques, mentioned in the following 
paragraph, may allow a significant dose reduction both in fluoroscopy and 
in cinegraphy mode.  
 
4.5.1 Dose saving handling and techniques 
1. Decrease beam-on time! Do not apply fluoroscopy while changing the 
position of patient, table, tube, collimator or partial thickness shields. 
The physician operating the fluoroscopy unit has the ability to 
significantly reduce radiation doses by reducing the exposure time [10, 
47, 99-101]. As this is possibly the most efficient technique for dose 
reduction, it is mentioned first. During catheter changing, brief looks 
should be sufficient for moving it up. Most cardiologists are aware of the 
value of tapping the foot switch rather than standing on it. With the 
availability of digital cinegraphy loops, repeated as often as necessary, 
some shortening of cinegraphy angiograms might be possible. Modern 
systems have the possibility to store images taken in fluoroscopy mode 
or to generate 1 pulse in order to take 1 image. These options are very 
useful when documenting on expansion of a balloon or stent. 
Use of fluoroscopy while changing table position or when rotating the 
tube in a different geometry only contributes to the dose without 
contribution to diagnostic information. Even in overscheduled 
catheterization laboratories, where interventionists and nursing 
personnel are highly occupied and urged to hurry, this is not acceptable.  
Last but not least, when the eye is not on the screen, the foot should not 
be on the paddle.  Do not tread the paddle when discussing. 
2. Involve the concept of personnel dose with patient dose. The rule of 
thumb in this topic is ‘what you give is what you receive’, meaning that the 
higher the patient dose is, the higher the operator dose will be [10, 99, 
111].  This point of view might perhaps break through the force of habit 
of persisting operator, paying relatively less attention to (patient) 
radiation burden. Without going into detail about measurement and 
quantification of staff dose, the relation with personnel/operator dose is 
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in the right place here. Besides lowering patient dose, another number of 
measures to decrease staff dose can be taken. Make use of the ‘inverse 
square law‘ and step backwards when performing a cinegraphy run. 
Make use of the hanging acrylic shielding [115], of lead aprons, lead 
collars and make sure they are properly stored on hangers in order to 
avoid cracks. Insist on consistent wearing of dosimetry badges [116].  
3. Follow a structured training program in your department.  Information 
sessions, seminars, and/or topic related talks should be organised at a 
regular base and within a structured training program. As well 
cardiologists, nurses, as technicians should be involved. A culture that 
strives toward radiation awareness and safety being present and 
maintained, will easily motivate the involved personnel to adapt 
catheterization practice to a dose-conscious action of high medical 
quality.   
It is of great importance to be familiar with the equipment available in 
your catheterization room. All options of the equipment should be 
known and this is particularly important when new modalities are put 
into practice [99]. Discussions with the manufacturer should provide 
insight and training by the manufacturer’s application engineer must be 
demanded.  
Extensive training programs for interventional cardiologists dealing with 
the treatment of paediatric patients are found in literature. The 
publication by Ruiz et al.  touches topics as ‘Principles of radiographic 
imaging and radiation safety’, ‘Diagnostic cardiac catheterization’ , 
‘Hemodynamics’, ‘Cardiac catheterization laboratory pharmacology’ and 
‘Additional core curriculum for interventional paediatric cardiology’  
and adds an extensive bibliography [112]. Another document resulted 
from The American College of Cardiology (ACC) / American Heart 
Association (AHA) / American College of Physicians (ACP) Task Force 
and describes recommendations regarding optimisation of patient safety 
and image quality in fluoroscopically guided invasive cardiovascular 
procedures [84]. Further reading regarding the IAEA’s initiatives for 
training of interventional cardiologists can be found in Rehani et al. [87] 
and related topics are described by Beller et al. [113], Picano et al. [114] 
and Vañó et al. [117]. 
4. Save dose indicating parameters, such as DAP, in patient’s record. 
Compare DAP to DAP action levels (interpretation for skin dose) and 
to DRLs (interpretation of general practice).  When sophisticated 
software that saves exposure parameters and calculates an estimate for 
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skin entrance doses [92, 93] is not present, use can be made of DAP 
action levels, as advised in  paragraph 3.1 (publication 1).  Practically 
this means that if DAP exceeds 125 Gycm2 (assigned to a MSD value of 2 
Gy), the entry site of the beam that is responsible for the highest skin 
dose should be included in patient’s record. A possible follow-up of the 
patient for radiation skin effect is to the cardiologist’s decision. In case 
DAP exceeds 250 Gycm2, (assigned to a MSD value of 3 Gy), the patient 
and his personal physician should be informed on the possible radiation 
effects, and a systematic follow-up should be performed. This is of great 
concern in the patient population that needs recurrent catheterizations, 
with possibly same projections as used beforehand to visualise the 
lesion(s). 
Secondly, in order to evaluate the current and general practice in a 
hospital, concerning radiation burden to the patient, a yearly comparison 
of the mean DAP value of an annual DAP distribution,  to (inter)national 
DRLs should be performed [85, 95]. Specific DRLs for diagnostic and 
therapeutic examinations in IC in Belgium, at this moment, are 71 Gycm2 
and 106 Gycm2 respectively.  
Thus, it is strongly advised to save dose indicators (e.g. DAP, if possible 
estimated skin dose) in patient’s record. An effective framework for 
measuring doses and saving dose values is necessary. 
5. Diagnostic information should be obtained primarily non-invasively. 
Physical examination and e.g. echocardiogram or MRI prior to cardiac 
catheterization, yield a prior understanding of the cardiovascular 
anatomy and results in a more focused catheterization study [101]. 
Information already known by non-invasive studies should not be re-
taken during catheterization “just because we’re there”. In clinical 
practice, this is most applicable in treatment of CHD, both in adults as in 
children. 
6. Plan the angiographic projections beforehand. Use the x-ray stand 
position memory-function. With respect to CHD in children, rare or 
unusual anatomic variants are difficult to image, with trial and error-
methods for best visualisation as possible consequence. Specialised 
textbooks contain tables, listing angiographic views for some common 
defects [47].  Reviewing of non-invasive prior studies can also bring 
some insight in geometries best chosen during catheterization. 
With respect to cardiac catheterization in adults, for diagnosis or 
treatment of CAD, it is advisable to define a set of standard projections 
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(paragraph 3.2) and describe them in terms of a clinical protocol [101]. 
This would be most applicable for the diagnostic part of a cardiac 
catheterization. The protocol should be optimised in terms of all 
recommendations mentioned above. Avoidance of lateral views should 
be encouraged. Apparently it is possible to set up a set of standard 
projections without the hazardous lateral geometry in terms of skin dose, 
as is current practice in hospital 9 (paragraph 3.2). Catheterization rooms 
with biplane geometry should avoid overuse of cinegraphy mode. As 
stated in paragraph 3.1 (publication 1), a significant larger contribution 
of cinegraphy in hospitals with biplane systems in comparison with 
hospitals with monoplane systems was measured. This means that the 
possibility of acquiring two cinegraphy runs simultaneously at two 
different projections with a biplane system is not fully exploited but 
rather leads to an overuse due to the ease and speed of the technique. A 
comparison of the set of projections of a certain hospital can be 
compared with the standard projections of the different hospitals 
involved in the multicentre study in publication 2 (paragraph 3.2). This 
can give a good idea of current practice with respect to colleague-
catheterization laboratories. Whenever possible LAO positions (of mage 
receptor, meaning a x-ray tube located at the right) should be minimized 
to minimize operator dose. At all time, ‘x-ray stand position memory’ 
should be used. This option allows to save the geometrical position of 
tube and IR (eg. RAO 30, CRAN 20) at predefined positions or at 
positions during the procedure. The system allows for returning to these 
positions fast, accurately and without use of fluoroscopy for 
repositioning. 
7. Use automated filter selection-function, preferably with additional 
copper (Cu) filtration.  Additional filtration removes the lower-energy 
photons that only contribute to patient’s dose from the beam [18]. The 
patient’s entrance exposure (and thus MSD) can be effectively lowered 
without degradation of image quality [13, 104]. Federal regulation 
requires a minimum of 2.5 mm of aluminium (Al) equivalent material for 
skin dose reduction. Increasing the filtration to an equivalent of 3.5mm 
of Al or even 0.1 mm of Cu can help further reduce the entrance skin 
dose by about 25% or more with no perceptible loss of image quality [52, 
105]. Since the fractional reduction in incident dose is greater than the 
fractional reduction in exit dose when Cu filtration is added, entrance 
skin dose will be reduced proportionately more than effective dose (E). 
8. Use adapted ABC curves (paediatric patients), with optimized 
parameters in function of image quality. As mentioned by Tapiovaara 
et al. [108] a remarkably increased dose efficiency for image generation 
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was obtained by use of a low x-ray potential combined with a  high 
filtration and grid use for all but the smallest patients. It resulted in 
improved detail contrast but increased image noise.  Adaptation of the 
ABC-curves towards these guidelines is advisable. It remains a challenge 
to keep SNR as high as possible with high filtration and at low tube 
voltages. The reason is the limited tube current, possible for the 
equipment. Therefore, with thicker patients, either filtration thickness 
should be decreased or tube potential should be increased, meaning that 
a less efficient x-ray spectrum in terms of dose-to-information conversion 
coefficient (CF) has to be chosen. Tapiovaara et al. mentioned possible 
fluoroscopic dose rate decreases of factors up to 6 in different 
catheterization laboratories, included in their study [108]. Considerations  
about SNR/dose rate and optimal tube voltages can be found in [109]. 
With adults, filtration values, tube potential values and tube current are 
differently chosen and combined, due to higher tissue material in the 
beam and larger vessels. 
Special attention should be paid to contrast-enhancing functions that 
lower tube potential, sometimes less than 80 kVp (adult population). 
With reduction of tube potential, the x-rays become less penetrating. 
This requires a greater entrance dose to the patient - posing the skin at 
higher risk - to achieve the exit dose necessary for fluoroscopic imaging. 
Therefore, it is reasonable to operate an IC unit not below 80 kVp during 
fluoroscopy in adults, unless the beam is very heavily filtered (>0.2 mm 
Cu) [52]. In contrast with adults, a lower tube potential of less than 80 
kVp is required for paediatric fluoroscopy. 
9. Maintain x-ray equipment in good repair and calibration, i.e. resign it 
to a periodically Quality Control Check. A qualified medical specialist 
should periodically (yearly) check performance of the equipment, 
including radiation levels and image quality. In the course of time, 
eventual defects should be reported immediately by the users of the 
equipment and repaired. Ideally, each hospital should foresee in a 
financial programme for replacement of interventional equipment every 
10 year [99]. Optimisation of exposure and image quality parameters 
should be performed. If necessary, a cooperation with the manufacturer 
has to be established. Operators should recognize that a good image 
contains noise to a certain extend and should not request calibration that 
contain excellent images containing redundant information [100, 101]. 
Aging image intensifiers should be replaced, as the efficiency of 
conversion of x-rays into light photons at the caesium iodide input 
phosphor decreases with time. In current practice, there is still little or no 
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information about the time evolution of flat detectors used for dynamic 
examinations, but radiation damage is very likely at the course of time. 
10. Keep the image receptor (IR) as close as possible to the patient (and 
the x-ray tube as far as possible) to minimize skin effects. Moving 
away the IR from the patient will imply higher input doses due to signal 
loss in the air gap at the exit of the patient. Contrarily, the x-ray tube 
should be kept as far as possible to the patient [10, 86, 99].  This is most 
feasible in monoplane systems, with enough freedom to maintain a 
workable situation for operator and nursing personnel whilst moving up 
the table and approaching the IR towards the patient. In biplane systems 
the patient’s heart is kept at the isocentre in order to have a correct image 
in both planes.  A right value for SID lies between 100 and 120 cm 
(adults), given the fact that the IR is positioned as close as possible to the 
patient. Certainly with highly steep cranial projections (40 degrees) it is 
important to ask the patient to turn the head sideward. This allows the 
IR to pass patient’s nose and chin to just touch the thorax. If not, this 
implies a distance from patient exit plane to IR of about 40 cm! 
11. Use collimators and partial thickness shields. As collimators are 
extremely effective in reduction of dose to both patient and operator, 
they should ever be used in clinical practice to define the diagnostic 
important field [99, 101]. Use of collimators decreases the overall amount 
of irradiated tissue and minimizes scatter. Less scatter means better 
subject contrast in the image and also less dose to organs in proximity of 
the radiation field. Moreover, use of collimators and shields in 
radiolucent areas such as the lungs, improves the image contrast, due to 
increased homogeneity in the image, being in favour of accurate ABC-
functioning.  A rule of thumb says that collimators should always be 
visible within the field.  No studies should be performed with the 
collimators wide open. Many systems are equipment with virtual 
markers to indicate collimator or partial thickness shield positions at the 
monitor. These should be used instead of verification by fluoroscopy. 
12. Remove unnecessary body parts (or instruments) from the field. Most 
frequent, patient’s arms are left in the beam. There is no reason to do 
this. It not only results in a considerable dose to the arms [53] but also to 
a substantial overall increase in patient’s tissue dose. ABC drives up 
radiation dose to compensate for the additional tissue (arms) in the 
beam. 
13. Remove anti-scatter grid when catheterising small children. 
Specifically for paediatric patients, the amount of scattered radiation, 
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negatively affecting image quality by elevating noise level, is less due to 
less tissue material in the beam [10, 86].  Within this patient group, 
removal of the anti-scatter grid will not seriously affect image quality 
and proves a significant dose reduction.  Shueler et al. mentioned a factor 
of 50% dose reduction [15]. Unfortunately, not all systems are designed 
to easily remove the grid. Whenever installing a new system, this should 
be required from the manufacturer, certainly when children are to be 
catheterised on the new equipment. 
14. Use the lowest acceptable frame rate. With almost all recent x-ray 
rotational systems, provided with pulsed fluoroscopy and cinegraphy 
mode, the lowest frame rate as diagnostically possible should be chosen. 
Only use higher frame rates (e.g. 25 f/s instead of 12.5 f/s) when 
necessary (e.g. for ventriculography, visualisation of rapidly moving 
prosthetic valve leaflets,…). It should be kept in mind that with 
paediatrics frame rate cannot be reduced unlimited, due to higher heart 
rate. Elder systems can possibly operate on continuous fluoroscopy. It 
has to be stressed that dose reduction with pulsed fluoroscopy is of the 
order of 25% [86, 102, 103] and that systems with continuous fluoroscopy 
mode should be replaced or upgraded [104]. 
15. Use the lowest acceptable magnification mode. A substantial dose 
increase is related to the use of magnification mode (paragraph 1.6) [86, 
101]. Magnification means reduction in ‘overview’ of anatomical 
structures, with panning, and thus waste of radiation dose as a result 
Panning is moving the table to find or follow the anatomical structure of 
interest, during cinegraphy and should be avoided. Do not forget to 
select the standard field size after an angiogram has been taken in 
magnification mode. Even so, it is not favourable to perform the entire 
procedure in magnification mode. 
16. Vary the site of the radiation entrance spot. For reduction of MSD, the 
radiographic position should be changed – if clinically feasible – during 
procedures that require long fluoroscopy times [10, 86]. 
17. Perform a test injection under fluoroscopy prior to cinegraphy. The test 
injection makes clear whether the catheter is correctly positioned, 
whether the correct magnification mode is used (prevent panning), 
whether the angiographic projection is as desired. A small amount of 
contrast and a few seconds of fluoroscopy are less costly to the patient 
than a wasted cinegraphy-run in terms of radiation and contrast load 
[47]. 
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18. Use roadmap and overlay features. A good angiogram of the culprit 
lesion can be used as roadmap or can even be superimposed on a live 
fluoroscopy image (and faded out when necessary) for vessels of interest 
to be found with minimal trial and error [47]. Certainly when an 
interventional therapeutic part is needed immediately after a diagnostic 
catheterization, this technique is of value.  Confirmation of the catheter 
position can be done without additional contrast injection. 
19. Take angiograms (cinegraphy-runs) only during inspiration. During 
expiration, the diaphragm shows up in the beam, causing the ABC to 
drive up exposure.  Because of inhomogeneity in the image (denser 
diaphragm versus lungs), the ABC will not function optimally. The 
vessel below the diaphragm will be ‘invisible’, while the part above will 
be ‘burnt out’ due to too high a dose. On full inspiration, the entire 
vessel is clearly seen with better contrast. An expiratory acquisition will 
generally have twice the radiation dose of one in full inspiration, and 
will be of less quality [107]. 
20. Avoid use of steep LAO-projections. In almost the entire clinical 
practice of cardiac catheterization, a lateral view of the heart is taken 
with the x-ray tube located at the patient’s right side, being the operator 
side. The IR at that stage is located at the left side (= closest to the heart) 
of the patient, and at the other side of the cardiologist. This convention is 
derived to minimize artefactual enlargement due to magnification of the 
heart.  However, within practice of IC (certainly with paediatric 
population for treatment of CHD), as much left-sided structures as right-
sided structures are likely to be involved in coronary angiograms. So, 
rotation of the tube for 180° would have little or no impact on clinical 
decision making in the catheterization laboratory [47]. As the current 
lateral convention is far most familiarised with interventionists, a change 
is not likely to be introduced yet, although repercussion on operator and 
patient dose is considerable.  Kuon et al. [110] and [100] state that steep 
LAO tube angulations (LAO views ≥ 60° with cranial or caudal 
angulation ≥ 20° are unjustifiable and obsolete. It is precisely those views 
which imply a longer SID and consequently, more radiation exposure to 
patients and staff [111]. 
21. Center the region of interest correctly to the field. With II, less 
geometric distortion is found at the centre of the image, however with 
FD this is not the case (paragraph 1.6.) [10, 106]. Centring allows tighter 
collimation, easier magnification (when necessary) without panning 
(moving the table to find or follow the anatomical structure of interest, 
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during cinegraphy) and optimal exposure, due to central location of the 
ABC-sensor (with II).   
22. Use last image hold-function. Practically all new (or recent) x-ray 
equipment for fluoroscopically guided (cardiovascular) interventions 
has last image hold function. The system holds and continuously 
displays the last frame after radiation is turned off [86]. Only elder 
equipment (II with video capture and monitoring) do not include this 
feature.  
4.6 Recent evolution in IC: flat detectors 
Since its introduction in 1950, II-technology grew and has become the golden 
standard for image reception in dynamical fluoroscopic x-imaging.  The 
latest step comprised coupling of the II with a CCD-camera, bringing along 
greater temporal stability and low electronic noise [79]. It was only recently, 
thanks to technological innovations, that a relatively new imaging 
technology started to compete with II for dynamical investigations.  In the 
late 1990’s, time resolution of flat-panel displays reached a sufficient level to 
be suitable as IRs for fluoroscopy guided interventions. Many of its 
advantages are very appreciated:  direct digitization of the images,  better 
ergonomics with better patient access, lack of geometric distortion, little or 
no veiling glare, no vignetting, insensitivity to magnetic fields and wider 
dynamic range, with an advanced image quality as a promise… [77-80]. 
With nowadays computer capacity and extended intra- and interhospital 
networking, digital data processing, storing, transporting, multiple viewing 
and duplicating are performed with ease and at a astonishing velocity. 
However, the successful story has also its minor side and some questions 
remain unanswered. This pertains to the relation between image quality and 
patient dose and especially at low exposure rates, since system noise seems 
to become a limiting factor in determining system performance [81, 83]. 
Paragraph 3.5 (Publication 5) tackles this problem and compares IQ by 
means of threshold contrast–detail analysis of an II and a FD-system and 
investigates patient dose on both modalities.  
From the study a difference became apparent in dose-IQ relation for the two 
modes used in IC practice: fluoroscopy and cinegraphy. In fluoroscopy 
mode an equal IQ performance was noted, whereas for cinegraphy a higher 
IQ performance was found for the FD system.  This reflects the intrinsic 
better imaging performance of the FD with higher EDR values (recall figure 
1, chapter 3.5, publication 5). 
 159 
 
 
 
 
 
 
 
 
 
Figure 28. Comparison of DQE(0) versus exposure (nGy) for an II and a FD-system. Values and 
behavior were taken from Antonuk et al. [81], Busse et al. [118] and Bruijns et al. [119]. Entrance 
dose per pulse at the IR for cardiac fluoroscopy mode ranges from 5 to 80 nGy whereas for 
cardiac cinegraphy mode it ranges from 80-400 nGy. 
Overlapping performance of II and FD for low exposure rates has also been 
previously reported considering DQE(f) (f = spatial frequency: lp/mm) [72, 
81, 119]. A comparison between DQE(0) values for FD and II based on refs. 
[81, 118, 119] (Antonuk et al., Busse et al. and Bruijns et al.) is represented in 
Figure 26. The behavior for FD is a consequence of the low SNR of low dose 
images. For these images not only signal amplitude but also electronic and 
other noise are increased in order to obtain the necessary signal level for 
digitisation. In contrast to FD-systems,  DQE(f) for II remains constant 
(values equal to that of FD corresponding to entrance doses of 10 nGy) while 
a decrease becomes only apparent for higher entrance doses starting from 
1000 nGy. 
From the measurements in clinical default settings (ABC mode) any 
significant difference in IQ in fluoroscopy mode could be assigned. In 
cinegraphy mode, however, IQ did differ significantly in favor of the FD 
system (recall figure 4, paragraph 3.5, publication 5). This means that for 
daily practice, profit was taken of the better IQ relation to dose of the FD for 
higher entrance dose rates to obtain images of better quality. Apparently the 
system was not tuned in terms of a possible dose reduction, with 
conservation of an IQ, as set with an II-system. However, optimization 
towards lower patient doses is preferred and evaluation of the default 
parameters in new equipment is strongly recommended. Technically, 
optimization of the exposure versus IQ relationship is possible through 
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adaptation of the ABC-parameters.  DAP-measurements to investigate the 
influence of this new technology on patient dose could not reveal a lowering 
nor increase in exposure burden. 
To conclude, FD IRs, specifically designed for fluoroscopic interventions 
provide a better IQ versus dose efficiency than II for the higher cinegraphy 
levels. Optimal benefit can be taken from this feature by a possible dose 
reduction, since IQ in II (being in good condition) has ever shown to fulfill 
clinical requirements. As with all technological innovations, there is a 
learning curve for implementation, optimal use and adjustment. Advantages 
of FD, being good uniformity, no geometric distortion, no veiling glare or 
vignetting and small, thin physical size for improved patient accessibility, 
can be an important consideration for paediatric imaging [79]. With respect 
to FD, the long term reliability, radiation tolerance and replacement costs are 
still unknown. Considering II, it is known that the conversion of incoming 
photons into light by the input CsI phosphor layer becomes less effective 
with time. However, as for all equipment, maintenance and yearly check-up 
is necessary and this does not diminish overall reliability [106].  
4.7 Alternative techniques for IC 
In Western World, myocardial infarction (MI) remains the leading cause of 
death for both men and women, and its prevalence is still increasing. The 
current gold standard for the detection of CAD is conventional CA, by 
means of catheterization. As already explained, this technique allows direct 
visualisation of the coronary lumen and its high spatial and temporal 
resolution are of great value. However, the procedure is invasive and 
drawbacks include a significant cost, a small risk of serious complications 
[120, 121] and the use of ionising radiation. Furthermore, in a substantial 
number of procedures (ranging from 10%  [122], to 41%  [123], no evidence 
of clinically important CAD is demonstrated. Thus, for patients with a low 
to intermediate pre-test likelihood of CAD, a non-invasive alternative for 
evaluation of the coronary arteries would be desirable. For high-risk patients 
with high pre-test likelihood, direct referral for invasive, catheter-based CA 
may still be preferred [124]. 
In following paragraphs, some alternatives for catheter-based CA will be 
presented.  These include Rotational x-ray CA, Multi-Slice CT Coronary 
Angiography (MSCT-CA), Echocardiography and Coronary Magnetic 
Resonance Angiography (CMRA). 
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4.7.1 Rotational x-ray coronary angiography 
During selective CA, angiograms have to be taken in multiple projections to 
overcome superimposition of cardiac structures and foreshortening of 
vessels. The intrinsic 2D character of the imaging technique imposes this.  In 
contrast to e.g. MRI, (MS)CT and echocardiography, x-ray angiography has 
only recently advanced into the area of 3D reconstruction and visualisation 
[125]. Active rotation of the imaging system around the patient, carefully 
positioned in the isocentre and during angiographic injection, makes 3D 
reconstruction of cardiac structures possible. This method is referred to as 
rotational x-ray coronary angiography (rotational CA).  
Several case reports and publications already mentioned the use of 
rotational CA in clinical practice [126-128] and comparative studies between 
standard and rotational CA have been performed [129, 130]. On the average 
four to six different projections are sufficient for visualisation of the left 
coronary artery (LCA) and three to four for the right coronary artery (RCA), 
during standard CA. The rotational protocol uses one or two rotations (e.g. 
of 100°) with a small tilt (e.g. 25° cranial or 30 ° caudal) for LCA acquisition 
and a single rotation  for the RCA acquisition [128-130]. Mostly the images 
are taken at 25 to 30 f/s and one spin acquisition takes about 5 seconds [127]. 
Besides a significant reduction in contrast media utilization of 19% [129], 
33% [131], and even up to 40% [130], which is in favour of patients with 
advanced renal insufficiency, a dose reduction of 28% [131] and 34% and 
59% for left and right coronary acquisition respectively [129] was reported. 
Panzer et al. not only endorsed to this viewpoint, recalling their experience 
in daily clinical practice, but also reported on possible lowering of skin dose, 
mentioning a value of 101 mGy for cumulative skin dose [127]. Indeed, the 
varying entrance site of the x-ray beam lets us expect lower peak values for 
skin doses. This means that the probability for radiation induced short-term 
effects on the skin could be largely reduced in rotational x-ray CA.  
All authors mentioned above, stated that rotational CA was a clinical 
valuable alternative for standard CA. No need for additional image 
acquisitions beyond the protocol acquisitions was reported with rotational 
CA [130], nor systematic tendency to over- or under-estimate percent 
stenosis with rotational CA was noted [129]. Following Kuon et al., ‘this 
method is able to exactly document multiple LCA lesions and to reliably 
disclose lesions at crucial regions, such as the RCA ostium and bifurcations 
in circumflex and obtuse marginal  arteries’ [128].  Moreover, with the cost 
of a 3D rotational CA system being comparable to a modern monoplane 
system, this new modality is very promising. 
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4.7.2 Echocardiography 
For treatment of ASD, both in adults and children, an extremely precise 
assessment of the defect is crucial. Different techniques are available: 
balloon-sizing manoeuvre, Trans-Esophageal Echocardiography (TEE) and 
recently Intracardiac Echography.  The latter technique comprises a catheter-
based transducer for ultrasonic visualization, moved up through the venous 
system to reach the heart. Rigatelli et al. [132] reported a significant 
reduction in terms of DAP and fluoroscopy time. This could be attributed to 
a more adequate imaging and estimation of the defect with improved safety 
and accuracy of the procedure as result. In comparison with TEE, no 
sedation or intubation is needed, meaning good patient acceptance for a 
relatively prolonged period of time (time of the procedure). Drawbacks 
include the high cost due to disposable catheter-system, large catheter size, 
which limits optimal use, certain in children or babies, and significantly 
increased procedure time  [132-134]. The technique has proven to be of 
potential value not only during catheter-based treatment of ASD but also 
during radiofrequency ablation, measurement of aortic valve area and other 
applications [134]. However, it does not belong to clinical routine (yet?).  In 
view of dose reduction, echography during catheter-based treatment of 
CHD on a paediatric population, reduces dose considerably.  
 
4.7.3 Multi-slice CT Coronary Angiography (MSCT-CA) 
Rapid evolution of Multi Slice Computed Tomography (MSCT) (16 and 64 
slice) facilitated an alternative for coronary angiography, performed by 
interventional methods  [135-138]. Its non-invasive character makes 
performance of MSCT-CA attractive.  Psychological burden e.g. to heart 
transplant patients who require yearly follow-up coronary angiogram can be 
relieved to a certain extend [139]. MSCT is automated, reliable, widely 
available and fast (certainly with nowadays 64-slice scanners, introduced in 
2004) in terms of breath-hold data acquisition. Spatial resolution is high 
enough to visualize adequately small anatomic structures such as coronary 
arteries (with diameter of at least 2 mm) [140] and temporal resolution 
satisfactorily avoids motion artefacts with heart beats < 65 beats/min [140-
142]. Disadvantages include lack of ability to image walls of arteries, or areas 
treated by stenting. The latter is due to artefacts in image reconstruction. 
High or arrhythmic heart rates hamper imaging with MSCT and there is still 
a need for iodinated contrast to be used [143, 144].  Yet, the highest 
drawback of this method is the ‘consuming’ of x-rays.  Remarkably higher 
 163 
doses for MSCT-CA compared to conventional CA in daily practice have 
been reported.  Higher tube currents necessary with thinner collimation and 
z-overscanning in helical applications are some of the reasons to fear high 
doses with implementation of higher number slices [145, 146].   
Radiation induced injuries to the skin, in terms of direct effects, practically 
do not exist with MSCT. The difference between entrance dose and dose 
central in the patient is only 30 % (in comparison with factors 100 to 1000 in 
projection radiography) due to rotational acquisition.  This however 
contrasts sharply with mounting E and risks for long term-effects.  
A recent study (2006, Coles et al.) [147], comparing doses from diagnostic 
coronary angiograms obtained by use of MSCT (MSCT-CA) and by use of 
coronary catheterization (conventional CA), performed on the same patient 
population, revealed significant differences in E. Ninety-one patients both 
underwent conventional CA in a modern Siemens mono- or biplane system 
and a coronary MSCT (MSCT-CA) examination on a Siemens Sensation 16-
slice scanner. The mean E for MSCT-CA (16-slice) was 15.3 mSv, compared 
to 5.6 mSv for the conventional CA.   Hausleiter et al. (2006) [148] illustrated 
that dose reduction techniques such as ECG dependent mAs modulation 
and use of low kilovoltage (100 kV instead of 120 kV) are effective to lower 
mean E-values to 5.0 mSv and 5.4 mSv for MSCT-CA at 16 and 64 slice 
scanners respectively. ECG dependent mAs modulation only applies tube 
current during diastolic phase of the cardiac cycle, at which less time 
imaging artefacts occur. As this technique depends on patient’s heart rate 
requiring a regular sinus rhythm, it is not always applicable for the whole 
population. However, when suitable, this technique has showed dose 
reduction by about 40 % [135, 149] and it is said to be ‘the most significant 
improvement in minimizing radiation from CT technology and the only one 
dedicated to cardiac imaging’ [150]. Abada et al. (2006) endorsed the 
viewpoint of Hausleiter et al. and applied low-kilovoltage protocols for slim 
patients together with ECG-dependent mAs modulation to obtain significant 
dose reduction, without image quality loss [150].  Firstly, it should be 
remarked, however, that tube voltage cannot be lowered infinitely as noise 
and contrast will increase and affect image quality at a certain point. 
Secondly, ECG-dependent mAs modulation is only applicable in clinical 
routine when heart rate is low and constant and therefore effective 
implementation in daily practice is difficult [145]. 
Within this context, it should be emphasized that the lack of information of 
clinicians and angiographers about the influence of different imaging 
protocols on radiation burden to the patient is of great concern.  Practically, 
implementation of new modalities at the imaging site of a hospital mostly 
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stands for unfamiliarity with the integrated protocols. Optimization of these 
protocols, adaptation of the ‘default’ parameters and thorough training on 
application of the new modality are strongly advised [148]. 
As a scan protocol for MSCT-CA mostly consists of a topogram, a calcium 
scoring scan, test bolus scan (sequence of scans to determine a time delay, 
necessary for contrast material to arrive at the organ of interest) and the 
actual coronary angiogram, proposals for dose reduction of the different 
parts have been suggested. Lowering of mAs values from 165 mAs to 55 
mAs for calcium scoring scan resulted in a dose lowering with one third 
with the same clinical outcome for diagnosis [151]. Omission of the test 
bolus scan would only yield a small reduction as it contributed for 5 % to the 
overall dose as shown in the study of Coles et al. [152]. 
The current debate about the appropriate use of MSCT-CA is certainly not 
yet closed and the topics discussed here, only raised a corner of the veil. 
Guidelines for inclusion novel modalities as MSCT-CA within standard 
diagnostic algorithms or screening programs need special attention [153]. As 
with overall medical practice, a clear medical justification is required in each 
specific case  [48].  
Due to higher heartbeat of children, MSCT-CA is only applicable to an adult 
population.  Nevertheless, paediatric CT of any other part of a child’s body 
remains hot topic with respect to radiation risk and late, long–term effects 
[42, 154-156]. 
Whenever dose saving techniques such as ECG dependent mAs modulation, 
and use of low kilo-voltage evolve to be applicable to the entire patient 
population submitted to coronaro-CT, further progress of the technique for 
diagnosis of CAD can be made. However, the situation becomes dangerous 
when intervention is needed for a patient, who was first thought to be of low 
risk with respect to CAD and therefore was referred to CT… With referral to 
the catheterization laboratory to receive the due PTCA or stenting, the 
following question will arise: ‘Will the diagnostic part be retaken 
(performing conventional CA) in order to get acquainted with the lesion, 
imaged with a different technique?’. As this is true, the added value of the 
MSCT-CA and its involved dose is strongly questioned. For these cases, the 
benefit of an ad-hoc dilatation or stenting, immediately following a 
diagnostic conventional CA probably involves less radiation exposure than 
the ‘alternative ‘, performing the diagnostic part by MSCT.   
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4.7.4 Coronary Magnetic Resonance Angiography (CMRA) 
Besides cardiac catheterization and MSCT, MRI has emerged as diagnostic 
cardiac imaging technique. Strengths for this technique are non-invasive 
character, lack of exposure to ionising radiation, possibilities to image wall, 
lumens and plaque composition and avoidance of iodinated contrast media 
[143, 144]. Weaknesses include exclusion of patients with pacemakers and 
implanted defibrillators, long scan-time (20-25 min), 3D post-processing time 
(up to 45 min) and less availability of MRI-scanners.  
Up to now, the technique has evolved a lot, and many studies have been 
published, comparing different approaches of CMRA, new software 
implementations, protocol optimisation or new equipment with catheter-
based CA. In 2004, Danias et al. [157] performed a meta-analysis of all 
available studies, at that time, comparing CMRA  and catheter-based CA. 
They concluded that the sensitivity of CMRA is moderately high (73%) and 
that the technique has satisfactory negative predictive value for excluding 
significant major epicardial coronary artery stenosis in patients with 
suspected CAD. 
With this technique being in full expansion regarding imaging of the 
coronary arteries, it could possibly provide a diagnostic pre-test for 
exclusion of CAD. Kim et al. [123] also reported possibility for exclusion of 
left-main coronary artery of three-vessel disease by the technique. And 
Prakken et al. described the evolution from multiple breathhold thin slab 
acquisition to whole heart free-breathing balanced turbo field echo  [158].  
However, even within these recent developments, the diagnostic accuracy of 
CMRA for detection of significant stenosis in coronary arteries is still 
suboptimal [124, 143, 158]. This and other drawbacks, with some of them 
mentioned above, are still to overcome and make the procedure difficult to 
implement in clinical environment at the moment.  
4.8 Future Prospects 
As radiation risks related to IC both on adult and paediatric populations are 
characterized now as accurate as possible, the priority for the future is 
practical implementation of dose monitoring and dose reduction. Possible 
measures to take for reducing probability of radiation induced injuries and 
cancer are clearly summarized in this work. In October 2006, the Federal 
Agency for Nuclear Control (Belgium) enacted an advisory regarding 
‘Patient Dosimetry in Medicine’ [159]. With respect to high-dose 
 166 
examinations as IC both on adults and children, a three-yearly extended 
inventory of patient dose has to be performed, a calibrated DAP meter has to 
be installed on the system and DAP values have to be saved in patient 
records. Up to now, only recently installed systems, have a DAP meter 
incorporated. Up to now, DAP values are not always included in patients’ 
record in a standardized way.  Once a considerable data set is available, 
annual statistics can be performed with comparison to DRLs. Possible 
corrective actions can be formulated. Thus, practical implementation of all 
regulations and recommendations regarding dose reduction and 
optimization is necessary in the near future. 
Innovative technologies, such as FD as image reception, are now well over 
their teething troubles and have shown good performance in daily practice 
[78, 79, 160]. However, improvement is possible, certainly in low dose rate 
applications, as in fluoroscopy mode. Different improvement strategies have 
already been proposed [81, 82], but up to now, they are not (yet) 
implemented in detectors for clinical daily use. A second topic related to FD 
is optimization towards a better IQ, taken into account the linear signal 
response and a wider dynamic range [161].  As became clear in chapter 3.5 
(publication 5) fine-tuning of the ABC-function is necessary in cinegraphy 
mode. Thirdly, the question regarding long-term reliability, detector 
radiation damage and degradation of IQ and associated replacement costs 
remains open. In the future these aspects have to be followed up and will 
more clearly outline the cost-benefit of these detectors. 
A recent evolution in imaging of coronary arteries, is the shift from 
conventional catheterization techniques towards non-invasive imaging 
techniques as MSCT and MRI [124, 141, 143, 162, 163]. Whereas MSCT shows 
a significantly higher accuracy to detect or exclude significant CAD by 
imaging of atherosclerosis in comparison to MRI, which of the two 
techniques is more likely to be implemented in the diagnostic workup of 
patients with suspected CAD is still a matter of debate [124]. Although 
MSCT has promising features as fast acquisition, sufficient spatial and 
temporal resolution and wide availability, the highest drawback of this 
method is the ‘consuming’ of x-rays. The topic of patient exposure in MSCT, 
all or not combined with therapeutic IC catheterizations as PTCA demands 
further investigation.  Some comparative studies were already performed 
between MSCT and conventional CA [147, 164] and did not show a lowering 
or even an equivalent in dose for MSCT. Some dose reducing techniques are 
possible but tend to be unusable for a considerable fraction of the patients 
[145, 148]. Not only for investigation of atherosclerosis but more explicitly in 
systematic screening of patients the use of MSCT has to be discussed in view 
of the high patient dose. 
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A very promising technology performed with the same x-ray C-arm 
modality as used in conventional standard CA, is rotational x-ray CA. An 
upgrade of the software and steering system of the modality enables 3D 
reconstruction of cardiac structures and vessels. Although in some studies 
DAP-values from conventional CA and from rotational CA have been 
compared, up to now actual skin dose has not been measured. Furthermore, 
this new application seems to get lost in the heated debate with respect to 
coronary CT angiography, although its remarkable advantages comprising 
significant dose and contrast utilization lowering [128-130]. 
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Chapter  5  
Conclusions 
 
Present work deals predominantly with radiation burden to both adults and 
children who underwent IC procedures. In a multicentre study of patient 
skin doses on an adult population, 3% of the procedures exceeded the 
threshold dose for transient erythema (2Gy) in one single procedure.  Given 
this prevalence, skin doses are likely to exceed values much larger than 2 Gy 
in subsequent and difficult interventions on adults with high BMI, even with 
state of the art equipment and by highly experienced cardiologists. 
Measurement of entire skin dose distributions by a grid of TLDs and 
analysis of exposure parameters and dose indicators such as DAP revealed 
the factors associated with high MSD. A method, using DAP action levels for 
interpreting DAP values recorded during IC procedures on adults was 
developed for prediction and follow-up of possible radiation induced skin 
injuries after IC. A value of 250 Gycm2 was proposed for dermatological 
follow up of patients.  Whereas deterministic effects related to the skin are a 
major radiation protection issue with adults, this is not the case for children. 
Median MSD values of 0.2 Gy and 0.5 Gy for diagnostic and therapeutic 
procedures on adults have to be compared with an overall median value of 
0.03 Gy for the paediatric population, being a factor of 10 in difference. 
However, interpretation of registered total cumulative DAP values for 
multiple IC procedures on children in terms of deterministic effects is 
recommended. Values of 100 Gycm2 (armpit) and 175 Gycm2 (back) could 
imply that the 2 Gy threshold for transient erythema has been passed in 
these children. 
Apart from the interpretation of DAP in terms of DAP action levels, DAP 
has also proven to be an operational quantity indicating differences  in 
patient radiation burden between hospitals and correlating well with 
effective dose (E).  Median values for diagnostic and therapeutic procedures 
were 44 Gycm2 and 65 Gycm2 for the adult population and 4.1 Gycm2 and 4.6 
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Gycm2 for the paediatric population, revealing roughly a difference by a 
factor of 10 between the two populations. DRLs for comparison of local 
mean DAP values (adult interventions) of 71 Gycm2 and 106 Gycm2 were 
obtained for diagnostic and therapeutic procedures respectively. These 
values are relatively high in comparison to European levels, resulting from 
the DIMOND III-project. The relative (mean) contribution of fluoroscopy to 
total DAP amounted to 33% and 50% for adult diagnostic and therapeutic 
examinations although a significant larger contribution of cinegraphy to 
total DAP resulted from biplane systems. The same contribution for 
fluoroscopy mode (31% and 55% for diagnostic and therapeutic procedures) 
was found for the paediatric population. 
E, a representative quantity for late stochastic effects, was calculated using 
exposure parameters and showed a very good correlation with DAP. Values 
of 9.6 mSv and 15.3 mSv for the adult population and 4.1 mSv and 4.6 mSv 
for the paediatric population (diagnostic and therapeutic examinations) 
showed a difference by a factor of 2 to 3.  However, risk estimation based on 
ICRP60 age dependent life-time risk factors, revealed a difference by a factor 
of 10. Values of 0.01% and 0.02% for diagnostic and therapeutic 
examinations for an adult population stand against risk factors of 0.1% for 
the very youngest generation (0-1 year) regarding cancer induction 
following IC procedures. The large variety in body mass, length and age of 
the paediatric population required an individual calculation method 
(MCNP), whereas adult E-values were derived by a more standardised way, 
using the standard projections assigned to the clinical protocol and an 
anthropomorphic phantom with the dimensions of an average person 
(PCXMC). The predicting value of DAP in terms of E, was translated into 
conversion factors (CF) that provide a fast and straightforward way of E-
assessment. 
The dose reducing effect of additional copper (Cu) filtration showed up 
throughout this work. A significant lowering of DAP and E was found for 
systems that used optimised an automated filtration insertion. Additional 
filtration in fluoroscopy not only has a positive effect on skin sparing, but 
also reduced total E by 18% for the paediatric population. Besides this 
technical improvement, a number of measures for radiation protection of the 
patient (and related staff dose) can be taken. Reduction of beam on time, 
fully exploitation of all dose reducing techniques on recent imaging 
modalities (pulsed fluoroscopy, last image hold, x-ray stand position 
memory,…), training and education, planning of procedure strategies and 
optimisation of protocols are some of them. With adult population, every 
measure should be taken to avoid high skin doses for critical patients with 
high BMI and difficult lesions. With respect to paediatric population, every 
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recommendation should be followed to lower E and with this the risk for 
cancer induction in these young children. 
Together with a discussion on reliability, cost-benefit balance and possible 
application in different patient populations, the development of new x-ray 
imaging technologies brings along questions about the relationship between 
IQ and dose.  In this work, we focussed on the recent introduction of FD in 
IC. In cinegraphy mode, a significantly better IQ for the same entrance dose 
rate was found for FD, whereas for fluoroscopy mode no difference was 
observed. The imaging performance of FD in cinegraphy mode was 
intrinsically better, in line with the higher detective quantum efficiency. 
However, measurements under daily working conditions (ABC) showed 
that the new modality was optimised rather in terms of IQ than in terms of 
radiation burden. Measurement of patient DAP values lacked significant 
difference for the two systems. With implementation of new modalities, care 
has to be taken that ABC setting take into account as well patient dose as IQ.  
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Appendix 
Recommendations for dose optimisation in IC (chapter 4.5) 
1. Decrease beam-on time ! Do not apply fluoroscopy while changing 
the position of patient, table, tube, collimator or partial thickness 
shields.  
2. Involve the concept of personnel dose with patient dose.  
3. Follow a structured training program in your department. 
4. Save dose indicating parameters, such as DAP, in patient’s record. 
Compare DAP to DAP action levels (interpretation for skin dose) 
and to DRLs (interpretation of general practice).   
5. Diagnostic information should be obtained primarily non-
invasively.  
6. Plan the angiographic projections beforehand. Use the x-ray stand 
position memory-function.  
7. Use automated filter selection-function, preferably with additional 
copper filtration.  
8. Use adapted AEC curves (paediatric patients), with optimized 
parameters in function of image quality.  
9. Maintain x-ray equipment in good repair and calibration, i.e. 
resign it to a periodically Quality Control Check.  
10. Keep the image receptor (IR) as close as possible to the patient 
(and the x-ray tube as far as possible) to minimize skin effects.  
11. Use collimators and partial thickness shields.  
12. Remove unnecessary body parts (or instruments) from the field. 
13. Remove anti-scatter grid when catheterising small children.  
14. Use the lowest acceptable frame rate.  
15. Use the lowest acceptable magnification mode.  
16. Vary the site of the radiation entrance spot. 
17. Perform a test injection under fluoroscopy prior to cinegraphy.  
18. Use roadmap and overlay features.  
19. Take angiograms (cinegraphy-runs) only during inspiration.  
20. Avoid use of steep LAO-projections.  
21. Center the region of interest correctly to the field.  
22. Use last image hold-function. 
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Catheterization of coronary arteries, heart cham-
bers and vessels of the heart, shortly denoted by 
‘interventional cardiology’ in medicine, is highly 
appreciated for its non-invasive character in com-
parison to surgery. Both adults and children can 
benefit of the technique either for diagnosis or 
treatment of heart and coronary specific disorders. 
However, as investigation is performed through dy-
namic x-ray imaging the radiation burden to the 
patient can be important. 
 
This work deals with the incidence of short-term ef-
fects related to the skin dose and long term effects 
such as cancer or tumour induction for adult and 
paediatric populations. It also comprises a com-
parative study between a conventional image in-
tensifier and a recent flat detector, being the new 
technology for image capture in interventional car-
diology. A practical approach is emphasised in this 
work.  
